
<html lang="en"     class="pb-page"  data-request-id="379ac9b2-17ee-471f-bb4f-a1e6453a8e67"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b01812"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles" /></meta><meta name="dc.Creator" content="Juliana&#xA;C. C.  Dallagnol" /></meta><meta name="dc.Creator" content="Elham  Khajehali" /></meta><meta name="dc.Creator" content="Emma T.  van der Westhuizen" /></meta><meta name="dc.Creator" content="Manuela  Jörg" /></meta><meta name="dc.Creator" content="Celine  Valant" /></meta><meta name="dc.Creator" content="Alan G.  Gonçalves" /></meta><meta name="dc.Creator" content="Ben  Capuano" /></meta><meta name="dc.Creator" content="Arthur  Christopoulos" /></meta><meta name="dc.Creator" content="Peter J.  Scammells" /></meta><meta name="dc.Description" content="Targeting allosteric sites at M1 muscarinic acetylcholine receptors is a promising strategy for the treatment of Alzheimer’s disease. Positive allosteric modulators not only may potentiate binding ..." /></meta><meta name="Description" content="Targeting allosteric sites at M1 muscarinic acetylcholine receptors is a promising strategy for the treatment of Alzheimer’s disease. Positive allosteric modulators not only may potentiate binding ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01812" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01812" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01812" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01812" /></link>
        
    
    

<title>Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01812" /></meta><meta property="og:title" content="Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0012.jpeg" /></meta><meta property="og:description" content="Targeting allosteric sites at M1 muscarinic acetylcholine receptors is a promising strategy for the treatment of Alzheimer’s disease. Positive allosteric modulators not only may potentiate binding and/or signaling of the endogenous agonist acetylcholine (ACh) but also may possess direct agonist activity (thus referred to as PAM-agonists). Recent studies suggest that PAM-agonists with robust intrinsic efficacy are more likely to produce adverse effects in vivo. Herein we present the synthesis and pharmacological evaluation of a series of pyrrole-3-carboxamides with a diverse range of allosteric profiles. We proposed structural modifications at top, core, or pendant moieties of a prototypical molecule. Although generally there was a correlation between the degree of agonist activity and the modulatory potency of the PAMs, some derivatives displayed weak intrinsic efficacy yet maintained strong allosteric modulation. We also identified molecules with the ability to potentiate mainly the affinity or both affinity and efficacy of ACh." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01812"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01812">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01812&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01812&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01812&amp;href=/doi/10.1021/acs.jmedchem.7b01812" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2875-2894</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01704" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01803" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M<sub>1</sub> Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Juliana C. C. Dallagnol</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juliana C. C. Dallagnol</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</div><div class="loa-info-affiliations-info">Department of Pharmacy, Federal University of Parana, Avenida Prefeito Lothario Meissner 632, Jardim Botanico, Curitiba, Parana, Brazil</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juliana%0AC.+C.++Dallagnol">Juliana C. C. Dallagnol</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elham Khajehali</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elham Khajehali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences & Department of Pharmacology, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elham++Khajehali">Elham Khajehali</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emma T. van der Westhuizen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emma T. van der Westhuizen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences & Department of Pharmacology, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emma+T.++van+der+Westhuizen">Emma T. van der Westhuizen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manuela Jörg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manuela Jörg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manuela++J%C3%B6rg">Manuela Jörg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Celine Valant</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Celine Valant</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences & Department of Pharmacology, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Celine++Valant">Celine Valant</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alan G. Gonçalves</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alan G. Gonçalves</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Federal University of Parana, Avenida Prefeito Lothario Meissner 632, Jardim Botanico, Curitiba, Parana, Brazil</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alan+G.++Gon%C3%A7alves">Alan G. Gonçalves</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ben Capuano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ben Capuano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Capuano">Ben Capuano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Arthur Christopoulos</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arthur Christopoulos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences & Department of Pharmacology, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</div></div><span class="conrtib-corresp"><strong>*</strong>A.C.: e-mail, <a href="/cdn-cgi/l/email-protection#9afbe8eef2efe8b4f9f2e8f3e9eef5eaf5eff6f5e9daf7f5f4fbe9f2b4fffeef">arthur.c<span class="__cf_email__" data-cfemail="1c746e756f68736c736970736f5c7173727d6f7432797869">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arthur++Christopoulos">Arthur Christopoulos</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Peter J. Scammells</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter J. Scammells</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</div></div><span class="conrtib-corresp"><strong>*</strong>P.J.S.: e-mail, <a href="/cdn-cgi/l/email-protection#4131243524336f3222202c2c242d2d32012c2e2f2032296f242534"><span class="__cf_email__" data-cfemail="59293c2d3c2b772a3a3834343c35352a19343637382a31773c3d2c">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Scammells">Peter J. Scammells</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2930-895X" title="Orcid link">http://orcid.org/0000-0003-2930-895X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01812&amp;href=/doi/10.1021%2Facs.jmedchem.7b01812" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2875–2894</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 15, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 December 2017</li><li><span class="item_label"><b>Published</b> online</span>15 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01812" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01812</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2875%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJuliana%250AC.%2BC.%2BDallagnol%252C%2BElham%2BKhajehali%252C%2BEmma%2BT.%2Bvan%2Bder%2BWesthuizen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D7%26contentID%3Dacs.jmedchem.7b01812%26title%3DSynthesis%2Band%2BPharmacological%2BEvaluation%2Bof%2BHeterocyclic%2BCarboxamides%253A%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BM1%2BMuscarinic%2BAcetylcholine%2BReceptor%2Bwith%2BWeak%2BAgonist%2BActivity%2Band%2BDiverse%2BModulatory%2BProfiles%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2894%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01812"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1224</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01812" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Juliana\nC.&quot;,&quot;last_name&quot;:&quot;C. Dallagnol&quot;},{&quot;first_name&quot;:&quot;Elham&quot;,&quot;last_name&quot;:&quot;Khajehali&quot;},{&quot;first_name&quot;:&quot;Emma&quot;,&quot;last_name&quot;:&quot;T. van der Westhuizen&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;Jörg&quot;},{&quot;first_name&quot;:&quot;Celine&quot;,&quot;last_name&quot;:&quot;Valant&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;G. Gonçalves&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Capuano&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;Christopoulos&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Scammells&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;2875-2894&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01812&quot;},&quot;abstract&quot;:&quot;Targeting allosteric sites at M1 muscarinic acetylcholine receptors is a promising strategy for the treatment of Alzheimer’s disease. Positive allosteric modulators not only may potentiate binding and/or signaling of the endogenous agonist acetylcholine (ACh) but also may possess direct agonist activity (thus referred to as PAM-agonists). Recent studies suggest that PAM-agonists with robust intrinsic efficacy are more likely to produce adverse effects in vivo. Herein we present the synthesis and pharmacological evaluation of a series of pyrrole-3-carboxamides with a diverse range of allosteric profiles. We proposed structural modifications at top, core, or pendant moieties of a prototypical molecule. Although generally there was a correlation between the degree of agonist activity and the modulatory potency of the PAMs, some derivatives displayed weak intrinsic efficacy yet maintained strong allosteric modulation. We also identified molecules with the ability to potentiate mainly the affinity or both affinity&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01812&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01812" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01812&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01812" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01812&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01812" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01812&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01812&amp;href=/doi/10.1021/acs.jmedchem.7b01812" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01812" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01812" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01812%26sid%3Dliteratum%253Aachs%26pmid%3D29544056%26genre%3Darticle%26aulast%3DDallagnol%26date%3D2018%26atitle%3DSynthesis%2Band%2BPharmacological%2BEvaluation%2Bof%2BHeterocyclic%2BCarboxamides%253A%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BM1%2BMuscarinic%2BAcetylcholine%2BReceptor%2Bwith%2BWeak%2BAgonist%2BActivity%2Band%2BDiverse%2BModulatory%2BProfiles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D7%26spage%3D2875%26epage%3D2894%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291631" title="Modulators">Modulators</a>,</li><li><a href="/action/doSearch?ConceptID=291188" title="Cooperativity">Cooperativity</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/jmcmar.2018.61.issue-7/20180412/jmcmar.2018.61.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Targeting allosteric sites at M<sub>1</sub> muscarinic acetylcholine receptors is a promising strategy for the treatment of Alzheimer’s disease. Positive allosteric modulators not only may potentiate binding and/or signaling of the endogenous agonist acetylcholine (ACh) but also may possess direct agonist activity (thus referred to as PAM-agonists). Recent studies suggest that PAM-agonists with robust intrinsic efficacy are more likely to produce adverse effects in vivo. Herein we present the synthesis and pharmacological evaluation of a series of pyrrole-3-carboxamides with a diverse range of allosteric profiles. We proposed structural modifications at top, core, or pendant moieties of a prototypical molecule. Although generally there was a correlation between the degree of agonist activity and the modulatory potency of the PAMs, some derivatives displayed weak intrinsic efficacy yet maintained strong allosteric modulation. We also identified molecules with the ability to potentiate mainly the affinity or both affinity and efficacy of ACh.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a progressive neurodegenerative disorder manifested by the decline of cognitive function including memory, attention, and language. The most recent World Alzheimer Report prevalence study estimated that 47 million people worldwide were suffering from AD in 2015 and further projected that without advances in rational drug therapy, the number of symptomatic cases might reach 131 million by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Dysfunction of cholinergic neurons and deficient acetylcholine (ACh) levels are believed to be the earliest events that trigger the pathology.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> On the basis of these findings, targeting cholinergic receptors is a promising strategy to slow down the disease progression and ameliorate symptoms.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In particular, the M<sub>1</sub> muscarinic acetylcholine receptor (M<sub>1</sub> mAChR) subtype has been linked to the process of cognition, thus considered an attractive therapeutic target.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Consequently, current pharmacotherapy for AD includes acetylcholinesterase inhibitors (i.e., anticholinesterases), which are able to increase the levels of the endogenous orthosteric ligand ACh. Even though these drugs provide some symptomatic relief, they are not well tolerated. The indiscriminate activation of all mAChR subtypes (M<sub>1</sub>–M<sub>5</sub>) leads to significant cholinergic toxicity, typically causing gastrointestinal and cardiovascular adverse effects, which are mainly mediated by activation of the peripheral M<sub>2</sub> and M<sub>3</sub> mAChRs.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For many years researchers had sought to develop M<sub>1</sub> mAChR selective agonists, and despite the numerous efforts in this area, little was achieved.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The recent high resolution crystal structures of the mAChRs<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> confirmed that this approach is unlikely to succeed due to the high homology of the orthosteric binding pocket across all five mAChR subtypes.</div><div class="NLM_p">A new therapeutic opportunity has emerged from targeting the topographically distinct less-conserved allosteric site on M<sub>1</sub> mAChRs which proved to be a fruitful strategy to overcome the lack of receptor subtype selectivity of orthosteric ligands. BQCA (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was the first selective positive allosteric modulator (PAM) of the M<sub>1</sub> mAChR to be described in the literature.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Subsequent to its disclosure a vast range of novel chemotypes was disclosed, and insights into the molecular basis of receptor–ligand interactions<a onclick="showRef(event, 'ref12 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref14 ref15 ref16 ref17">(12,14−17)</a> as well as enriched structure–activity relationship (SAR) studies<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23 ref24">(18−24)</a> have been published. Allosteric molecules may also possess direct agonist activity in their own right and are referred to as “allosteric agonists” if they activate the receptor but do not modulate the orthosteric ligand or as “PAM-agonists” (also “ago-PAMs”) if they possess both positive allosteric modulatory properties and agonism.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Although several M<sub>1</sub> PAM-agonists with aligned physicochemical properties and efficacy in rodent cognitive function models were developed, recent studies reported evidence of cholinergic toxicity associated with highly selective M<sub>1</sub> PAMs.<a onclick="showRef(event, 'ref22 ref23 ref24 ref26'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref26">(22−24,26)</a> The authors suggested that overactivation of the M<sub>1</sub> mAChR, as a result of the direct agonist activity of PAM-agonists, could underlie the AEs. It was therefore hypothesized that pure M<sub>1</sub> PAMs would have improved safety profiles.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of M<sub>1</sub> mAChR PAM-agonists from Merck <b>1</b>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Pfizer <b>2</b>, <b>3</b>, <b>4</b>,<a onclick="showRef(event, 'ref21 ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref24">(21,22,24)</a> and Vanderbilt <b>5</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with the relevant pharmacological data. PAM EC<sub>50</sub> concentrations were obtained using calcium mobilization assays in the presence of a fixed EC<sub>20</sub> concentration of ACh (methodologies may differ slightly). Allosteric agonist EC<sub>50</sub> concentrations (Ago EC<sub>50</sub>) were obtained from concentration–response curves for the modulators in the absence of ACh. τ<sub>B</sub> values represent a measure of the efficacy of the modulators derived from operational model-fitting and were estimated in the present work from IP<sub>1</sub> accumulation assays. NA, not available.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Pfizer published the SAR associated with a series of potent azaindole M<sub>1</sub> mAChR PAM-agonists, with the lead compound being PF-06764427 (<b>2</b>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Shortly after, the same group disclosed a pyridine series (lead compound PF-06767832, <b>3</b>), also reporting in vivo adverse effects for this class of compounds.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A subsequent study reported a series of γ- and δ-lactam PAMs (lead compound PF-06827443, <b>4</b>), structurally related to pyridine derivative <b>3</b>, which, despite displaying less agonist activity, presented adverse effects.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> An independent study by the Vanderbilt Center for Neuroscience Drug Discovery investigated the adverse effect liability of compound <b>2</b> together with their fluorinated indole derivative, VU6004256 (<b>5</b>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> They have reported that <b>5</b> acts as a M<sub>1</sub> mAChR PAM-agonist in vitro and unlike compound <b>2</b> enhances recognition memory without severe behavioral convulsions and peripheral cholinergic effects in rodents. Nonetheless, it was not possible to draw a clear correlation between the subtle structural changes of the studied compounds and their pharmacological and safety profiles.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> It has therefore remained unclear which structural features drive allosteric agonism relative to allosteric modulation or contribute to adverse effect liability.</div><div class="NLM_p">Herein, we report the development of a pyrrole-3-carboxamide series closely related to compound <b>2</b> and detailed pharmacological characterization of selected PAMs in this series. We performed systematic modifications on three different regions (top, core, and pendant, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) of the prototypical molecule <b>6a</b> in order to gain molecular diversity. Representative building blocks were selected to be incorporated in each of the regions of the molecule, which included revisiting some of the moieties used in previous studies by Pfizer<a onclick="showRef(event, 'ref21 ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref24">(21,22,24)</a> and Vanderbilt University.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We have obtained an enriched allosteric SAR profile by dissecting different pharmacological parameters (i.e., binding affinity, <i>K</i><sub>B</sub>; binding and functional cooperativity with ACh, α and αβ, respectively; and direct allosteric agonist efficacy, τ<sub>B</sub>),<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> thus providing new insights into the structural basis of allosteric modulation.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of the representative M<sub>1</sub> mAChR PAM-agonist <b>6a</b>, labeling top, core, and pendant components of the molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our optimization efforts were focused toward the development of M<sub>1</sub> mAChR PAMs with distinct pharmacological properties, in particular PAMs with weak agonist activity. The full pharmacological characterization of six selected PAMs in our series and three literature compounds, in binding and functional assays, indicated that there was no correlation between the binding and functional cooperativity with ACh, suggesting that these PAMs could modulate only the affinity or both affinity and efficacy of ACh. However, there was a significant correlation between the intrinsic efficacy of PAMs and their functional cooperativity with ACh, consistent with a two-state model of action.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">We first synthesized our prototypical compound <b>6a</b>, which consists of a hydroxycyclohexyl top, 1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine core, and a 4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl pendant. The 2-hydroxycyclohexylcarbamoyl motif was first employed in Merck analogues<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and has been present in many M<sub>1</sub> PAMs ever since. It appears to be well tolerated and maintain cooperativity in a range of different scaffolds. The 1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine core (also referred to as 4-azaindole) was maintained in order to preserve the intramolecular hydrogen bond (IMHB) between the fused pyridine nitrogen and the carboxamide hydrogen in some of our analogues. This IMBH was observed in both <sup>1</sup>H NMR and computational torsional energy experiments of <b>2</b>, and it was considered key to preorganize the ligand into a putative bioactive conformation, thus diminishing interaction-energy requirements to a favorable binding.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Finally, the 4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl moiety was chosen as it has been used in a range of M<sub>1</sub> mAChR allosteric ligands (similar to the moiety in the PAM-agonist <b>5</b>) and has been shown to contribute to affinity toward the receptor.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> During the study of structural modifications in certain regions of the molecule, the remaining two other key moieties were kept unaltered allowing a direct comparison with <b>6a</b>.</div><div class="NLM_p">We used a practical two-step synthetic route (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a>), thereby taking advantage of two key disconnection points of prototypical compound <b>6a</b>, namely, the C–N bonds of the carboxamide group and the N-alkylated nitrogen of the azaindole core, to obtain a variety of compounds. A collection of 1<i>H</i>-indole-3-carboxylic acids and related building blocks were commercially available, thus allowing the installation of a variety of amines on the top part of the molecule via amide coupling. N-Alkylation was achieved by nucleophilic substitution by the secondary amine of the core structure with the corresponding benzyl halide pendant. The modifications to the top region included N-substituted homo- or heterocyclic alcohols and their amine bioisosteres as well as acyclic and aromatic amides (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The core modifications were largely based on bicyclic scaffolds related to indole, halogenated bicyclic analogues, and the truncated pyrrole, where the peripheral fused aryl ring was absent (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Finally, for the pendant modifications, we deleted or replaced the <i>N</i>-methylpyrazole moiety at the 4-position of the benzyl group by bioisosteric motifs (oxazole, thiazole) or more simple substituents (−OMe, −COOMe, −COOH, or −CONH<sub>2</sub>) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). These modifications allowed us to explore the structural determinants of the different allosteric features (affinity, cooperativity with ACh, and intrinsic efficacy of PAMs).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route To Obtain a Diverse Range of Top Motifs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCTU, DIPEA, DMF; 21–46% yield; (b) <b>10</b>, K<sub>2</sub>CO<sub>3</sub>, DMF; 58–94% yield; (c) NH<sub>4</sub>OH<sub>(aq)</sub>, MeOH; 38% and 33% yield for <b>7b</b> and <b>7c</b>, respectively; (d) Boc<sub>2</sub>O, DCM/dioxane, 0 °C to rt; 15% yield; (e) TFA, DCM, 0 °C to rt; 67% and 86% yield for <b>6q</b> and <b>6r</b>, respectively; (f) CrO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, H<sub>2</sub>O, acetone, 0 °C to rt; 13% yield. All reactions were conducted overnight at rt unless otherwise stated.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of N,N-Disubstituted Amides and Oxazole Top Motifs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCTU, DIPEA, DMF; 17–25% for <b>14a</b>–<b>d</b> and 30–51% yield for <b>17a</b>–<b>e</b>; (b) <b>10</b>, K<sub>2</sub>CO<sub>3</sub>, DMF; 46–55% for <b>15a</b>–<b>d</b>, 58–98% for <b>18a</b>–<b>e</b>, and 19% yield for <b>21</b>; (c) TFA, DCM, 0 °C to rt; 56% yield; (d) 2-hydroxy-3-butanone, EDC·HCl, DMAP, DMF; <b>19</b> was not isolated; (e) NH<sub>4</sub>OAc, AcOH, 120 °C; 2% yield. All reactions were conducted overnight at rt unless otherwise stated.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route To Obtain a Diverse Range of Core Motifs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCTU, <i>trans</i>-2-aminocyclohexanol <b>7a</b>, DIPEA, DMF; 34–66% yield; (b) <b>10</b>, K<sub>2</sub>CO<sub>3</sub>, DMF; 47–82% yield. All reactions were conducted overnight at rt.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route To Obtain Compounds with a Range of Pendant Motifs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, THF/1 M Na<sub>2</sub>CO<sub>3</sub>, reflux; 70–72% yield; (b) SOCl<sub>2</sub>, DCM, 0 °C to rt; 95% yield; (c) <b>9a</b>, K<sub>2</sub>CO<sub>3</sub>, DMF; 26–83% yield; (d) EtOH/NaOH<sub>(aq)</sub>, reflux; 45% yield; (e) MeOH/NH<sub>4</sub>OH<sub>(aq)</sub>, reflux, 3 d; 32% yield. All reactions were conducted overnight at rt unless otherwise stated.</p></p></figure><div class="NLM_p">The synthesis of N-substituted carboxamides from a variety of primary amines <b>7a</b>–<b>p</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The reaction of <i>trans</i>-2-aminocyclohexanol (<b>7a</b>) and 4-azaindole-3-carboxylic acid (<b>8</b>) using HCTU (2-(6-chloro-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate) as the coupling agent afforded the amide <b>9a</b> in 46% yield. Attempts with different coupling reagents, including HATU (2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and EDC·HCl (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride), produced significantly lower yields of the desired product (29% and 15% yield, respectively). Amides <b>9b</b>–<b>p</b> were obtained from their parent amines <b>7b</b>–<b>p</b> by applying the same methodology used for the synthesis of <b>9a</b>, giving yields ranging from 21% to 45%. Some of the amines were prepared from suitable starting materials or Boc-protected prior to incorporation (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, bottom). The reaction of 3,7-dioxabicyclo[4.1.0]heptane (<b>11</b>) and concentrated ammonium hydroxide aqueous solution resulted in both positional isomers <i>trans</i>-aminotetrahydro-2<i>H</i>-pyranol <b>7b</b> and <b>7c</b> in a 1:1 ratio, which were separable by column chromatography yielding 30% of each isomer. Boc-protected amine <b>7d</b> was prepared using an excess of <i>trans</i>-1,2-diaminocyclohexane <b>12</b> to avoid the doubly protected product. The desired amine <b>7d</b> was obtained in 15% yield after column chromatography.</div><div class="NLM_p">The second step was the N-alkylation to attach the 4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl moiety to intermediates <b>9a</b>–<b>p</b>. The benzyl chloride <b>10</b> was prepared in-house (see <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). We used a convergent synthesis, preparing this moiety prior to the nucleophilic substitution in order to avoid one additional step for the synthesis of each individual analogue. Alternatively, intermediates <b>9a</b>–<b>p</b> would have had to be N-alkylated with bromobenzyl bromide followed by a Suzuki reaction to introduce the pyrazole moiety. The N-alkylations were performed in DMF using potassium carbonate as base obtaining compounds <b>6a</b>–<b>p</b> in good yields from 58% to 94% (except for compound <b>6l</b>). The synthesis of <b>6l</b> afforded two byproducts due to O-alkylation of the phenolic group. The more complex mixture forced us to adopt a different purification strategy, which included the use of preparative HPLC, resulting in a final yield of 18%. Boc-protection was essential for the synthesis of intermediates <b>6d</b> and <b>6i</b> to prevent alkylation of the free amino groups. These derivatives were subsequently subjected to Boc-deprotection (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, bottom) under acidic conditions to give the final compounds <b>6q</b> and <b>6r</b> in good yields. Ketone analogue <b>6s</b> was obtained in 13% yield by oxidation of the hydroxyl group of derivative <b>6j</b> using Jones reagent. The reaction was stopped as soon as byproducts were detected by TLC, even though total consumption of the starting material was not observed at this point. Although alternative oxidizing agents could be considered, ample material was obtained for pharmacological evaluation; therefore optimization of this reaction was not attempted.</div><div class="NLM_p">One of the most promising derivatives of our initial series was the primary amide <b>6m</b>. Therefore, we designed structurally related N,N-disubstituted amides (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Both acyclic <b>13a</b>–<b>d</b> and cyclic <b>16a</b>–<b>e</b> amines were installed using the same approach presented before. Intermediates <b>14a</b>–<b>d</b> (open carbon chains) were obtained in 17–25% yield and <b>17a</b>–<b>e</b> (cyclic analogues) in 30–51% yield. Final compounds <b>15a</b>–<b>d</b> and <b>18a</b>–<b>e</b> were obtained upon N-alkylation of the corresponding amide intermediates (<b>14</b>, <b>17</b>) with the benzyl chloride pendant <b>10</b>. The unprotected piperazine derivative <b>18f</b> was afforded after Boc-deprotection of <b>18e</b> under acid conditions (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). As a bioisostere of <b>6m</b>, compound <b>21</b> was synthesized by functionalizing the carboxylic acid group in <b>8</b> to the corresponding ester in <b>19</b> and then undergoing a cyclocondensation to obtain the oxazole top motif in <b>20</b>. The next step consisted of the introduction of the pendant group to afford <b>21</b>. We failed to obtain the mentioned oxazole compound by reacting carboxamide <b>6m</b> and 2-chloro-3-butanone following literature methodologies.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></div><div class="NLM_p">A smaller series of analogues with modifications on the core region of <b>6a</b> was achieved by attaching the key moieties (<b>7a</b> and <b>10</b>) to commercially available heterocyclic carboxylic acids (<b>22a</b>–<b>e</b>) (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Amide intermediates <b>23a</b>–<b>e</b> were obtained from their corresponding parent carboxylic acids <b>22a</b>–<b>e</b> by applying the same amide coupling conditions used in the synthesis of <b>9a</b>, in yields ranging from 34% to 66%. The benzyl pendant <b>10</b> was installed as described previously. The electronic withdrawing character of the core moiety had the opposite effect on the yields of the N-alkylation since the nucleophile strength depends on the availability of the lone pair of electrons on the aryl-1<i>H</i>-pyrrole nitrogen. As a result, the lowest yields were observed for <b>24c</b> and <b>24d</b> (54% and 47%, respectively), while <b>24b</b> was synthesized in 82% yield.</div><div class="NLM_p last">The final set of compounds shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> possess different benzyl pendants. Benzyl alcohols <b>27a</b> and <b>27b</b> were prepared in-house through Suzuki coupling between 4-bromobenzyl alcohol <b>25</b> and the corresponding 1-methylpyrazole boronic acid pinacol esters. Next, the alcohol was activated using thionyl chloride to give the corresponding substituted benzyl chlorides <b>10</b> (from <b>27a</b>) and <b>28b</b> (from <b>27b</b>). Attempts to produce the benzyl bromide analogue of <b>10</b> were unsuccessful. All classic methodologies of bromination (using hydrogen bromide, phosphorus tribromide, and NBS) failed to yield the expected product or resulted in a complex mixture of products. Benzyl halides <b>28c</b>–<b>g</b> were purchased from commercial suppliers rather than prepared in-house. Compounds <b>29b</b>–<b>g</b> were obtained after N-alkylation of carboxamide <b>9a</b> with the respective benzyl halide <b>28b</b>–<b>g</b>. Final derivatives <b>29h</b> and <b>29i</b> were afforded by hydrolysis or aminolysis of the methyl ester <b>29g</b>, respectively.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pharmacology</h3><div class="NLM_p">We previously established a rational analysis methodology to describe allosterism and provided enriched SAR of BQCA analogues<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> as well as exploring different M<sub>1</sub> PAM chemotypes, 4-phenylpyrphenylpyridinones,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and fused arylpyrimidinones.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This strategy allowed us to correlate chemical modifications to the changes in parameters that describe allosteric modulation and agonism at the M<sub>1</sub> mAChR. Here, we adopted a similar approach to evaluate the allosteric features of our selected heterocyclic carboxamide derivatives.</div><div class="NLM_p">Our initial IP<sub>1</sub> accumulation assays provided a robust method to assess the modulation of ACh response by 41 novel putative M<sub>1</sub> mAChR PAMs at 1 μM and 10 μM. The ability of the novel PAMs to modulate the ACh concentration–response curves was determined by calculating the difference in pEC<sub>50</sub> (ΔpEC<sub>50</sub>) as a surrogate for the cooperativity (αβ), and the increase in baseline (Δbaseline) was used as a surrogate for the intrinsic efficacy (τ<sub>B</sub>) of the test allosteric ligand. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> shows the magnitude of the increase in potency of the ACh concentration–response curve and the elevation in the baseline in the presence of 10 μM test compound compared to ACh alone (ΔpEC<sub>50</sub> vs Δbaseline). In this manner, we could systematically track the chemical modifications yielding distinct pharmacological properties, such as weak intrinsic efficacy (low Δbaseline), while preserving cooperativity (large ΔpEC<sub>50</sub>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of ΔpEC<sub>50</sub> vs Δbaseline for carboxamide variants. Parameters were estimated from ACh concentration–response curves in the presence or absence of 10 μM of each compound in IP<sub>1</sub> accumulation assays in FlpIn CHO cells stably expressing the hM<sub>1</sub> mAChR. Plotted values represent the mean ± SEM of at least three experiments performed in duplicate. ΔpEC<sub>50</sub> = pEC<sub>50</sub> of (ACh + 10 μM compound) – pEC<sub>50</sub> of ACh (basal). Δbaseline = maximal stimulation of (ACh basal +10 μM compound) – maximal stimulation of ACh (basal). ΔpEC<sub>50</sub> was used as a surrogate of functional cooperativity for 10 μM modulator and Δbaseline as a surrogate of its direct agonism at the same concentration. In all graphs <b>1</b>, <b>2</b>, <b>3</b> (in blue) and <b>6a</b> (green) were included as reference compounds. Graphs: (A) plot of N-substituted carboxamides <b>6b</b>–<b>s</b>, top variants; (B) plot of N,N-disubstituted carboxamides <b>15a</b>–<b>d</b>, <b>18a</b>–<b>f</b>, and <b>21</b>, top variants. The estimated ΔpEC<sub>50</sub> and Δbaseline values are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf" class="ext-link">Supporting Information Table S1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A shows the effect of the modifications to the top motif. Compounds <b>6a</b> (2-hydroxyclyclohexyl), <b>6b</b> (2-hydroxytetrahydopyran-3-yl), <b>6c</b> (2-hydroxytetrahydopyran-4-yl), <b>6e</b> (2-hydroxycyclopentyl), <b>6f</b> (1-deoxy-3,6-anhydrogalactitol), <b>6g</b> (cyclohexyl), <b>6h</b> (tetrahydropyranyl), <b>6j</b> (4-hydroxyclohexyl), <b>6k</b> (phenyl), <b>6r</b> (piperidinyl), and <b>6s</b> (4-oxocyclohexyl) displayed varying degrees of cooperativity with ACh but stronger intrinsic efficacy than BQCA (<b>1</b>) when tested at 10 μM, suggesting that the presence of cyclic substituents at the top of the molecule correlates with strong intrinsic efficacy of the allosteric modulator. Compound <b>6l</b> (2-hydroxyphenyl) was an exception to this general phenomenon, displaying low intrinsic efficacy and only weakly potentiating the ACh-mediated IP<sub>1</sub> response. The <sup>1</sup>H NMR spectrum of the compound showed deshielding of the phenolic group, with the −OH signal moving downfield (10.02 ppm), supporting the presence of an additional IMHB. This may impair the activity of <b>6l</b> by increasing the energy required to adopt its bioactive conformation upon the receptor–ligand interaction. Deletion of −OH group as in <b>6k</b> effectively rescued the intrinsic efficacy of the molecule (Δbaseline <b>6l</b>, ∼14%; <b>6k</b>, ∼73%). Interestingly, whereas compound <b>6q</b> (2-aminocyclohexyl top motif) displayed a stronger potentiation of the ACh-mediated IP<sub>1</sub> response, its intrinsic efficacy was significantly lower than that observed for compound <b>6a</b> (2-hydroxycyclohexyl), suggesting that positively charged groups in the top part of the molecule may have an important influence on intrinsic efficacy. The primary carboxamide <b>6m</b> and acyclic N-substituted carboxamide <b>6n</b> and <b>6o</b> also reduced the intrinsic efficacy of the compounds relative to <b>1</b> while maintaining a similar potentiation of the ACh response. However, by the simple addition of a hydroxyl group to the carbon chain, as in <b>6p</b>, the intrinsic efficacy of the molecule was returned to that in the range observed with BQCA (<b>1</b>).</div><div class="NLM_p">The presence of H-bond donors (−OH, −NH) and acceptors (O/N) commonly has a substantial impact on the receptor–ligand interactions, possibly creating (or deleting) interactions within amino acids in the binding site.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In our series, the deletion of the hydroxyl group in compound <b>6a</b> (ΔpEC<sub>50</sub> = 0.44 ± 0.63) resulted in a significant increase in the pEC<sub>50</sub> (compound <b>6g</b>, ΔpEC<sub>50</sub> = 2.55 ± 0.75). This top moiety has never been reported in previous SAR of indoles or azaindoles M<sub>1</sub> mAChR PAMs.<a onclick="showRef(event, 'ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref23">(21,23)</a> However, the presence or absence of hydroxyl groups or −O– or HN– heteroatoms on the cyclohexyl top motif did not have a significant impact on the agonist activity of the derivatives (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). This represents an opportunity to modify physicochemical properties without losing activity. Polyhydroxylated compound <b>6f</b>, for example, is unlikely to cross the BBB (predicted cLogP = 0.177,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> while preferred range for brain penetration is cLogP = 2–4).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Its activity as M<sub>1</sub> mAChR PAM-agonist could therefore be repurposed to treat peripheral disorders in which the M<sub>1</sub> mAChR is involved (e.g., exocrine glands and gut smooth muscle conditions).</div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B shows that addition of an <i>N</i>,N-disubstituted amide to the top part of the molecule, as seen in analogues <b>15a</b>–<b>d</b> and <b>18a</b>–<b>f</b>, decreased the intrinsic efficacy of the compounds when compared to BQCA <b>1</b>. Compounds <b>15a</b> (<i>N</i>,<i>N</i>-dimethyl), <b>15b</b> (<i>N</i>,<i>N</i>-diethyl), <b>15d</b> (<i>N-</i>methyl-<i>N</i>-cyclohexyl), and <b>18b</b> (pyrrolidine) potentiated the ACh response to a similar extent as seen with BQCA <b>1</b> (ΔpEC<sub>50</sub> for <b>1</b>, 1.17 ± 0.34; <b>15a</b>, 0.89 ± 0.09; <b>15b</b>, 1.07 ± 0.12; <b>15d</b>, 1.00 ± 0.17; <b>18b</b>, 0.76 ± 0.12) while having lower intrinsic efficacy. Compound <b>15d</b> also had lower intrinsic efficacy than its monosubstituted counterparts <b>6a</b> and <b>6g</b>. However, the piperidinyl and <i>N</i>-Boc-piperazinyl top motifs (e.g., in <b>18a</b>, <b>18e</b>) resulted in a complete loss of ACh potentiation. Interestingly, the piperazine top motif, as in compound <b>18f</b>, increased the intrinsic efficacy relative to the bioisostere <b>18d</b> (morpholine), while the bioisostere <b>18a</b> (piperidine) remained essentially inactive. The more rigid incorporation of a dimethyloxazole (compound <b>21</b>) was not well tolerated and completely obliterated the intrinsic efficacy and cooperativity with ACh. Overall, the N,N-disubstituted compounds (<b>15</b> and <b>18</b>) proved that the removal of the capacity to form an IMHB by replacing the amide hydrogen with an alkyl chain is not significantly detrimental to the modulation of ACh response and that this modification may contribute to the diminished intrinsic efficacy of these PAMs. However, compounds <b>6m</b>–<b>o</b>, which have the IMHB intact, also showed reduced intrinsic efficacy compared to <b>1</b> and retained strong cooperativity with ACh.</div><div class="NLM_p">In <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, the effects of modifications to the core part of the molecule and the benzyl pendant were explored. Compound <b>6a</b> and other bicyclic scaffolds, <b>24a</b>–<b>d</b>, showed essentially a PAM-agonist profile and were all more potent allosteric agonists than <b>1</b>. Creating a new scaffold by simplification of the azaindole core, as shown in compound <b>24e</b>, caused a dramatic drop in intrinsic efficacy while still maintaining cooperativity with ACh (7-fold potentiation of ACh activity). Similar to the N,N-disubstituted carboxamide series, the absence of a IMHB did not result in a critical decrease in the modulatory effect.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of ΔpEC<sub>50</sub> vs Δbaseline for core and pendant variants. Parameters were estimated from ACh concentration–response curves in the presence or absence of 10 μM of each compound in IP<sub>1</sub> accumulation assays in FlpIn CHO cells stably expressing the hM<sub>1</sub> mAChR. Plotted values represent the mean ± SEM of three experiments performed in duplicate. Plotted values represent the mean ± SEM of at least three experiments performed in duplicate. ΔpEC<sub>50</sub> = pEC<sub>50</sub> of (ACh + 10 μM compound) – pEC<sub>50</sub> of ACh (basal). Δbaseline = maximal stimulation of (ACh basal + 10 μM compound) – maximal stimulation of ACh (basal). ΔpEC<sub>50</sub> was used as a surrogate of functional cooperativity for 10 μM modulator and Δbaseline as a surrogate of its direct agonism at the same concentration. In all graphs <b>1</b>, <b>2</b>, <b>3</b> (in blue) and <b>6a</b> (green) were included as reference compounds. Graphs: (A) plot of compounds <b>24a</b>–<b>e</b>, core variants; (B) plot of compounds <b>29b</b>–<b>i</b>, pendant variants. The estimated ΔpEC<sub>50</sub> and Δbaseline values are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_002.csv" class="ext-link">Supporting Information Table S1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B shows the effects of alterations to the pendant moiety on the intrinsic efficacy and cooperativity of the novel PAMs. The positional isomers 4- and 3-<i>N</i>-methylpyrazole motif, as in compounds <b>6a</b> and <b>29b</b>, had significantly different fold-shift values (ΔpEC<sub>50:</sub> 0.45 ± 0.63 and 2.35 ± 0.30, respectively), consistent with previously published data by Rook and colleagues.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> By replacement of the methylpyrazole motif in <b>6a</b> with an −OMe group (<b>29f</b>), the cooperativity with ACh was decreased while the strong intrinsic efficacy was maintained, in agreement with previously published results by Davoren and colleagues.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Changing the pendant group to an oxazole (compound <b>29c</b>), thiazole (<b>29d</b>), or hydrogen (<b>29e</b>) had minimal overall effects on the cooperativity or intrinsic efficacy of these compounds when compared to <b>1</b>. However, changing the pendant group to a −CONH<sub>2</sub> group (<b>29i</b>) afforded a significant increase in intrinsic efficacy and improved cooperativity with ACh, consistent with our previous findings on other scaffolds.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> In contrast, its bioisosteres <b>29h</b> (−COOH) and <b>29g</b> (−COOMe) had similar cooperativity but lower intrinsic efficacy compared to <b>1</b>.</div><div class="NLM_p">Overall, in search of compounds with improved cooperativity with ACh and reduced intrinsic efficacy compared to the prototypical allosteric modulator BQCA <b>1</b>, compounds <b>6o</b>, <b>15b</b>, <b>15d</b> (top part modified), <b>24e</b> (core modified), and <b>29h</b> (pendant modified), as well as <b>6a</b> and the literature compounds <b>2</b> and <b>3</b> (for comparison), were selected for further pharmacological characterization.</div><div class="NLM_p">To determine the affinity and binding cooperativity of the allosteric modulators with the radiolabeled antagonist, [<sup>3</sup>H]N-methylscopolamine ([<sup>3</sup>H]NMS), at the M<sub>1</sub> mAChR, whole cell equilibrium binding studies were performed. Increasing concentrations of the endogenous agonist, ACh, competed for [<sup>3</sup>H]NMS binding to the M<sub>1</sub> mAChR (p<i>K</i><sub>i</sub> = 5.41 ± 0.08). Compounds <b>1</b>, <b>2</b>, <b>3</b>, and <b>6a</b> also almost completely inhibited [<sup>3</sup>H]NMS binding (i.e., via high negative cooperativity), and their binding affinity (p<i>K</i><sub>B</sub>) values could therefore be estimated from these experiments (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf" class="ext-link">Supporting Information Figure S1A</a>). All the other PAMs tested had no or weak effects in their own right. To determine the binding cooperativities (log α) between ACh and PAMs, increasing concentrations of the modulators were titrated against an EC<sub>20</sub> concentration of ACh (3 μM) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf" class="ext-link">Supporting Information Figure S1B</a>), and the data were analyzed using an allosteric ternary complex model (<a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>, <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The binding affinities for <b>6o</b>, <b>15b</b>, <b>15d</b>, <b>24e</b>, and <b>29h</b> were also obtained from these analyses (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding and Functional Allosteric Parameters for Selected Carboxamides and Literature Compounds at the M<sub>1</sub> mAChR<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0010.gif" alt="" id="GRAPHIC-d94e1822-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">radioligand binding ([<sup>3</sup>H]NMS)</th><th class="rowsep1 colsep0" colspan="2" align="center">IP<sub>1</sub> accumulation</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>B</sub></th><th class="colsep0 rowsep0" align="center">log α′ <a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">log α (α)<a class="ref internalNav" href="#t1fn4" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">log αβ (αβ)<a class="ref internalNav" href="#t1fn5" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">log τ<sub>B</sub> (τ<sub>B</sub>)<a class="ref internalNav" href="#t1fn6" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">5.48 ± 0.09<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–0.91 ± 0.12</td><td class="colsep0 rowsep0" align="left">1.58 ± 0.09 (38.0)</td><td class="colsep0 rowsep0" align="left">1.44 ± 0.10 (27.5)</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.05 (2.09)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">6.41 ± 0.05*<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–1.28 ± 0.05</td><td class="colsep0 rowsep0" align="left">1.52 ± 0.08 (33.1)</td><td class="colsep0 rowsep0" align="left">1.94 ± 0.10 (87.1)*</td><td class="colsep0 rowsep0" align="left">1.12 ± 0.03 (13.2)*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">6.20 ± 0.04*<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–1.32 ± 0.12</td><td class="colsep0 rowsep0" align="left">1.71 ± 0.08 (51.3)</td><td class="colsep0 rowsep0" align="left">1.97 ± 0.08 (93.3)*</td><td class="colsep0 rowsep0" align="left">1.02 ± 0.03 (10.5)*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">5.92 ± 0.09*<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–1.35 ± 0.28</td><td class="colsep0 rowsep0" align="left">1.66 ± 0.07 (45.7)</td><td class="colsep0 rowsep0" align="left">2.66 ± 0.07 (457)*<sup>,†</sup></td><td class="colsep0 rowsep0" align="left">1.36 ± 0.03 (22.9)*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6o</b></td><td class="colsep0 rowsep0" align="left">4.61 ± 0.02*<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">1.55 ± 0.09 (35.5)</td><td class="colsep0 rowsep0" align="left">2.19 ± 0.05 (155)*<sup>,†</sup></td><td class="colsep0 rowsep0" align="left">0.56 ± 0.04 (3.63)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">4.43 ± 0.09*<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">–0.11 ± 0.04</td><td class="colsep0 rowsep0" align="left">1.28 ± 0.06 (19.0)</td><td class="colsep0 rowsep0" align="left">1.34 ± 0.08 (21.9)</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15d</b></td><td class="colsep0 rowsep0" align="left">4.91 ± 0.09*<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">1.23 ± 0.07 (17.0)*</td><td class="colsep0 rowsep0" align="left">1.73 ± 0.07 (53.7)<sup>,†</sup></td><td class="colsep0 rowsep0" align="left">–0.24 ± 0.11 (0.57)*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24e</b></td><td class="colsep0 rowsep0" align="left">4.19 ± 0.06*<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">–0.05 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.81 ± 0.08 (64.6)</td><td class="colsep0 rowsep0" align="left">2.06 ± 0.11 (115)*</td><td class="colsep0 rowsep0" align="left">0.52 ± 0.09 (3.31)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29h</b></td><td class="colsep0 rowsep0" align="left">4.63 ± 0.20*<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">–0.26 ± 0.15</td><td class="colsep0 rowsep0" align="left">1.76 ± 0.12 (57.5)</td><td class="colsep0 rowsep0" align="left">1.97 ± 0.06 (93.3)*</td><td class="colsep0 rowsep0" align="left">0.46 ± 0.04 (2.88)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean ± SEM of at least four individual experiments in duplicate. *Significant difference (<i>p</i> < 0.05) was determined using one-way ANOVA with Dunnett’s post-test compared to <b>1</b> as the reference PAM. <sup>†</sup>Significant difference (<i>p</i> < 0.05) between log α and log αβ values for each compound was determined using unpaired <i>t</i> test.</p></div><div class="footnote" id="t1fn1"><sup><sup>b</sup></sup><p class="last">Values were estimated from one way competition with [<sup>3</sup>H]NMS.</p></div><div class="footnote" id="t1fn2"><sup><sup>c</sup></sup><p class="last">Values were estimated from competition with [<sup>3</sup>H]NMS in the presence of an EC<sub>20</sub> concentration of ACh. For compound <b>1</b>, <b>2</b>, <b>3</b>, and <b>6a</b>, the log α′ with [<sup>3</sup>H]NMS was fixed to the value obtained in footnote <i>b</i>, for all other ligands was fixed to 0.</p></div><div class="footnote" id="t1fn3"><sup><sup>d</sup></sup><p class="last">Binding cooperativity with [<sup>3</sup>H]NMS.</p></div><div class="footnote" id="t1fn4"><sup><sup>e</sup></sup><p class="last">Binding cooperativity with ACh.</p></div><div class="footnote" id="t1fn5"><sup><sup>f</sup></sup><p class="last">Functional cooperativity with ACh. For compound <b>1</b>, <b>2</b>, <b>3</b>, and <b>6a</b>, p<i>K</i><sub>B</sub> was fixed to the value obtained in footnote <i>b</i>, for all other PAMs was fixed to the value obtained in footnote <i>c</i>.</p></div><div class="footnote" id="t1fn6"><sup><sup>g</sup></sup><p class="last">Intrinsic efficacy of the modulator.</p></div></div></div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the binding affinities were improved for <b>2</b>, <b>3</b>, and our prototypical PAM <b>6a</b> (2-hydroxycyclohexyl top motif) compared to BQCA <b>1</b>. However, modifications to the core, top, and pendant motif of <b>6a</b> reduced affinities of PAMs at the M<sub>1</sub> mAChR. Davoren and co-workers<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> have proposed that the π–π interactions between the azaindole core and Trp400 and Tyr179 residues are important to the overall potency of this class of compounds. Similarly, interaction between the heterocycle at the 4-position of the benzyl pendant is supposed to be key for eletrostatic and π interactions within a tyrosine and aromatic pocket. However, no information about the relevance of the hydroxycyclohexyl top moiety interactions within the allosteric pocket is available in the literature. Interestingly, all PAMs tested in our work, except for <b>15d</b>, displayed similar binding cooperativities with ACh, as seen by BQCA <b>1</b>, although having lower affinities.</div><div class="NLM_p">To investigate the effects of selected PAMs on receptor function, concentration–response curves for ACh-stimulated IP<sub>1</sub> accumulation were generated in the absence or presence of increasing concentrations of the test compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>). An operational model of allosterism and agonism was applied to estimate their intrinsic efficacy (τ<sub>B</sub>) and functional cooperativity with ACh (αβ). The binding affinities were fixed to the values obtained in the binding studies, shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Consistent with previously published data,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> we observed approximately 5-fold increase in intrinsic efficacy of <b>2</b> and <b>3</b> compared to <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, in contrast to previous studies,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> where <b>3</b> displayed lower agonism than <b>2</b> (Ago EC<sub>50</sub> is 590 nM for <b>2</b> and 3900 nM for <b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), we obtained similar τ<sub>B</sub> values for these compounds. In our series, the two N,N-disubstituted carboxamides (<b>15b</b> and <b>15d</b>) displayed the weakest intrinsic efficacy, whereas the agonist activity of only <b>6a</b> was increased compared to <b>1</b>.</div><div class="NLM_p">Interestingly, unlike the binding cooperativities, the functional cooperativities of all the PAMs tested, except for <b>15b</b> and <b>15d</b>, were significantly increased compared to <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The log αβ values for compounds <b>6a</b>, <b>6o</b>, and <b>15d</b> were significantly higher than the log α values, whereas for all other PAMs tested there were no significant differences between log α and log αβ values, suggesting that the modulation of ACh signaling by these PAMs is mainly derived from their binding cooperativity. Overall, there was no significant correlation between the log α and log αβ values (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), indicating that the differences are not solely due to the different experimental conditions in binding and IP<sub>1</sub> accumulation assays. Compounds <b>6a</b>, <b>6o</b>, and <b>15d</b> may therefore modulate both the affinity and efficacy of ACh, whereas compounds <b>1</b>, <b>2</b>, <b>3</b>, <b>15b</b>, <b>24e</b>, and <b>29h</b> may act as only affinity modulators.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Correlation analysis of the binding and functional parameters for the selected PAMs at the M<sub>1</sub> mAChR: (A) no significant correlation between binding cooperativity (α) estimates from whole cell radioligand binding assays and functional cooperativity (αβ) estimates from IP<sub>1</sub> accumulation assays; (B) significant correlation between functional cooperativity and intrinsic efficacy (τ<sub>B</sub>) values estimated from IP<sub>1</sub> accumulation assays. The solid line is the line of best fit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As it was suggested by Alt and co-workers,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> M<sub>1</sub> PAMs with weak agonist activity and appreciable potentiation of ACh response might have better in vivo safety profiles by fine-tuning native receptor signaling. Our previous studies demonstrate that generally the magnitude of ACh potentiation by an allosteric modulator (αβ) is correlated to an increase in the intrinsic efficacy (τ<sub>B</sub>) of the PAM. However, particular structural modifications can tune specifically one of the allosteric features over the other.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> The results of the present study also show a direct correlation between log τ<sub>B</sub> and log αβ (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B), consistent with a two-state model of action, where the functional cooperativity of a PAM tracks with the degree of orthosteric agonist efficacy and stimulus-response coupling.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Although such a mechanism can result in higher degrees of potentiation for stronger agonists or for more amplified (e.g., downstream) signaling pathways, it does not predict biased modulation. Intriguingly a recent study by Davoren et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> suggested that even M<sub>1</sub> PAMs with weak agonist activity could exhibit cholinergic side effects (lead compound <b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). However, it remains unclear whether this was a chemotype-specific effect since the fused lactam ring in <b>4</b> is solely a covalent formalization of the IMHB present in <b>3</b>.</div><div class="NLM_p last">Notably, a fluorinated indole derivative <b>5</b>, which potentially lacks the IMHB, typically present on structural related compounds (as seen in <b>2</b>), was reported to display stronger modulatory effects than direct agonist activity. Although the extirpation of the IMHB in our series also resulted in compounds with lower τ<sub>B</sub> values, further studies are required to link structural features of M<sub>1</sub> PAMs to their in vivo profile.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we reported the synthesis and optimization of the PAM activity of azaindole, indole, and pyrrole derivatives inspired by prototypical M<sub>1</sub> PAM-agonist, PF-06764427 (<b>2</b>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and provided a detailed in vitro pharmacological evaluation of selected compounds within our series and three reference M<sub>1</sub> PAMs from the literature, BQCA (<b>1</b>), PF-06764427 (<b>2</b>), and PF-06767832 (<b>3</b>). Although some of the indole and azaindole scaffolds were evaluated in recent studies by Pfizer<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and Vanderbilt University,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> we were able to obtain a series of compounds bearing a wider range of structural modifications. Typically, the 2-hydroxyclyclohexyl (as in <b>6a</b>) and 2-hydroxytetrahydopyran-3-yl motifs (as in <b>6b</b>) are present in the structure of several M<sub>1</sub> mAChR PAM-agonists; here we have demonstrated that many other cyclic motifs, such as the cyclohexyl as in <b>6g</b>, the bulky polyhydroxylated furanoside as in <b>6f</b>, and the aromatic phenyl group as in <b>6k</b>, are tolerated on the top part of the molecule without suffering significant changes to the allosteric effects. This represents an exceptional opportunity to optimize physicochemical properties and to link structural features to pharmacological parameters and ultimately to in vivo response profiles of the M<sub>1</sub> PAMs.</div><div class="NLM_p">We showed that unprecedented modifications, such as the substitution of the amide hydrogen by short alkyl chains (as in <b>15b</b>, <b>15d</b>) and the deletion of the core fused aryl ring (as in <b>24e</b>), yielded promising PAMs with weak agonist activities. Interestingly, the removal of the cyclic top part (<b>6m</b>–<b>p</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) and the elimination of the IMHB (in <b>15a</b>, <b>15b</b>, <b>15d</b>, <b>18b</b>, and <b>18c</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) were not too detrimental to the modulatory effect of the M<sub>1</sub> PAMs. Similarly, the deletion of the heteroaromatic nitrogen in the fused pyridine ring, by either replacing it with a carbon (<b>24a</b>–<b>d</b>) or removing the aromatic ring (compound <b>24e</b>), did not affect the modulatory response (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Modifications to the benzyl pendant in the original structure <b>6a</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) provided compounds with diverse pharmacological behaviors. The N,N-disubstituted series stand out with compounds presenting a modulatory effect similar to the reference PAM <b>1</b> but much lower inherent agonism. Compound <b>24e</b> bears a pyrrole core and represents a new scaffold to M<sub>1</sub> PAMs, thus offering a promising lead for future structure–activity studies of this class of compounds.</div><div class="NLM_p last">Our detailed analysis of the allosteric features of selected M<sub>1</sub> PAMs revealed diverse allosteric profiles (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Overall, when compared to the reference molecule <b>1</b>, all the selected compounds but our prototypical PAM <b>6a</b> have lower affinities (p<i>K</i><sub>B</sub>) at the M<sub>1</sub> mAChR; however, except for <b>15d</b>, they all display similar binding cooperativities with ACh (α). Interestingly, all modifications, except N,N-disubstituted carboxamides, which display the weakest intrinsic efficacies (<b>15b</b> and <b>15d</b>), result in higher functional cooperativities with ACh (αβ) when compared to <b>1</b>. The significant difference between log α and log αβ values for <b>6a</b>, <b>6o</b>, and <b>15d</b> indicates that the potentiation of ACh signaling by these PAMs is derived from both modulation of ACh affinity and efficacy, whereas all the other PAMs are mainly affinity modulators. Within our series, only <b>6a</b> has higher intrinsic efficacy compared to <b>1</b>, and generally, the degree of ACh potentiation correlates with the intrinsic efficacy of PAMs, consistent with a two-state model of allosterism. Taken altogether, we suggest compound <b>15d</b> as a promising PAM for future studies as it has appreciable affinity at the M<sub>1</sub> mAChR, functional cooperativity in the same range of the reference PAM <b>1</b> yet possessing significantly lower intrinsic efficacy (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Our detailed pharmacological evaluations provide novel insights into the SAR at the M<sub>1</sub> mAChR, which may aid in predicting in vivo efficacy and AEs liability of M<sub>1</sub> PAMs. However, further studies on more physiologically relevant systems, such as mouse primary culture neurons and pharmacokinetic studies, are needed prior to testing this compound in animal models.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p last">Chemicals and solvents were purchased from standard suppliers and used without further purification. Davisil silica gel (40–63 μm), for flash column chromatography (FCC), was supplied by Grace Davison Discovery Sciences (Victoria, Australia), and deuterated solvents were purchased from Cambridge Isotope Laboratories, Inc. (distributed by Novachem PTY. Ltd., Victoria, Australia). PF-06764427 and PF-06767832 were purchased from Sigma-Aldrich. Reactions were monitored by thin layer chromatography on commercially available precoated aluminum-backed plates (Merck Kieselgel 60 F<sub>254</sub>). Visualization was by examination under UV light (254 and 366 nm). Appropriate staining was carried out using a solution of ninhydrin (in ethanol) to visualize primary and secondary amines. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance Nanobay III 400 MHz Ultrashield Plus spectrometer at 400.13 and 100.62 MHz, respectively. Chemical shifts (δ) were recorded in parts per million (ppm) with reference to the chemical shift of the deuterated solvent. Coupling constants (<i>J</i>) were recorded in Hz and the significant multiplicities described by singlet (s), doublet (d), triplet (t), quadruplet (q), broad (br), multiplet (m), doublet of doublets (dd), and doublet of triplets (dt). Two-dimensional (2D) experiments including HSQC and HMBC where used to assign the compounds only when necessary. LC–MS were run to verify reaction outcome and purity using the following system: Agilent 6120 series single quad coupled to an Agilent 1260 series HPLC; buffers, A, 0.1% formic acid in H<sub>2</sub>O; B, 0.1% formic acid in MeCN;. The gradient was 0–1 min 95% buffer A and 5% buffer B, from 1 to 2.5 min up to 0% buffer A and 100% buffer B, held at this composition until 3.8 min, 3.8–4 min 95% buffer A and 5% buffer B, held until 5 min at this composition. The flow rate was 0.5 mL/min and total run time was 5 min at a Poroshell 120 EC-C18 50 mm × 3.0 mm, 2.7 μm column. Retention times (<i>t</i><sub>R</sub>) are quoted, in minutes, for all final coumpounds. Mass spectra were acquired in positive and negative ion mode with a scan range of 100–1000 <i>m</i>/<i>z</i>. UV detection was carried out at 214 and 254 nm. HRMS analyses were carried out on an Agilent 6224 TOF LC/MS spectrometer coupled to an Agilent 1290 Infinity (Agilent, Palo Alto, CA). Preparative HPLC was performed using an Agilent 1260 infinity coupled with a binary preparative pump and Agilent 1260 FC-PS fraction collector, using Agilent OpenLAB CDS software (revision C.01.04) and an Agilent 7 μm XDB-C8 21.2 mm × 250 mm column. The following buffers were used: buffer A, 0.1% TFA in H<sub>2</sub>O; buffer B, 0.1% TFA in MeCN, with sample being run at a gradient of 5% buffer B to 100% buffer B over 10 min, at a flow rate of 20 mL/min. All screening compounds were of >95% purity.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedure A. Amide Coupling</h3><div class="NLM_p last">A mixture of the carboxylic acid (1.0 equiv) and HCTU (1.2 equiv) in DMF (1 mL) was stirred for 5 min until a homogeneous suspension was observed. A solution of the respective amine (1.2 equiv) and DIPEA (2 equiv) in DMF (1 mL) was added dropwise, and the reaction was stirred overnight at rt. DMF was coevaporated with water and ethanol under reduced pressure at 50 °C. The residue was diluted with 1 M Na<sub>2</sub>CO<sub>3</sub> solution (80 mL) and extracted with EtOAc (3 × 80 mL). The combined organic layers were washed with brine (80 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. Unless stated otherwise stated, the crude products were purified by flash column chromatography.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Procedure B. N-Alkylation</h3><div class="NLM_p last">A mixture of the carboxamide (1 equiv), the respective benzyl halide (1 equiv), and K<sub>2</sub>CO<sub>3</sub> (2 equiv) in DMF (1 mL/0.2 mmol of starting material) was stirred at rt overnight. DMF was coevaporated with water and ethanol under reduced pressure at 50 °C. Unless stated otherwise, crude products were purified by flash column chromatography.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6a</b>)</h3><div class="NLM_p last">Compounds <b>9a</b> (50 mg, 0.19 mmol) and <b>10</b> (40 mg, 0.19 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6a</b> as a white solid (73 mg, 89%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.77 (d, <i>J</i> = 7.7 Hz, 1H), 8.49 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.39 (s, 1H), 8.09 (dd, <i>J</i> = 8.3/1.2 Hz, 1H), 8.08 (s, 1H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.30 (dd, <i>J</i> = 8.3/4.7 Hz, 1H), 7.27 (d, <i>J</i> = 8.2 Hz, 2H), 5.50 (s, 2H), 4.79 (d, <i>J</i> = 5.4 Hz, 1H), 3.84 (s, 3H), 3.77–3.69 (m, 1H), 3.46–3.38 (m, 1H), 2.08–2.00 (m, 1H), 1.92–1.85 (m, 1H), 1.68–1.60 (m, 2H), 1.37–1.20 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.2, 143.5, 143.3, 135.9, 135.4, 134.1, 132.4, 129.8, 127.8, 127.6, 125.4, 122.4, 118.8, 117.2, 109.5, 72.8, 54.4, 50.0, 37.5, 33.7, 31.2, 24.0, 23.6. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub> calcd: 430.2243. Found: 430.2247. LC–MS <i>t</i><sub>R</sub> = 2.99.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>N</i>-((3<i>R</i>,4<i>S</i>)-3-Hydroxytetrahydro-2<i>H</i>-pyran-4-yl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6b</b>)</h3><div class="NLM_p last">Compounds <b>9b</b> (25 mg, 0.10 mmol) and <b>10</b> (20 mg, 0.10 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6b</b> as a white solid (26 mg, 62%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.83 (d, <i>J</i> = 7.4 Hz, 1H), 8.50 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.42 (s, 1H), 8.08 (dd, <i>J</i> = 8.3/1.2 Hz, 1H), 8.06 (s, 1H), 7.80 (s, 1H), 7.51 (d, <i>J</i> = 8.0 Hz, 2H), 7.30 (d, <i>J</i> = 8.0 Hz, 2H), 7.24 (dd, <i>J</i> = 8.3/4.7 Hz, 1H), 5.50 (s, 2H), 5.18 (d, <i>J</i> = 5.4 Hz, 1H), 3.94–3.87 (m, 1H), 3.87–3.78 (m, 5H), 3.52–3.45 (m, 1H), 3.45–3.40 (m, 1H), 3.16–3.10 (m, 1H), 2.12–2.05 (m, 1H), 1.58–1.46 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.0, 144.0, 143.1, 136.5, 136.3, 134.8, 132.7, 129.7, 128.5, 128.2, 125.7, 121.8, 119.8, 117.7, 110.3, 71.6, 69.3, 66.1, 52.2, 50.0, 39.1, 32.3. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>24</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub> calcd: 432.2036. Found: 432.2046. LC–MS <i>t</i><sub>R</sub> = 2.87.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-Hydroxytetrahydro-2<i>H</i>-pyran-3-yl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6c</b>)</h3><div class="NLM_p last">Compounds <b>7c</b> (25 mg, 0.10 mmol) and <b>10</b> (20 mg, 0.10 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6c</b> as a white solid (25 mg, 60%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.85 (d, <i>J</i> = 7.7 Hz, 1H), 8.50 (dd, <i>J</i> = 4.4 Hz, 1H), 8.41 (s, 1H), 8.07 (m, 2H), 7.80 (s, 1H), 7.51 (d, <i>J</i> = 8.0 Hz, 2H), 7.30 (m, 3H), 5.50 (s, 2H), 5.12 (d, <i>J</i> = 5.4 Hz, 1H), 4.01–3.95 (m, 1H), 3.83 (s, 3H), 3.83–3.78 (m, 1H), 3.73–3.66 (m, 1H), 3.53–3.45 (m, 1H), 3.37–3.34 (m, 1H), 2.27–2.17 (m, 1H), 1.97–1.90 (m, 1H), 1.57–1.49 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.3, 144.1, 143.1, 136.5, 136.4, 134.8, 132.7, 129.7, 128.5, 128.3, 125.7, 121.9, 119.9, 117.8, 110.3, 68.3, 68.0, 65.0, 51.8, 50.0, 39.1, 33.4. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>24</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub> calcd: 432.2036. Found: 432.2048. LC–MS <i>t</i><sub>R</sub> = 2.88.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>tert</i>-Butyl(2-(1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamido)cyclohexyl)carbamate (<b>6d</b>)</h3><div class="NLM_p last">Compounds <b>9d</b> (89 mg, 0.25 mmol) and <b>10</b> (51 mg, 0.25 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6d</b> as a colorless oil (97 mg, 74%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 8.94 (d, <i>J</i> = 8.2 Hz, 1H), 8.46 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.03 (s, 1H), 7.68 (s, 1H), 7.57 (dd, <i>J</i> = 8.3/1.2 Hz, 1H), 7.54 (s, 1H), 7.37 (d, <i>J</i> = 8.2 Hz, 2H), 7.10–7.06 (m, 3H), 5.35 (d, <i>J</i> = 7.0, 1H), 5.25 (s, 2H), 3.99–3.90 (m, 1H), 3.88 (s, 3H), 3.50–3.40 (m, 1H), 2.23–2.16 (m, 1H), 2.11–2.04 (m, 1H), 1.78–1.67 (m, 2H), 1.57–1.30 (m, 4H), 1.21 (s, 9H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 529.2.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclopentyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6e</b>)</h3><div class="NLM_p last">Compounds <b>9e</b> (61 mg, 0.25 mmol) and <b>10</b> (51 mg, 0.25 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6e</b> as a white solid (84 mg, 80%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.43 (dd, <i>J</i> = 4.6/0.8 Hz, 1H), 8.13 (s, 1H), 7.81 (dd, <i>J</i> = 8.3/0.8 Hz, 1H), 7.80 (s, 1H), 7.71 (s, 1H), 7.42 (d, <i>J</i> = 8.2 Hz, 2H), 7.17 (dd, <i>J</i> = 8.3/4.6 Hz, 1H), 7.15 (d, <i>J</i> = 8.2 Hz, 2H), 5.33 (s, 2H), 4.22–4.11 (m, 2H), 3.84 (s, 3H), 2.28–2.17 (m, 1H), 2.06–2.96 (m, 1H), 1.88–1.74 (m, 2H), 1.69–1.57 (m, 2H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 165.0, 143.6, 143.2, 135.9, 135.2, 134.0, 132.4, 129.8, 127.8, 127.6, 125.4, 122.3, 118.8, 117.2, 109.2, 77.6, 58.0, 50.0, 37.6, 31.7, 29.7, 20.4. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>24</sub>H<sub>26</sub>N<sub>5</sub>O<sub>2</sub> calcd: 416.2087. Found: 416.2087. LC–MS <i>t</i><sub>R</sub> = 3.00.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-((2<i>R</i>)-2-((3<i>R</i>,4<i>S</i>)-3,4-Dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6f</b>)</h3><div class="NLM_p last">Compounds <b>9f</b> (36 mg, 0.11 mmol) and <b>10</b> (24 mg, 0.11 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6f</b> as a white oil (32 mg, 58%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.40 (d, <i>J</i> = 4.2 Hz, 1H), 8.11 (s, 1H), 7.79 (s, 1H), 7.73 (d, <i>J</i> = 8.0 Hz, 1H), 7.70 (s, 1H), 7.37 (d, <i>J</i> = 8.2 Hz, 2H), 7.10 (m, 3H), 5.29 (s, 2H), 4.14 (br s, 1H), 4.07 (br s, 1H), 4.00–3.94 (m, 2H), 3.85–3.81 (m, 4H), 3.79–3.75 (m, 1H), 3.74–3.72 (m, 1H), 3.62–3.55 (m, 1H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 165.3, 143.6, 143.2, 136.0, 135.3, 134.0, 132.4, 129.7, 127.8, 127.7, 125.4, 122.3, 118.7, 117.2, 109.4, 86.6, 78.8, 77.4, 73.3. 70.1, 50.0, 42.0, 37.6. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>5</sub> calcd: 478.2090. Found: 478.2085. LC–MS <i>t</i><sub>R</sub> = 2.77.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-Cyclohexyl-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6g</b>)</h3><div class="NLM_p last">Compounds <b>9g</b> (61 mg, 0.25 mmol) and <b>10</b> (51 mg, 0.25 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6g</b> as a white solid (68 mg, 66%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 8.85 (d, <i>J</i> = 4.9 Hz, 1H), 8.48 (dd, <i>J</i> = 4.2/1.2 Hz, 1H), 8.08 (s, 1H), 7.71 (s, 1H), 7.59–7.53 (m, 2H), 7.39–7.35 (m, 2H), 7.13–7.07 (m, 3H), 5.29 (s, 2H), 4.08 (br s, 1H), 3.91 (s, 3H), 2.07–1.95 (m, 2H), 1.82–1.73 (m, 2H), 1.65–1.23 (m, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 162.9, 143.7, 143.6, 136.7, 135.2, 133.3, 132.2, 129.6, 127.6, 127.0, 126.3, 122.4, 118.0, 117.1, 111.4, 50.8, 47.4, 47.3, 39.1, 33.3, 33.2, 25.8, 24.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O calcd: 414.2294. Found: 414.2289. LC–MS <i>t</i><sub>R</sub> = 3.00.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6h</b>)</h3><div class="NLM_p last">Compounds <b>9h</b> (25 mg, 0.10 mmol) and <b>10</b> (20 mg, 0.10 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6h</b> as a white solid (26 mg, 63%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 8.96 (d, <i>J</i> = 7.8 Hz, 1H), 8.48 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.08 (s, 1H), 7.71 (s, 1H), 7.60 (dd, <i>J</i> = 8.3/1.2 Hz, 1H), 7.57 (s, 1H), 7.39 (d, <i>J</i> = 8.2 Hz, 2H), 7.20–7.10 (m, 3H), 5.30 (s, 2H), 4.33–4.25 (m, 1H), 4.03–3.97 (m, 2H), 3.91 (s, 3H), 3.61–3.54 (m, 2H), 2.07–2.00 (m, 2H), 1.78–1.67 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 163.2, 143.8, 143.6, 136.7, 135.2, 133.2, 132.9, 129.7, 127.7, 127.0, 126.0, 122.4, 118.2, 117.2, 111.0, 66.8, 66.7, 50.9, 44.8, 44.7, 39.1, 33.3. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>24</sub>H<sub>26</sub>N<sub>5</sub>O<sub>2</sub> calcd: 416.2087. Found: 416.2095. LC–MS <i>t</i><sub>R</sub> = 2.95.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>tert</i>-Butyl 4-(1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamido)piperidine-1-carboxylate (<b>6i</b>)</h3><div class="NLM_p last">Compounds <b>9i</b> (34 mg, 0.10 mmol) and <b>10</b> (20 mg, 0.10 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6i</b> as a light yellow oil (30 mg, 60%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 8.96 (d, <i>J</i> = 7.7 Hz, 1H), 8.46 (dd, <i>J</i> = 4.6/1.2 Hz, 1H), 8.07 (s, 1H), 7.70 (s, 1H), 7.60 (dd, <i>J</i> = 8.3/1.2 Hz, 1H), 7.56 (s, 1H), 7.38 (d, <i>J</i> = 8.2 Hz, 2H), 7.14–7.06 (m, 3H), 5.29 (s, 2H), 4.28–4.20 (m, 1H), 4.05–3.95 (m, 2H), 3.90 (s, 3H), 3.12–3.01 (m, 2H), 2.06–1.98 (m, 2H), 1.65–1.55 (m, 2H), 1.46 (s, 9H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 515.2.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-((1<i>R</i>,4<i>R</i>)-4-Hydroxycyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6j</b>)</h3><div class="NLM_p last">Compounds <b>9j</b> (40 mg, 0.15 mmol) and <b>10</b> (31 mg, 0.15 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 20:1) to afford <b>6j</b> as a white solid (62 mg, 94%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 8.80 (d, <i>J</i> = 7.9 Hz, 1H), 8.44 (dd, <i>J</i> = 4.7/1.1 Hz, 1H), 8.08 (s, 1H), 7.69 (s, 1H), 7.58 (dd, <i>J</i> = 8.4/1.1 Hz, 1H), 7.55 (s, 1H), 7.38 (d, <i>J</i> = 8.2 Hz, 2H), 7.10 (m, 3H), 5.27 (s, 2H), 4.08–3.97 (m, 1H), 3.88 (s, 3H), 3.74–3.64 (m, 1H), 2.50–2.32 (m, 1H), 2.19–2.09 (m, 2H), 2.07–1.98 (m, 2H), 1.52–1.40 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 163.3, 143.7, 143.6, 136.7, 135.4, 133.3, 132.8, 129.7, 127.7, 127.1, 126.0, 122.4, 118.2, 117.2, 111.3, 69.7, 50.8, 47.0, 46.9, 39.0, 34.0, 30.9, 30.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub> calcd: 430.2243. Found: 430.2247. LC–MS <i>t</i><sub>R</sub> = 2.93.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-(4-(1-Methyl-1<i>H</i>-pyrazol-3-yl)benzyl)-<i>N</i>-phenyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6k</b>)</h3><div class="NLM_p last">Compounds <b>9k</b> (15 mg, 0.06 mmol) and <b>10</b> (15 mg, 0.06 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6k</b> as a white solid (16 mg, 64%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.96 (s, 1H), 8.61–8.58 (m, 2H), 8.16 (dd, <i>J</i> = 8.3/1.2 Hz, 1H), 8.08 (s, 1H), 7.81 (s, 1H), 7.77 (d, <i>J</i> = 8.2 Hz, 2H), 7.53 (d, <i>J</i> = 8.2 Hz, 2H), 7.41–7.32 (m, 5H), 7.12–7.07 (m, 1H), 5.55 (s, 2H), 3.83 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 161.6, 144.2, 142.8, 139.4, 137.2, 136.5, 134.7, 132.8, 129.9, 129.2, 128.6, 128.3, 125.7, 123.7, 121.8, 120.4, 119.6, 118.1, 109.9, 50.2, 39.1. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>22</sub>N<sub>5</sub>O calcd: 408.1824. Found: 408.1822. LC–MS <i>t</i><sub>R</sub> = 3.46.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(2-Hydroxyphenyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-3-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6l</b>)</h3><div class="NLM_p last">Compounds <b>9l</b> (35 mg, 0.14 mmol) and <b>10</b> (35 mg, 0.14 mmol) were reacted according to general procedure B. The crude product was purified by preparative HPLC to afford <b>6l</b> as a colorless oil (10 mg, 18%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.96 (s, 1H), 10.02 (s, 1H), 8.56 (s, 1H), 8.54 (dd, <i>J</i> = 4.6/1.2 Hz, 1H), 8.36 (d, <i>J</i> = 7.6 Hz, 1H), 8.13 (dd, <i>J</i> = 8.3/1.2 Hz, 1H), 8.08 (s, 1H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.36–7.28 (m, 3H), 6.92–6.88 (m, 2H), 6.84–6.79 (m, 1H), 5.54 (s, 2H), 3.83 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 161.6, 146.9, 144.2, 142.9, 137.2, 136.5, 134.8, 132.8, 129.7, 128.6, 128.3, 128.0, 127.5, 125.7, 121.8, 120.6, 120.0, 119.5, 118.0, 115.2, 110.7, 50.2, 39.1. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub> calcd: 424.1773. Found: 424.1767. LC–MS <i>t</i><sub>R</sub> = 3.57.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6m</b>)</h3><div class="NLM_p last">Compounds <b>9m</b> (20 mg, 0.12 mmol) and <b>10</b> (24 mg, 0.12 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6m</b> as a white solid (32 mg, 82%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.48 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.38 (s, 1H), 8.23 (d, <i>J</i> = 3.0 Hz, 1H), 8.10–8.04 (m, 2H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.40 (d, <i>J</i> = 3.0 Hz, 1H), 7.31 (d, <i>J</i> = 8.2 Hz, 2H), 7.26 (dd, <i>J</i> = 8.3/4.7 Hz, 1H), 5.49 (s, 2H), 3.83 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.7, 144.1, 143.3, 136.5, 134.8, 132.8, 129.7, 128.6, 128.3, 125.7, 121.8, 119.8, 117.7, 110.6, 50.0, 39.1. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>19</sub>H<sub>18</sub>N<sub>5</sub>O calcd: 332.1511 found: 332.1508. LC–MS <i>t</i><sub>R</sub> = 2.81.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-Methyl-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6n</b>)</h3><div class="NLM_p last">Compounds <b>9n</b> (12 mg, 0.06 mmol) and <b>10</b> (16 mg, 0.06 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6n</b> as a white solid (16 mg, 72%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.59 (q, <i>J</i> = 5.0 Hz, 1H), 8.48 (dd, <i>J</i> = 4.3/0.9 Hz, 1H), 8.39 (s, 1H), 8.07 (m, 2H), 7.80 (s, 1H), 7.51 (d, <i>J</i> = 8.1 Hz, 2H), 7.30 (d, <i>J</i> = 8.1 Hz, 2H), 7.25 (dd, <i>J</i> = 8.4/4.3 Hz, 1H), 5.49 (s, 2H), 3.83 (s, 3H), 2.92 (d, <i>J</i> = 5.0 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.8, 143.9, 143.1, 136.5, 136.1, 134.9, 132.7, 129.7, 128.6, 128.3, 125.7, 121.8, 119.8, 117.7, 110.5, 50.0, 39.1, 25.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>20</sub>H<sub>20</sub>N<sub>5</sub>O calcd: 346.1668 found: 346.1668. LC–MS <i>t</i><sub>R</sub> = 2.87.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-Ethyl-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6o</b>)</h3><div class="NLM_p last">Compounds <b>9o</b> (19 mg, 0.10 mmol) and <b>10</b> (21 mg, 0.10 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 20:1) to afford <b>6o</b> as a white solid (22 mg, 60%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.68 (t, <i>J</i> = 5.7 Hz, 1H), 8.48 (dd, <i>J</i> = 4.7/0.9 Hz, 1H), 8.39 (s, 1H), 8.10–8.06 (m, 2H), 7.80 (s, 1H), 7.51 (d, <i>J</i> = 8.2 Hz, 2H), 7.30 (d, <i>J</i> = 8.2 Hz, 2H), 7.26 (dd, <i>J</i> = 8.4/4.7 Hz, 1H), 5.49 (s, 2H), 3.83 (s, 3H), 3.45–3.37(m, 2H) 1.71 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.1, 144.0, 143.1, 136.5, 136.2, 134.9, 132.7, 129.7, 128.6, 128.3, 125.7, 121.8, 119.8, 117.7, 110.4, 50.0, 39.1, 33.5, 15.8. HRMS <i>m</i>/<i>z</i> [M + H]+ (Q-TOF/ESI) C<sub>21</sub>H<sub>22</sub>N<sub>5</sub>O calcd: 360.1824, found: 360.1825. LC–MS <i>t</i><sub><i>R</i></sub>= 2.97.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(2-Hydroxyethyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6p</b>)</h3><div class="NLM_p last">Compounds <b>9p</b> (25 mg, 0.12 mmol) and <b>10</b> (25 mg, 0.12 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>6p</b> as a colorless oil (31 mg, 69%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.86 (t, <i>J</i> = 5.7 Hz, 1H), 8.49 (dd, <i>J</i> = 4.7/0.8 Hz, 1H), 8.41 (s, 1H), 8.09–8.05 (m, 2H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.30 (d, <i>J</i> = 8.2 Hz, 2H), 7.25 (dd, <i>J</i> = 8.4/4.7 Hz, 1H), 5.49 (s, 2H), 4.84 (t, <i>J</i> = 5.2 Hz, 1H), 3.83 (s, 3H), 3.59–3.54 (m, 2H), 3.51–3.45 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.3, 144.0, 143.1, 136.5, 136.3, 134.9, 132.7, 129.7, 128.5, 128.3, 125.7, 121.8, 119.8, 117.7, 110.5, 60.7, 50.0, 41.5, 39.1. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>21</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub> calcd: 376.1773, found: 376.1779. LC–MS <i>t</i><sub>R</sub> = 2.80.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Aminocyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6q</b>)</h3><div class="NLM_p last">The <i>N</i>-Boc protected intermediate <b>6d</b> (80 mg, 0.15 mmol) was dissolved in DCM (2 mL), cooled in an ice bath, and TFA (200 μL, 10 equiv) was added dropwise. The reaction was stirred at rt overnight. The mixture was then diluted with 1 M NaOH solution (50 mL) and extracted with EtOAc (5 × 50 mL), and the combined organic layers were washed with brine (100 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 20:1) to afford <b>6q</b> as a white solid (44 mg, 67%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.69 (d, <i>J</i> = 8.5 Hz, 1H), 8.50 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.42 (s, 1H), 8.10 (dd, <i>J</i> = 8.4/1.2 Hz, 1H), 8.08 (s, 1H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.32 (d, <i>J</i> = 8.2 Hz, 2H), 7.27 (dd, <i>J</i> = 8.4/4.7 Hz, 1H), 5.50 (s, 2H), 3.84 (s, 3H), 3.72–3.71 (m, 1H), 2.65–2.60 (m, 1H), 2.00–1.85 (m, 2H), 1.70–1.60 (m, 2H), 1.34–1.17 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.3, 144.0, 143.2, 136.5, 136.3, 134.8, 132.7, 129.7, 128.6, 128.3, 125.7, 121.9, 119.8, 117.8, 110.5, 55.0, 54.5, 50.0, 39.1, 34.5, 32.5, 25.1, 24.6. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>29</sub>N<sub>6</sub>O calcd: 429.2403. Found: 429.2404. LC–MS <i>t</i><sub>R</sub> = 2.83.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-<i>N</i>-(piperidin-4-yl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6r</b>)</h3><div class="NLM_p last">The <i>N</i>-Boc protected intermediate <b>6i</b> (20 mg, 0.40 mmol) was dissolved in DCM (2 mL), cooled in an ice bath, and TFA (300 μL, 10 equiv) was added dropwise. The reaction was stirred at rt overnight. The mixture was then diluted with 1 M NaOH solution (50 mL) and extracted with EtOAc (5 × 50 mL), and the combined organic layers were washed with brine (100 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 20:1) to afford <b>6r</b> as a yellow solid (14 mg, 86%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.73 (d, <i>J</i> = 7.7 Hz, 1H), 8.48 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.38 (s, 1H), 8.09–8.04 (m, 2H), 7.79 (s, 1H), 7.49 (d, <i>J</i> = 8.2 Hz, 2H), 7.28 (d, <i>J</i> = 8.2 Hz, 2H), 7.25 (dd, <i>J</i> = 4.7/8.3 Hz, 1H), 5.48 (s, 2H), 4.02–3.92 (m, 1H), 3.82 (s, 3H), 3.03–2.96 (m, 1H), 2.69–2.59 (m, 1H), 1.93–1.84 (m, 2H), 1.47–1.19 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.2, 144.8, 143.9, 137.5, 137.1, 135.6, 133.5, 130.5, 129.3, 129.1, 126.5, 122.6, 120.7, 118.5, 111.1, 50.8, 49.8, 46.5, 45.5, 39.9, 34.0, 30.3. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>24</sub>H<sub>27</sub>N<sub>6</sub>O calcd: 415.2246. Found: 415.2246. LC–MS <i>t</i><sub>R</sub> = 2.75.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-<i>N</i>-(4-oxocyclohexyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>6s</b>)</h3><div class="NLM_p last">Cyclohexanol carboxamide <b>6j</b> (40 mg, 0.10 mmol) was dissolved in acetone (10 mL), cooled in an ice bath, and Jones reagent (20 μL, 0.4 equiv) was added [Jones reagent: 0.5 g of CrO<sub>3</sub>, 0.5 mL of H<sub>2</sub>SO<sub>4</sub>, 1.5 mL of H<sub>2</sub>O]. The reaction was allowed to warm to room temperature and stirred overnight. The mixture was then diluted with water (75 mL) and extracted with CHCl<sub>3</sub> (3 × 75 mL), and the combined organic layers were washed with brine (75 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. This crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>6s</b> as a white solid (5.3 mg, 13%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 9.14 (d, <i>J</i> = 7.0 Hz, 1H), 8.48 (dd, <i>J</i> = 4.6/1.0 Hz, 1H), 8.11 (s, 1H), 7.71 (s, 1H), 7.64 (dd, <i>J</i> = 8.4/1.0 Hz, 1H), 7.57 (s, 1H), 7.42 (d, <i>J</i> = 8.1 Hz, 2H), 7.16–7.12 (m, 3H), 5.32 (s, 2H), 4.60–4.50 (m, 1H), 3.92 (s, 3H), 2.60–2.38 (m, 4H), 2.36–2.28 (m, 2H), 2.07–1.98 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 210.5, 163.3, 144.8, 144.6, 136.7, 135.2, 133.1, 133.0, 129.7, 127.7, 127.0, 126.1, 122.4, 118.3, 117.3, 110.9, 77.2, 76.9, 51.0, 45.2, 39.1, 39.0, 32.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>26</sub>N<sub>5</sub>O<sub>2</sub> calcd: 428.2087. Found: 428.2090. LC–MS <i>t</i><sub>R</sub> = 2.98.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (3<i>S</i>,4<i>R</i>)-4-Aminotetrahydro-2<i>H</i>-pyran-3-ol (<b>7b</b>) and (3<i>S</i>,4<i>S</i>)-3-Aminotetrahydro-2<i>H</i>-pyran-4-ol (<b>7c</b>)</h3><div class="NLM_p last">Neat aqueous ammonium hydroxide (3 mL, 20 equiv) was added to a solution of 3,7-dioxabicyclo[4.1.0]heptane (200 mg, 0.50 mmol) in methanol (6 mL), and the reaction was stirred overnight at rt. Volatiles were removed under reduced pressure and the crude product was purified by FCC (eluent MeOH 100%) to afford <b>7c</b> (first band, <i>R</i><sub><i>f</i></sub> = 0.250, colorless viscous oil, 77 mg, 33%) and <b>7b</b> (second band, <i>R</i><sub><i>f</i></sub> = 0.125, white solid, 90 mg, 38%). Compound <b>7b</b>: <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 3.92–3.83 (m, 2H), 3.45–3.30 (m, 2H), 3.06 (t, <i>J</i> = 10.6 Hz, 1H), 2.62–2.54 (m, 1H), 1.93–1.86 (m, 1H), 1.60–1.49 (m, 1H); <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 72.8, 70.4, 66.4, 53.8, 32.3. Compound <b>7c</b>: <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 3.91–3.82 (m, 2H), 3.45–3.32 (m, 1H), 3.26–3.18 (m, 1H), 3.03 (t, <i>J</i> = 10.6 Hz, 1H), 2.65–2.56 (m, 1H), 1.87–1.80 (m, 1H), 1.52–1.40 (m, 1H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 72.4, 70.4, 65.7, 53.8, 33.0.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>tert</i>-Butyl ((1<i>R</i>,2<i>R</i>)-2-Aminocyclohexyl)carbamate (<b>7d</b>)</h3><div class="NLM_p last">A solution of di-<i>tert</i>-butyl dicarbonate (0.95 g, 4.13 mmol) in DCM (3 mL) was added dropwise to a cold (0 °C) solution of <i>trans</i>-1,2-diaminocyclohexane (1 mL, 8.3 mmol) in dioxane (5 mL) under vigorous stirring. After 30 min the reaction medium was allowed to warm up to rt and then stirred overnight. The volatiles were removed under reduced pressure. The residue was diluted with 1 M Na<sub>2</sub>CO<sub>3</sub> solution (50 mL) and extracted with DCM (5 × 50 mL). The combined organic layers were washed with brine (50 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>7d</b> as a yellow oil (140 mg, 15%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 4.46 (br s, 1H), 3.07 (br s, 1H), 2.29–2.20 (m, 1H), 1.95–1.84 (m, 2H), 1.66–1.60 (m, 2H), 1.45–1.37 (m, 1H), 1.38 (s, 9H), 1.25–0.99 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 156.1, 79.3, 57.6, 55.7, 35.2, 32.9, 28.4, 25.2, 25.0. LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 215.1.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9a</b>)</h3><div class="NLM_p last">4-Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and <i>trans</i>-2-aminocyclohexanol (<b>7a)</b> (86 mg, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9a</b> as a white solid (73 mg, 46%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.46 (dd, <i>J</i> = 4.6/1.3 Hz, 1H), 8.11 (s, 1H), 7.86 (dd, <i>J</i> = 8.2/1.3 Hz, 1H), 7.23 (dd, <i>J</i> = 8.2/4.6 Hz, 1H), 3.92–3.84 (m, 1H), 3.62–3.53 (m, 1H), 2.18–2.06 (m, 2H), 1.80–1.70 (m, 2H), 1.60–1.32 (m, 4H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 260.0.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-((3<i>R</i>,4<i>S</i>)-3-Hydroxytetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9b</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and <i>trans</i>-4-aminotetrahydropuran-3-ol (<b>7b</b>) (86 mg, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9b</b> as a white solid (52 mg, 32%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.48 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.13 (s, 1H), 7.88 (dd, <i>J</i> = 8.2/1.2 Hz, 1H), 7.26 (dd, <i>J</i> = 8.2/4.7 Hz, 1H), 4.12–4.03 (m, 1H), 4.03–3.96 (m, 1H), 3.69–3.63 (m, 1H), 3.58–3.50 (m, 1H), 3.33–3.25 (m, 2H), 2.21–2.14 (m, 1H), 1.76–1.66 (m, 1H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 262.0.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-Hydroxytetrahydro-2<i>H</i>-pyran-3-yl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9c</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and <i>trans</i>-3-aminotetrahydropuran-4-ol (<b>7c</b>) (86 mg, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9c</b> as a colorless oil (25 mg, 23%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.52–8.48 (m, 1H), 8.14 (s, 1H), 7.89–7.86 (m, 1H), 7.30–7.25 (m, 1H), 4.20–4.08 (m, 1H), 4.08–3.98 (m, 1H), 3.94–3.85 (m, 1H), 3.67–3.57 (m, 1H), 3.46–3.38 (m, 1H), 3.35–3.28 (m, 1H), 2.17–2.08 (m, 1H), 1.76–1.66 (m, 1H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 261.9.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl ((1<i>S</i>,2<i>S</i>)-2-(1<i>H</i>-Pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamido)cyclohexyl)carbamate (<b>9d</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and <i>tert</i>-butyl ((1<i>R</i>,2<i>R</i>)-2-aminocyclohexyl)carbamate (<b>7d</b>) (115 mg, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9d</b> as a yellow oil (90 mg, 41%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.47 (dd, <i>J</i> = 4.6/0.8 Hz, 1H), 8.12 (s, 1H), 7.84 (dd, <i>J</i> = 8.2/0.8 Hz, 1H), 7.21 (dd, <i>J</i> = 8.2/4.6 Hz, 1H), 3.92–3.82 (m, 1H), 3.55–3.45 (m, 1H), 2.79 (s, 9H), 2.18–2.08 (m, 1H), 2.05–1.98 (m, 1H), 1.80–1.70 (m, 2H), 1.50–1.32 (m, 4H). <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 359.0</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclopentyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9e</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and <i>trans</i>-2-aminocyclopentanol hydrochloride (<b>7e</b>) (101 mg, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9e</b> as a white solid (68 mg, 45%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.44 (dd, <i>J</i> = 4.7/1.3 Hz, 1H), 8.10 (s, 1H), 7.82 (dd, <i>J</i> = 8.3/1.3 Hz, 1H), 7.18 (dd, <i>J</i> = 8.3/4.7 Hz, 1H), 4.22–4.14 (m, 2H), 2.30–2.21 (m, 1H), 2.08–1.98 (m, 1H), 1.88–1.82 (m, 2H), 1.75–1.65 (m, 2H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 245.9.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-((2<i>S</i>)-2-((3<i>R</i>,4<i>S</i>)-3,4-Dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9f</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and amino-1-deoxy-3,6-<span class="smallcaps smallerCapital">l</span>-anhydrogalactose<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (<b>7f</b>) (77 mg, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by two FCC (eluent 1, EtOAc/MeOH 4:1; eluent 2, DCM/MeOH 100:1 to 10:1) to afford <b>9f</b> as a colorless oil (18 mg, 29% yield). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.46 (d, <i>J</i> = 4.3 Hz, 1H), 8.11 (s, 1H), 7.86 (t, <i>J</i> = 8.2 Hz, 1H), 7.23–7.18 (m, 1H), 4.15–4.10 (m, 1H), 4.12–4.04 (m, 1H), 4.00–3.96 (m, 2H), 3.87–3.79 (m, 1H), 3.80–3.70 (m, 2H), 3.61 (dd, <i>J</i> = 12.3/7.6 Hz, 1H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 308.1.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-Cyclohexyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9g</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and cyclohexylamine (<b>7g</b>) (85 μL, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9g</b> as a yellow oil (60 mg, 40%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.47 (dd, <i>J</i> = 4.3/1.3 Hz, 1H), 8.10 (s, 1H), 7.87 (dd, <i>J</i> = 8.2/1.3 Hz, 1H), 7.25 (dd, <i>J</i> = 8.2/4.3 Hz, 1H), 4.05–3.95 (m, 1H), 2.10–1.96 (m, 2H), 1.85–1.75 (m, 2H), 1.55–1.32 (m, 6H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 244.0.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(Tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9h</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and 4-aminotetrahydropyranol (<b>7h</b>) (83 μL, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9h</b> as a colorless oil (52 mg, 34%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.47 (dd, <i>J</i> = 4.7/1.1 Hz, 1H), 8.12 (s, 1H), 7.89 (dd, <i>J</i> = 8.2/1.1 Hz, 1H), 7.26 (dd, <i>J</i> = 8.2/4.7 Hz, 1H), 4.25–4.35 (m, 1H), 4.04–3.96 (m, 2H), 3.64–3.55 (m, 2H), 2.05–1.97 (m, 2H), 1.80–1.68 (m, 2H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 246.0.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>tert</i>-Butyl 4-(1<i>H</i>-Pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamido)piperidine-1-carboxylate (<b>9i</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and 1-<i>N-</i>Boc-4-aminopiperidine (<b>7i</b>) (148 mg 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9i</b> as a brown oil (86 mg, 40%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.51–8.45 (m, 1H), 8.16–8.12 (m, 1H), 7.92–7.86 (m, 1H), 7.29–7.22 (m, 1H), 4.24–4.14 (m, 1H), 4.05–3.96 (m, 2H), 3.19–3.07 (m, 2H), 2.09–2.00 (m, 2H), 1.67–1.54 (m, 2H), 1.48 (s, 9H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 345.1.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-((1<i>R</i>,4<i>R</i>)-4-Hydroxycyclohexyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9j</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and <i>trans</i>-4-aminocyclohexanol hydrochloride (<b>7j</b>) (112 mg, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9j</b> as a white solid (42 mg, 26%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.45 (dd, <i>J</i> = 4.7/1.3 Hz, 1H), 8.10 (s, 1H), 7.85 (dd, <i>J</i> = 8.2/1.3 Hz, 1H), 7.22 (dd, <i>J</i> = 8.2/4.7 Hz, 1H), 3.94–3.84 (m, 1H), 3.69–3.59 (m, 1H), 2.15–2.05 (m, 2H), 2.06–1.98 (m, 2H), 1.55–1.32 (m, 4H). LRMS <i>m</i>/<i>z</i> [M – H]<sup>−</sup> (TOF ES<sup>+</sup>) 258.0.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-Phenyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9k</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and aniline (<b>7k</b>) (86 μL, 1.5 equiv) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9k</b> as a white solid (58 mg, 40%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.46 (dd, <i>J</i> = 4.6/1.2 Hz, 1H), 8.12 (s, 1H), 7.83 (dd, <i>J</i> = 8.3/1.3 Hz, 1H), 7.66 (d, <i>J</i> = 8.2 Hz, 2H), 7.28 (dt, <i>J</i> = 7.8 Hz, 2H), 7.19 (dd, <i>J</i> = 8.3/4.7 Hz, 1H), 7.03 (t, <i>J</i> = 7.8 Hz, 1H). LRMS <i>m</i>/<i>z</i> [M – H]<sup>+</sup> (TOF ES<sup>+</sup>) 238.1.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(2-Hydroxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9l</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and 2-aminophenol (<b>7l</b>) (101 mg, 1.5 equiv) were reacted according to general procedure A. The crude extract was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:2) to afford <b>9l</b> as a white solid (40 mg, 26%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.45 (br s, 1H), 8.12 (s, 1H), 7.97 (dd, <i>J</i> = 8.0/1.5 Hz, 1H), 7.81 (d, <i>J</i> = 8.2 Hz, 1H), 7.17 (dd, <i>J</i> = 8.0/4.2 Hz, 1H), 6.89–6.77 (m, 3H). LRMS <i>m</i>/<i>z</i> [M – H]<sup>+</sup> (TOF ES<sup>+</sup>) 253.9.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1<i>H</i>-Pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9m</b>)</h3><div class="NLM_p last">A mixture of azaindole-3-carboxylic acid <b>8</b> (81 mg, 0.50 mmol) and HCTU (265 mg, 1.2 equiv) in DMF (1 mL) was stirred for 5 min until a fine homogeneous suspension was observed. Concentrated ammonium hydroxide aqueous solution (28%, 3 equiv) was added dropwise, and the reaction was stirred overnight at rt. The reaction medium was diluted with 1 M Na<sub>2</sub>CO<sub>3</sub> solution (80 mL) and extracted with EtOAc (3 × 80 mL), and the combined organic layers were washed with brine (80 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The crude product was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9m</b> as a white solid (19 mg, 23%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.47 (dd, <i>J</i> = 4.0/0.6 Hz, 1H), 8.14 (s, 1H), 7.86 (dd, <i>J</i> = 8.1/0.6 Hz, 1H), 7.23 (dd, <i>J</i> = 8.1/4.0 Hz, 1H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 162.0.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-Methyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9n</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and methylamine hydrochloride (<b>7n</b>) (50 mg, 0.74 mmol) reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford <b>9n</b> as a white solid (20 mg, 22%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.46 (dd, <i>J</i> = 4.0/0.7 Hz, 1H), 8.10 (s, 1H), 7.86 (dd, <i>J</i> = 8.2/0.7 Hz, 1H), 7.24 (dd, <i>J</i> = 8.2/4.0 Hz, 1H), 3.03 (s, 3H). <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 176.0.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-Ethyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9o</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and ethylamine (<b>7o</b>) (30% in ethanol) (150 μL, 1.6 equiv) reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 20:1) to afford the <b>9o</b> as a yellow oil (25 mg, 22%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.47 (dd, <i>J</i> = 4.0/1.0 Hz, 1H), 8.10 (s, 1H), 7.87 (dd, <i>J</i> = 8.2/1.0 Hz, 1H), 7.23 (dd, <i>J</i> = 8.2/4.0 Hz, 1H), 3.54 (q, <i>J</i> = 7.2 Hz, 2H), 1.30 (t, <i>J</i> = 7.2 Hz, 3H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 190.1.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(2-Hydroxyethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>9p</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and ethanolamine (<b>7p</b>) (60 μL, 1.6 equiv) reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 10:1) to afford <b>9p</b> as a colorless oil (27 mg, 21%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.45 (dd, <i>J</i> = 4.0/1.0 Hz, 1H), 8.10 (s, 1H), 7.85 (dd, <i>J</i> = 8.2/1.0 Hz, 1H), 7.22 (dd, <i>J</i> = 8.2/4.0 Hz, 1H), 3.79 (t, <i>J</i> = 5.6 Hz, 2H), 3.63 (t, <i>J</i> = 5.6 Hz, 2H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 206.1.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-(4-(Chloromethyl)phenyl)-1-methyl-1<i>H</i>-pyrazole (<b>10</b>)</h3><div class="NLM_p last">A solution of <b>27a</b> (1.00 g, 5.30 mmol) in DCM (100 mL) was placed in an ice bath. Thionyl chloride (2 mL, 5.0 equiv) was added dropwise under vigorous stirring. The reaction mixture was allowed to warm to rt and stirred for 1 h. Saturated NaHCO<sub>3</sub> solution (100 mL) was added to the reaction mixture, and the product was extracted with chloroform (3 × 100 mL). The combined organic layers were washed with brine (150 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The crude product was purified by FCC (eluent CHCl<sub>3</sub>) to afford <b>10</b> as a white solid (840 mg, 76%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) 7.75 (s, 1H), 7.60 (s, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 2H), 7.38 (d, <i>J</i> = 8.2 Hz, 2H), 4.59 (s, 2H), 3.93 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) 136.9, 135.4, 132.9, 129.2, 127.0, 125.8, 122.6, 46.2, 39.1. LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 207.0.</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>,<i>N</i>-Dimethyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>14a</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and dimethylamine hydrochloride (76 mg, 1.5 equiv) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 9:1) to afford <b>14a</b> as a white solid (22 mg, 18%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.46 (br s, 1H), 7.94 (br s, 1H), 7.86 (s, 1H), 7.30 (br s, 1H), 3.15 (s, 6H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 190.1.</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>,<i>N</i>-Diethyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>14b</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and diethylamine (100 μL, 1.5 equiv) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 9:1) to afford <b>14b</b> as a white solid (30 mg, 22%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.41 (d, <i>J</i> = 4.2 Hz, 1H), 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 7.82 (s, 1H), 7.22 (dd, <i>J</i> = 4.2/8.2 Hz, 1H), 3.60 (br s, 4H), 1.40–1.10 (m, 6H). LRMS <i>m</i>/<i>z</i> [M – H]<sup>−</sup> (TOF ES<sup>+</sup>) 216.0.</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>,<i>N</i>-Diallyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>14c</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and diallylamine (115 μL, 1.5 equiv) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 9:1) to afford <b>14c</b> as a light yellow oil (25 mg, 18%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.47 (dd, <i>J</i> = 5.2/1.1 Hz, 1H), 8.09 (dd, <i>J</i> = 8.3/1.1 Hz, 1H), 8.00 (s, 1H), 7.39 (dd, <i>J</i> = 8.3/5.2 Hz, 1H), 6.00–5.90 (m, 2H), 5.23 (d, <i>J</i> = 10.0 Hz, 4H), 4.20 (d, <i>J</i> = 5.6 Hz, 4H). LCMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 242.0.</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-Cyclohexyl-<i>N</i>-methyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>14d</b>)</h3><div class="NLM_p last">A mixture of azaindole-3-carboxylic acid (<b>8</b>) (300 mg, 1.85 mmol) and <i>N</i>-methylcyclohexanamine (<b>13d</b>) (314 mL, 2.22 mmol) reacted according to general procedure A. The crude product was purified by FCC (eluent EtOAC 100% → EtOAc/MeOH 8:2) to afford <b>14d</b> as a white solid (82 mg, 17%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.68 (s, 1H), 8.38 (d, <i>J</i> = 3.8 Hz, 1H), 7.86 (s, 1H), 7.82 (dd, <i>J</i> = 8.2/1.5 Hz, 1H), 7.16 (dd, <i>J</i> = 8.2/4.6 Hz, 1H), 4.45–4.21 (m, 0.5H, rotamer), 4.01–3.75 (m, 0.5H, rotamer), 2.90 (s, 3H), 1.84–1.64 (m, 4H), 1.62–1.47 (m, 3H), 1.43–0.77 (m, 3H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 258.0.</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>,<i>N</i>-Dimethyl-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>15a</b>)</h3><div class="NLM_p last">A mixture of <b>14a</b> (22 mg, 0.12 mmol) and <b>10</b> (24 mg, 0.12 mmol) was reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>15a</b> as a white solid (22 mg, 53%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.42 (dd, <i>J</i> = 4.6/1.3 Hz, 1H), 8.13 (s, 1H), 8.07 (s, 1H), 8.00 (dd, <i>J</i> = 8.1/1.3 Hz, 1H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.29 (d, <i>J</i> = 8.2 Hz, 2H), 7.19 (dd, <i>J</i> = 8.1/4.6 Hz, 1H), 5.46 (s, 2H), 3.83 (s, 3H), 3.04 (s, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.8, 143.9, 142.9, 136.5, 135.1, 135.0, 132.7, 128.7, 128.5, 128.3, 125.7, 121.9, 118.9, 117.3, 112.5, 49.8, 39.1, 38.6 (HSQC), 35.2 (HSQC). HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>21</sub>H<sub>22</sub>N<sub>5</sub>O calcd: 360.1824 found: 360.1828. LCMS <i>t</i><sub>R</sub> = 2.80.</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>,<i>N</i>-Diethyl-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>15b</b>)</h3><div class="NLM_p last">A mixture of <b>14b</b> (19 mg, 0.09 mmol) and <b>10</b> (18 mg, 0.09 mmol) was reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>15b</b> as a white solid (19 mg, 55%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.41 (d, <i>J</i> = 4.3 Hz, 1H), 7.90–7.86 (m, 3H), 7.79 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.24–7.18 (m, 3H), 5.46 (s, 2H), 3.90 (s, 3H), 3.60 (br s, 4H), 1.34–1.04 (m, 6H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 166.6, 143.3, 142.5, 136.0, 134.5, 132.7, 132.4, 129.2, 127.8, 127.5, 125.4, 122.4, 118.9, 117.1, 111.6, 49.8, 39.9 (HSQC), 37.5, 16.6 (HSQC). HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>23</sub>H<sub>26</sub>N<sub>5</sub>O calcd: 388.2137, found: 388.2133. LCMS <i>t</i><sub>R</sub> = 2.87.</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>,<i>N</i>-Diallyl-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>15c</b>)</h3><div class="NLM_p last">A mixture of <b>14c</b> (19 mg, 0.08 mmol) and <b>10</b> (16 mg, 0.08 mmol) was reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>15c</b> as a white solid (15 mg, 46%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.44 (dd, <i>J</i> = 4.8/1.2 Hz, 1H), 7.94 (s, 1H), 7.91(s, 1H), 7.90 (dd, <i>J</i> = 8.4/1.2 Hz, 1H), 7.79 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.23–7.19 (m, 3H), 5.92 (br s, 2H), 5.45 (s, 2H), 5.18 (br s, 4H), 4.18 (br s, 4H), 3.90 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 167.1, 143.5, 142.6, 136.0, 134.4, 133.3, 132.4, 130.2 (HSQC), 129.3, 127.8, 127.6, 125.4, 122.4, 118.9, 117.2, 116.6 (HSQC), 110.9, 49.8, 49.5 (HSQC), 37.5. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>26</sub>N<sub>5</sub>O calcd: 412.2137, found: 412.2137. LC–MS <i>t</i><sub>R</sub> = 2.94.</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-Cyclohexyl-<i>N</i>-methyl-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>15d</b>)</h3><div class="NLM_p last">A mixture of <b>14d</b> (50 mg, 0.19 mmol) and <b>10</b> (40 mg, 0.19 mmol) was reacted according to general procedure B. The crude product was purified by FCC (eluent DCM 100% → DCM/MeOH 9:1) followed by trituration with PET to afford <b>15d</b> as a colorless oil (38 mg, 46%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 3.9 Hz, 1H), 8.15–8.04 (m, 2H), 7.99 (dd, <i>J</i> = 8.3/1.3 Hz, 1H), 7.81 (s, 1H), 7.54–7.45 (m, 2H), 7.27 (d, <i>J</i> = 8.0 Hz, 2H), 7.18 (dd, <i>J</i> = 8.3/4.6 Hz, 1H), 5.46 (s, 2H), 4.54–4.11 (m, 1H), 3.84 (s, 3H), 2.91 (s, 3H), 1.85–1.64 (m, 4H), 1.62–1.44 (m, 3H), 1.28–0.79 (m, 3H). <sup>13</sup>C NMR (MeOD-<i>d</i><sub>3</sub>) δ 170.8, 147.2, 146.6, 139.9, 138.5, 137.7, 136.3, 133.2, 131.8, 131.5, 129.4, 126.4, 122.8, 121.1, 115.6, 63.0, 58.0, 53.8, 41.5, 34.4, 33.3, 29.4. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> C<sub>26</sub>H<sub>30</sub>N<sub>5</sub>O calcd: 428.2450; found 428.2444. LCMS <i>t</i><sub>R</sub> = 2.92.</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Piperidin-1-yl(1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)methanone (<b>17a</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and piperidine (91 μL, 1.5 equiv) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 10:1) to afford <b>17a</b> as a white solid (72 mg, 51%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.40 (dd, <i>J</i> = 4.8/1.2 Hz, 1H), 7.90 (dd, <i>J</i> = 8.1/1.2 Hz, 1H), 7.85 (s, 1H), 7.23 (dd, <i>J</i> = 4.8/8.1 Hz, 1H), 3.80–3.45 (m, 4H), 1.80–1.50 (m, 6H). LRMS <i>m</i>/<i>z</i> [M – H]<sup>−</sup> (TOF ES<sup>+</sup>) 230.0.</div></div><div id="sec4_3_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Pyrrolidin-1-yl(1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)methanone (<b>17b</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and pyrrolidine (76 μL, 1.5 equiv) reacted according to general procedure A. The crude product was purified by FCC (eluent EtOAc/MeOH 8:1) to afford <b>17b</b> as a white solid (53 mg, 40%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.41 (dd, <i>J</i> = 4.6/1.2 Hz, 1H), 7.88 (dd, <i>J</i> = 8.1/1.2 Hz, 1H), 7.88 (s, 1H), 7.22 (dd, <i>J</i> = 4.6/8.1 Hz, 1H), 3.70–3.60 (m, 4H), 2.05–1.98 (m, 2H), 1.96–1.88 (m, 2H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 216.0.</div></div><div id="sec4_3_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Azetidin-1-yl(1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)methanone (<b>17c</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (100 mg, 0.62 mmol) and azetidine hydrochloride (87 mg, 1.5 equiv) were reacted according to general procedure A. The crude product was purified by FCC (eluent EtOAc/MeOH 5:1) to afford <b>17c</b> as a white solid (57 mg, 45%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.48 (d, <i>J</i> = 4.4 Hz, 1H), 7.99 (s, 1H), 7.92 (dd, <i>J</i> = 8.4/1.3 Hz, 1H), 7.27 (dd, <i>J</i> = 8.3/4.4 Hz, 1H), 4.45–4.38 (m, 2H), 4.28–4.20 (m, 2H), 2.43–2.34 (m, 2H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 202.0.</div></div><div id="sec4_3_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Morpholino(1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)methanone (<b>17d</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (80 mg, 0.50 mmol) and morpholine (100 μL, 1.2 equiv) were reacted according to general procedure A. The crude product was purified by FCC (eluent EtOAc/MeOH 10:1) to afford <b>17d</b> as a white solid (34 mg, 30%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.42 (d, <i>J</i> = 4.3 Hz, 1H), 7.93 (s, 1H), 7.91 (d, <i>J</i> = 8.1 Hz, 1H), 7.25 (dd, <i>J</i> = 8.1/4.3 Hz, 1H), 3.72 (br s, 8H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>−</sup> (TOF ES<sup>+</sup>) 232.0.</div></div><div id="sec4_3_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>tert</i>-Butyl 4-(1<i>H</i>-Pyrrolo[3,2-<i>b</i>]pyridine-3-carbonyl)piperazine-1-carboxylate (<b>17e</b>)</h3><div class="NLM_p last">Azaindole-3-carboxylic acid (<b>8</b>) (80 mg, 0.5 mmol) and <i>N</i>-Boc piperazine (140 μL, 1.5 equiv) were reacted according to general procedure A. The crude extract was purified by FCC (eluent EtOAc/MeOH 10:1) to afford <b>17e</b> as a white solid (85 mg, 51%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.43 (d, <i>J</i> = 4.2 Hz, 1H), 7.94 (s, 1H), 7.90 (d, <i>J</i> = 8.1 Hz, 1H), 7.26 (dd, <i>J</i> = 8.1/4.2 Hz, 1H), 3.71 (br s, 4H), 3.55 (br s, 4H), 1.48 (s, 9H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>−</sup> (TOF ES<sup>+</sup>) 331.0.</div></div><div id="sec4_3_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)(piperidin-1-yl)methanone (<b>18a</b>)</h3><div class="NLM_p last">Compounds <b>17a</b> (38 mg, 0.17 mmol) and <b>10</b> (36 mg, 0.17 mmol) were reacted according to general procedure B. The crude was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>18a</b> as a white solid (59 mg, 88%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.42 (dd, <i>J</i> = 4.6/1.3 Hz, 1H), 8.12 (s, 1H), 8.07 (s, 1H), 8.00 (dd, <i>J</i> = 8.3/1.3 Hz, 1H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H) 7.29 (d, <i>J</i> = 8.2 Hz, 2H), 7.16 (dd, <i>J</i> = 8.3/4.6 Hz, 1H), 5.45 (s, 2H), 3.83 (s, 3H), 3.54 (br s, 4H), 1.60–1.40 (m, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.2, 143.9, 142.9, 136.5, 135.1, 135.0, 132.7, 128.6, 128.5, 126.3, 125.6, 121.8, 118.8, 117.3, 112.4, 49.8, 39.1, 31.1, 26.2, 24.6. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>24</sub>H<sub>26</sub>N<sub>5</sub>O calcd: 400.2137 found: 400.2136. LC–MS <i>t</i><sub>R</sub> = 2.90.</div></div><div id="sec4_3_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)(pyrrolidin-1-yl)methanone (<b>18b</b>)</h3><div class="NLM_p last">Compounds <b>17b</b> (36 mg, 0.17 mmol) and <b>10</b> (36 mg, 0.17 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>18b</b> as a white solid (64 mg, 98%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.42 (dd, <i>J</i> = 4.6/1.3 Hz, 1H), 8.16 (s, 1H), 8.07 (s, 1H), 7.98 (dd, <i>J</i> = 8.3/1.3 Hz, 1H), 7.81 (s, 1H), 7.50 (d, <i>J</i> = 8.2 Hz, 2H), 7.29 (d, <i>J</i> = 8.2 Hz, 2H), 7.16 (dd, <i>J</i> = 8.3/4.6 Hz, 1H), 5.46 (s, 2H), 3.83 (s, 3H), 3.70–3.61 (m, 2H), 3.53–3.47 (m, 2H), 1.90–1.76 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.1, 143.9, 142.9, 136.5, 135.1, 135.0, 132.7, 128.8, 128.5, 128.2, 125.6, 121.9, 118.8, 117.2, 113.6, 49.8, 48.2, 48.3, 39.1, 26.1, 24.5. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>23</sub>H<sub>24</sub>N<sub>5</sub>O calcd: 386.1981 found: 386.1980. LC–MS <i>t</i><sub>R</sub> = 2.80.</div></div><div id="sec4_3_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Azetidin-1-yl(1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)methanone (<b>18c</b>)</h3><div class="NLM_p last">Compounds <b>17c</b> (13 mg, 0.06 mmol) and <b>10</b> (12 mg, 0.06 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:2) to afford <b>18c</b> as a white solid (21 mg, 95%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.43 (d, <i>J</i> = 4.1 Hz, 1H), 8.25 (s, 1H), 8.07 (s, 1H), 7.98 (d, <i>J</i> = 8.0 Hz, 1H), 7.81 (s, 1H), 7.50 (d, <i>J</i> = 8.2 Hz, 2H), 7.30 (d, <i>J</i> = 8.2 Hz, 2H), 7.18 (dd, <i>J</i> = 8.0/4.1 Hz, 1H), 5.46 (s, 2H), 4.37 (br s, 2H), 4.02 (br s, 2H), 3.83 (s, 3H), 2.27–2.18 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.7, 144.1, 142.9, 136.5, 136.2, 135.0, 132.7, 129.2, 128.6, 128.3, 125.7, 121.8, 118.9, 117.3, 110.8, 52.3, 49.8, 48.2, 39.1, 15.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>22</sub>H<sub>22</sub>N<sub>5</sub>O calcd: 372.1824. Found: 372.1824. LC–MS <i>t</i><sub>R</sub> = 2.75.</div></div><div id="sec4_3_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)(morpholino)methanone (<b>18d</b>)</h3><div class="NLM_p last">Compounds <b>17d</b> (34 mg, 0.14 mmol) and <b>10</b> (20 mg, 0.14 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>18d</b> as a white solid (32 mg, 58%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 4.4 Hz, 1H), 8.20 (s, 1H), 8.08 (s, 1H), 8.02 (d, <i>J</i> = 8.2 Hz, 1H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.30 (d, <i>J</i> = 8.2 Hz, 2H), 7.19 (dd, <i>J</i> = 8.2/4.4 Hz, 1H), 5.46 (s, 2H), 3.83 (s, 3H), 3.69–3.54 (m, 8H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.5, 144.2, 142.6, 136.5, 136.0, 135.0, 132.7, 128.8, 128.5, 128.3, 125.7, 121.8, 119.0, 117.4, 111.5, 79.6, 66.9, 49.8, 39.1. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>23</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub> calcd: 402.1930 found: 402.1931. LC–MS <i>t</i><sub>R</sub> = 3.02.</div></div><div id="sec4_3_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>tert</i>-Butyl 4-(1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carbonyl)piperazine-1-carboxylate (<b>18e</b>)</h3><div class="NLM_p last">Compounds <b>17e</b> (83 mg, 0.25 mmol) and <b>10</b> (52 mg, 0.25 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>18e</b> as a white solid (93 mg, 75%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 4.4 Hz, 1H), 8.20 (s, 1H), 8.08 (s, 1H), 8.01 (d, <i>J</i> = 8.5 Hz, 1H), 7.81 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.31 (d, <i>J</i> = 8.2 Hz, 2H), 7.20 (dd, <i>J</i> = 8.5/4.4 Hz, 1H), 5.47 (s, 2H), 3.83 (s, 3H), 3.57 (br s, 4H), 3.42 (br s, 4H), 1.41 (s, 9H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.5, 154.3, 144.2, 142.7, 136.5, 136.1, 135.0, 132.7, 128.8, 128.6, 128.3, 125.7, 121.8, 119.0, 117.4, 111.6, 79.5, 65.4, 49.8, 39.1, 28.5, 15.6. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>28</sub>H<sub>33</sub>N<sub>6</sub>O<sub>3</sub> calcd: 501.2614 found: 501.2617. LC–MS <i>t</i><sub>R</sub> = 2.83.</div></div><div id="sec4_3_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (1-(4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)(piperazin-1-yl)methanone (<b>18f</b>)</h3><div class="NLM_p last"><i>N</i>-Boc protected intermediate <b>18e</b> (20 mg, 0.04 mmol) was dissolved in DCM (2 mL), cooled in an ice bath, and TFA (30 μL, 10 equiv) was added dropwise. The reaction was stirred overnight at rt. The mixture was then diluted with 1 M NaOH solution (50 mL) and extracted with EtOAc (5 × 50 mL), and the combined organic layers were washed with brine (50 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 20:1 to 1:1) to afford <b>18f</b> as a colorless oil (9 mg, 56%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.42 (d, <i>J</i> = 4.4 Hz, 1H), 8.00 (s, 1H), 7.91 (s, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.77 (s, 1H), 7.51 (d, <i>J</i> = 8.2 Hz, 2H), 7.26 (d, <i>J</i> = 8.2 Hz, 2H), 7.25–7.18 (m, 1H), 5.46 (s, 2H), 3.89 (s, 3H), 3.69 (br s, 4H), 2.88 (br s, 4H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 165.6, 143.6, 142.3, 136.0, 134.4, 134.3, 132.4, 129.3, 127.8, 127.6, 125.4, 122.4, 119.0, 117.2, 110.5, 49.9, 48.4, 45.1, 37.5. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>23</sub>H<sub>25</sub>N<sub>6</sub>O calcd: 401.2090 found: 401.2092. LC–MS <i>t</i><sub>R</sub> = 2.75.</div></div><div id="sec4_3_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 4,5-Dimethyl-2-(1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)oxazole (<b>20</b>)</h3><div class="NLM_p last">To a solution of azaindole-3-carboxylic acid (<b>8</b>) (1.00 g, 6.20 mmol) and 2-hydroxy-3-butanone (1.20 g, 2.2 equiv) in DMF (8 mL) was added EDC·HCl (1.78 g, 1.5 equiv) and DMAP (80 mg, 0.1 equiv). The reaction mixture was stirred at rt for 3 d. The reaction mixture was diluted with saturated NaHCO<sub>3</sub> (200 mL) and extracted with EtOAc (3 × 200 mL), and the combined organic layers were washed with brine (200 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The residue containing <b>19</b> (100 mg) was diluted with acidic acid (1 mL), and ammonium acetate was added (100 mg). The reaction was conducted under reflux for 24 h. The crude productwas diluted with saturated NaHCO<sub>3</sub> (50 mL) and extracted with EtOAc (3 × 50 mL), and the combined organic layers were washed with brine (200 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The crude extract was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 10:1) to afford <b>20</b> as a yellow oil (26 mg, 2%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) 8.50–8.40 (m, 1H), 8.12 (s, 1H), 7.94–7.89 (m, 1H), 7.30–7.22 (m, 1H), 2.36 (s, 3H), 2.14 (s, 3H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 214.0.</div></div><div id="sec4_3_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4,5-Dimethyl-2-(1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-(4-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)oxazole (<b>21</b>)</h3><div class="NLM_p last">Compounds <b>20</b> (16 mg, 0.08 mmol) and <b>10</b> (16 mg, 0.08 mmol) were reacted according to general procedure B. The crude product was purified by preparative HPLC to afford <b>21</b> as a yellow oil (5 mg, 19%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.79 (d, <i>J</i> = 8.8 Hz, 1H), 8.74–8.70 (m, 2H), 7.94 (s, 1H), 7.85–7.78 (m, 1H), 7.79 (s, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.36 (d, <i>J</i> = 8.2 Hz, 2H), 5.70 (s, 2H), 3.90 (s, 3H), 2.38 (s, 3H), 2.21 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 154.4, 142.6, 141.1, 137.7, 136.5, 134.4, 134.3, 132.4, 128.7, 127.8, 127.6, 125.7, 122.4, 121.4, 119.0, 117.2, 102.8, 50.5, 39.1, 11.9, 10.4. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>23</sub>H<sub>22</sub>N<sub>5</sub>O calcd: 384.1824 found: 384.1825. LC–MS <i>t</i><sub>R</sub> = 3.01.</div></div><div id="sec4_3_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1<i>H</i>-indazole-3-carboxamide (<b>23a</b>)</h3><div class="NLM_p last">Indazole-3-carboxylic acid (<b>22a</b>) (100 mg, 0.62 mmol) and <i>trans</i>-aminocyclohexanol <b>7a</b> (86 mg, 0.74 mmol) were reacted according to general procedure A. The crude product was purified by FCC (eluent EtOAc) to afford <b>23a</b> as a white solid (106 mg, 66%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.20 (dt, <i>J</i> = 8.3/0.9 Hz, 1H), 7.54 (dt, <i>J</i> = 8.5/0.9 Hz, 1H), 7.36 (td, <i>J</i> = 8.5/1.1 Hz, 1H), 7.19 (dt, <i>J</i> = 8.0/0.9, 1H), 3.86–3.80 (m, 1H), 3.57–3.48 (m, 1H), 2.10–2.00 (m, 2H), 1.75–1.65 (m, 2H), 1.45–1.25 (m, 4H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 260.1.</div></div><div id="sec4_3_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1<i>H</i>-indole-3-carboxamide (<b>23b</b>)</h3><div class="NLM_p last">Indole-3-carboxylic acid (<b>22b</b>) (100 mg, 0.62 mmol) and <i>trans</i>-aminocyclohexanol <b>7a</b> (86 mg, 0.74 mmol) were reacted according to general procedure A. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:2) to afford <b>23b</b> as a white solid (55 mg, 34%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 8.14–8.08 (m, 1H), 7.95–7.91 (m, 1H), 7.46–7.39 (m, 1H), 7.20–7.12 (m, 2H), 3.85–3.79 (m, 1H), 3.56–3.48 (m, 1H), 2.10–2.02 (m, 2H), 1.79–1.71 (m, 2H), 1.48–1.30 (m, 4H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) found: 259.1.</div></div><div id="sec4_3_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 4-Fluoro-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1<i>H</i>-indole-3-carboxamide (<b>23c</b>)</h3><div class="NLM_p last">4-Fluoro-1<i>H</i>-indole-3-carboxylic acid (<b>22c</b>) (100 mg, 0.62 mmol) and <i>trans</i>-2-aminocyclohexanol (<b>7a</b>) (86 mg, 0.74 mmol) were reacted according to general procedure A. The crude extract was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:2) to afford <b>23c</b> as a white solid (85 mg, 49%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 7.92 (s, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 1H), 7.16 (dd, <i>J</i> = 8.0/5.0 Hz, 1H), 6.89 (dd, <i>J</i> = 13.1/8.0 Hz, 1H), 3.85–3.79 (m, 1H), 3.52–3.44 (m, 1H), 2.20–2.10 (m, 1H), 2.06–1.98 (m, 1H), 1.79–1.71 (m, 2H), 1.48–1.30 (m, 4H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) C<sub>15</sub>H<sub>18</sub>FN<sub>2</sub>O<sub>2</sub> calcd: 277.13. Found: 277.1.</div></div><div id="sec4_3_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 4-Chloro-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1<i>H</i>-indole-3-carboxamide (<b>23d</b>)</h3><div class="NLM_p last">4-Chloro-1<i>H</i>-indole-3-carboxylic acid (<b>22d</b>) (100 mg, 0.62 mmol) and <i>trans</i>-2-aminocyclohexanol (<b>7a</b>) (86 mg, 0.74 mmol) were reacted according to general procedure A. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:2) to afford <b>23d</b> as a white solid (87 mg, 48%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 7.72 (s, 1H), 7.37 (t, <i>J</i> = 4.8 Hz, 1H), 7.14–7.10 (m, 2H), 3.83–3.75 (m, 1H), 3.50–3.44 (m, 1H), 2.18–2.09 (m, 2H), 1.79–1.71 (m, 2H), 1.43–1.28 (m, 4H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 293.1.</div></div><div id="sec4_3_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1<i>H</i>-pyrrole-3-carboxamide (<b>23e</b>)</h3><div class="NLM_p last">Pyrrole-3-carboxylic acid (<b>22e</b>) (69 mg, 0.62 mmol) and <i>trans</i>-2-aminocyclohexanol (<b>7a</b>) (86 mg, 0.74 mmol) were reacted according to general procedure A. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:2) to afford <b>23e</b> as a white solid (56 mg, 43%). <sup>1</sup>Η NMR (CD<sub>3</sub>OD) δ 7.38 (d, <i>J</i> = 1.5 Hz, 1H), 6.73 (dd, <i>J</i> = 2.3 Hz, 1H), 6.58 (dd, <i>J</i> = 2.3/1.5 Hz, 1H), 3.76–3.72 (m, 1H), 3.49–3.43 (m, 1H), 2.08–1.96 (m, 2H), 1.75–1.65 (m, 2H), 1.41–1.26 (m, 4H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 209.1.</div></div><div id="sec4_3_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-indazole-3-carboxamide (<b>24a</b>)</h3><div class="NLM_p last">Compounds <b>23a</b> (50 mg, 0.20 mmol) and <b>10</b> (40 mg, 0.20 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>24a</b> as a white solid (60 mg, 73%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.23 (d, <i>J</i> = 8.1 Hz, 1H), 8.07 (s, 1H), 7.90 (d, <i>J</i> = 8.2 Hz, 1H), 7.82 (d, <i>J</i> = 0.7 Hz, 1H), 7.76 (d, <i>J</i> = 8.5 Hz, 1H), 7.51 (d, <i>J</i> = 8.2 Hz, 2H), 7.45–7.40 (m, 1H), 7.28–7.21 (m, 3H), 5.74 (s, 2H), 3.84 (s, 3H), 3.71–3.62 (m, 1H), 3.52–3.45 (m, 1H), 1.99–1.87 (m, 2H), 1.69–1.58 (m, 2H), 1.39–1.18 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 162.1, 141.1, 138.5, 136.4, 134.8, 132.6, 128.3, 128.2, 127.2, 125.6, 123.0, 122.8, 122.5, 121.9, 110.9, 71.4, 55.2, 52.6, 39.1, 35.1, 31.7, 25.0, 24.6. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub> calcd: 430.2246. Found: 430.2248. LC–MS <i>t</i><sub>R</sub> = 3.26.</div></div><div id="sec4_3_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-indole-3-carboxamide (<b>24b</b>)</h3><div class="NLM_p last">Compounds <b>23b</b> (26 mg, 0.10 mmol) and <b>10</b> (20 mg, 0.10 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>24b</b> as a white solid (35 mg, 82%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.20–8.16 (m, 2H), 8.07 (s, 1H), 7.81 (s, 1H), 7.62–7.49 (m, 4H), 7.24 (d, <i>J</i> = 8.2 Hz, 2H), 7.21–7.11 (m, 2H), 5.42 (s, 2H), 4.66 (d, <i>J</i> = 5.0 Hz, 1H), 3.84 (s, 3H), 3.72–3.63 (m, 1H), 3.45–3.38 (m, 1H), 1.97–1.88 (m, 2H), 1.70–1.60 (m, 2H), 1.32–1.18 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.8, 136.6, 136.5, 135.5, 132.5, 131.4, 128.3, 128.2, 127.3, 125.6, 122.5, 121.9, 121.8, 121.0, 111.2, 111.0, 72.1, 55.0, 49.7, 39.1, 35.0, 32.0, 25.0, 24.6. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>26</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> calcd: 429.2291. Found: 429.2289. LC–MS <i>t</i><sub>R</sub> = 3.23.</div></div><div id="sec4_3_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 4-Fluoro-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-indole-3-carboxamide (<b>24c</b>)</h3><div class="NLM_p last">Compounds <b>23c</b> (85 mg, 0.30 mmol) and <b>10</b> (63 mg, 0.30 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>24c</b> as a white solid (72 mg, 54%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.13 (s, 1H), 8.07 (s, 1H), 7.82 (s, 1H), 7.54–7.48 (m, 3H), 7.42 (d, <i>J</i> = 7.3 Hz, 1H), 7.26 (d, <i>J</i> = 8.2 Hz, 2H), 7.22–7.15 (m, 1H), 6.99–6.92 (m, 1H), 5.46 (s, 2H), 4.77 (d, <i>J</i> = 4.8 Hz, 1H), 3.84 (s, 3H), 3.69–3.62 (m, 1H), 3.46–3.35 (m, 1H), 2.07–1.98 (m, 1H), 1.96–1.87 (m, 1H), 1.72–1.58 (m, 2H), 1.36–1.17 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.4, 157.0 (d, <i>J</i><sub>CF</sub><i>=</i> 245 Hz), 139.5 (d, <i>J</i><sub>CF</sub><i>=</i> 10.9 Hz), 136.5, 135.0, 135.2, 132.5, 128.3, 128.2, 125.6, 123.3 (d, <i>J</i><sub>CF</sub><i>=</i> 8.1 Hz), 121.9, 113.7 (d, <i>J</i><sub>CF</sub><i>=</i> 19.3 Hz), 111.0 (d, <i>J</i><sub>CF</sub><i>=</i> 2.9 Hz), 108.2 (d, <i>J</i><sub>CF</sub><i>=</i> 2.5 Hz), 106.8 (d, <i>J</i><sub>CF</sub><i>=</i> 21.7 Hz), 71.9, 55.2, 49.9, 39.1, 34.5, 31.4, 24.5, 24.2. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>26</sub>H<sub>28</sub>FN<sub>4</sub>O<sub>2</sub> calcd: 447.2196. Found: 447.2201. LC–MS <i>t</i><sub>R</sub> = 3.29.</div></div><div id="sec4_3_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 4-Chloro-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-indole-3-carboxamide (<b>24d</b>)</h3><div class="NLM_p last">Compounds <b>23d</b> (30 mg, 0.10 mmol) and <b>10</b> (20 mg, 0.10 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>24d</b> as a white solid (21 mg, 47%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.07 (s, 1H), 7.92 (s, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 1H), 7.81 (s, 1H), 7.53–7.48 (m, 3H), 7.26 (d, <i>J</i> = 8.1 Hz, 2H), 7.15–7.11 (m, 2H), 5.43 (s, 2H), 4.61 (d, <i>J</i> = 4.6 Hz, 1H), 3.84 (s, 3H), 3.54–3.66 (m, 1H), 3.40–3.33 (m, 1H), 2.01–1.85 (m, 2H), 1.67–1.58 (m, 2H), 1.30–1.15 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.6, 137.5, 136.5, 135.5, 133.3, 132.6, 132.1, 128.4, 128.3, 125.6, 123.5, 123.1, 121.9, 121.6, 113.5, 110.3, 71.8, 55.6, 49.7, 39.1, 34.5, 31.2, 24.6, 24.3. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>26</sub>H<sub>28</sub>ClN<sub>4</sub>O<sub>2</sub> calcd: 463.1901. Found: 463.1896. LC–MS <i>t</i><sub>R</sub> = 3.25.</div></div><div id="sec4_3_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)-1<i>H</i>-pyrrole-3-carboxamide (<b>24e</b>)</h3><div class="NLM_p last">Compounds <b>23e</b> (52 mg, 0.25 mmol) and <b>10</b> (51 mg, 0.25 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>24e</b> as a white solid (51 mg, 54%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.07 (s, 1H), 7.83 (s, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.40–7.35 (m, 2H), 7.20 (d, <i>J</i> = 8.2 Hz, 2H), 6.68 (dd, <i>J</i> = 2.6/0.8 Hz, 1H), 6.50 (dd, <i>J</i> = 2.6/1.6 Hz, 1H), 5.08 (s, 2H), 4.57 (d, <i>J</i> = 5.1 Hz, 1H), 3.85 (s, 3H), 3.58–3.49 (m, 1H), 3.35–3.29 (m, 1H), 1.90–1.77 (m, 2H), 1.65–1.56 (m, 2H), 1.25–1.14 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.3, 136.5, 136.2, 132.5, 128.5, 128.3, 125.6, 123.8, 122.0, 121.9, 120.9, 108.5, 72.1, 54.9, 52.7, 39.1, 35.0, 32.0, 25.0, 24.6. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> calcd: 379.2063. Found: 379.2137. LC–MS <i>t</i><sub>R</sub> = 3.09.</div></div><div id="sec4_3_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (4-(1-Methyl-1<i>H</i>-pyrazol-4-yl)phenyl)methanol (<b>27a</b>)</h3><div class="NLM_p last">A solution of 4-bromobenzyl alcohol (<b>25</b>) (1.0 g, 5.30 mmol) and 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>26a</b>) (8.00 mmol) in 40 mL of degassed THF/1 M Na<sub>2</sub>CO<sub>3</sub> 3:1 was flushed with nitrogen. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (373 mg, 0.1 equiv) was added, and the reaction was stirred under reflux for 6 h. The THF was evaporated under reduced pressure and the mixture was diluted with water (150 mL) and extracted with EtOAc (3 × 150 mL). The combined organic layers were washed with brine (150 mL), filtered over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under reduced pressure. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>27a</b> as a pale yellow solid (710 mg, 70%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 7.72 (s, 1H), 7.59 (s, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 2H), 7.35 (d, <i>J</i> = 8.2 Hz, 2H), 4.67 (s, 2H), 3.92 (s, 3H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 189.1.</div></div><div id="sec4_3_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (4-(1-Methyl-1<i>H</i>-pyrazol-3-yl)phenyl)methanol (<b>27b</b>)</h3><div class="NLM_p last">4-Bromobenzyl alcohol (<b>25</b>) (125 mg, 0.60 mmol) and 1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>26b</b>) (208 mg, 1.00 mmol) were coupled according to procedures used for the synthesis of compound <b>10</b>. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>27b</b> as a pale white solid (90 mg, 72%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 7.61 (d, <i>J</i> = 8.23 Hz, 2H), 7.24 (d, <i>J</i> = 2.2 Hz, 1H), 7.22 (d, <i>J</i> = 8.23 Hz, 2H), 6.41 (d, <i>J</i> = 2.2 Hz, 1H), 4.54 (d, <i>J</i> = 3.9 Hz, 2H), 3.79 (s, 3H). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 189.1.</div></div><div id="sec4_3_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 3-(4-(Chloromethyl)phenyl)-1-methyl-1<i>H</i>-pyrazole (<b>28b</b>)</h3><div class="NLM_p last">Benzyl alcohol (<b>27b</b>) (90 mg, 0.48 mmol) was reacted according to procedures used for the synthesis of compound <b>10</b>. The crude product was purified by FCC (eluent CHCl<sub>3</sub>) to afford <b>28b</b> as a white solid (93 mg, 95%). <sup>1</sup>Η NMR (CDCl<sub>3</sub>) δ 7.75 (s, 1H), 7.60 (s, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 2H), 7.38 (d, <i>J</i> = 8.2 Hz, 2H), 4.59 (s, 2H), 3.93 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 136.9, 135.4, 132.9, 129.2, 127.0, 125.8, 122.6, 46.2, 39.1. LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (TOF ES<sup>+</sup>) 207.0.</div></div><div id="sec4_3_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1-(4-(1-methyl-1<i>H</i>-pyrazol-3-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>29b</b>)</h3><div class="NLM_p last">Compounds <b>9a</b> (28 mg, 0.11 mmol) and <b>28b</b> (22 mg, 0.11 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>29b</b> as a white solid (12 mg, 26%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.77 (d, <i>J</i> = 7.7 Hz, 1H), 8.49 (dd, <i>J</i> = 4.6/1.0 Hz, 1H), 8.40 (s, 1H), 8.06 (dd, <i>J</i> = 8.3/1.0 Hz, 1H), 7.74 (d, <i>J</i> = 8.2 Hz, 2H), 7.69 (d, <i>J</i> = 2.1, 1H), 7.32 (d, <i>J</i> = 8.2 Hz, 2H), 7.27 (dd, <i>J</i> = 8.3/4.6 Hz, 1H), 6.63 (d, <i>J</i> = 2.1 Hz, 1H), 5.53 (s, 2H), 4.81 (d, <i>J</i> = 5.0 Hz, 1H), 3.85 (s, 3H), 3.78–3.70 (m, 1H), 3.46–3.37 (m, 1H), 2.06–1.99 (m, 1H), 1.92–1.84 (m, 1H), 1.69–1.58 (m, 2H), 1.37–1.21 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.1, 155.7, 149.9, 144.0, 143.2, 136.3, 133.5, 132.8, 129.7, 128.2, 125.7, 119.8, 117.7, 110.7, 103.0, 71.8, 54.0, 50.0, 39.1, 34.4, 31.5, 24.4, 23.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub> calcd: 430.2243. Found: 430.2248. LC–MS <i>t</i><sub>R</sub> = 3.04.</div></div><div id="sec4_3_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1-(4-(oxazol-2-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>29c</b>)</h3><div class="NLM_p last">A mixture of <b>9a</b> (15 mg, 0.06 mmol) and the substituted benzyl chloride <b>28c</b> (15 mg, 0.06 mmol) was reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>29c</b> as a white solid (15 mg, 63%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.75 (d, <i>J</i> = 7.6 Hz, 1H), 8.50 (dd, <i>J</i> = 4.6/1.0 Hz, 1H), 8.42 (s, 1H), 8.18 (s, 1H), 8.03 (dd, <i>J</i> = 8.3/1.0 Hz, 1H), 7.92 (d, <i>J</i> = 8.2 Hz, 2H), 7.42 (d, <i>J</i> = 8.2 Hz, 2H), 7.35 (s, 1H), 7.26 (dd, <i>J</i> = 8.3/4.6 Hz, 1H), 5.62 (s, 2H), 4.80 (br s, 1H), 3.78–3.69 (m, 1H), 3.45–3.38 (m, 1H), 2.07–1.99 (m, 1H), 1.93–1.85 (m, 1H), 1.68–1.60 (m, 2H), 1.39–1.22 (m, 4H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 163.2, 160.9, 144.1, 143.2, 140.6, 139.9, 136.4, 129.8, 129.0, 128.5, 126.9, 126.8, 119.7, 117.8, 110.9, 71.8, 53.9, 49.8, 34.4, 31.5, 24.4, 23.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> calcd: 417.1927. Found: 417.1923. LC–MS <i>t</i><sub>R</sub> = 3.01.</div></div><div id="sec4_3_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1-(4-(thiazol-2-yl)benzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>29d</b>)</h3><div class="NLM_p last">Compound <b>9a</b> (15 mg, 0.06 mmol) and the substituted benzyl chloride <b>28d</b> (12 mg, 0.06 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>29d</b> as a white solid (20 mg, 80%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.76 (d, <i>J</i> = 7.6 Hz, 1H), 8.50 (dd, <i>J</i> = 4.6/1.2 Hz, 1H), 8.43 (s, 1H), 8.05 (dd, <i>J</i> = 8.4/1.2 Hz, 1H), 7.93–7.89 (m, 3H), 7.76 (d, <i>J</i> = 3.2 Hz, 1H), 7.40 (d, <i>J</i> = 8.2 Hz, 2H), 7.26 (dd, <i>J</i> = 8.4/4.6 Hz, 1H), 5.60 (s, 2H), 4.81 (d, <i>J</i> = 5.0 Hz, 1H), 3.78–3.70 (m, 1H), 3.46–3.38 (m, 1H), 2.07–1.99 (m, 1H), 1.92–1.85 (m, 1H), 1.69–1.58 (m, 2H), 1.37–1.22 (m, 4H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 167.0, 163.2, 144.3, 144.1, 143.2, 139.5, 136.4, 133.0, 129.7, 128.6, 127.0, 121.0, 119.7, 117.8, 110.9, 71.9, 55.0, 49.8, 34.4, 31.5, 24.4, 23.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub>S calcd: 433.1698. Found: 433.1695. LC–MS <i>t</i><sub>R</sub> = 3.07.</div></div><div id="sec4_3_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 1-Benzyl-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>29e</b>)</h3><div class="NLM_p last">Compound <b>9a</b> (28 mg, 0.11 mmol) and benzyl bromide (<b>28e</b>) (13 μL, 0.11 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>29e</b> as a white solid (31 mg, 83%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.76 (d, <i>J</i> = 7.6 Hz, 1H), 8.50 (dd, <i>J</i> = 4.5/1.3 Hz, 1H), 8.38 (s, 1H), 8.06 (dd, <i>J</i> = 8.3/1.1 Hz, 1H), 7.35–7.23 (m, 6H), 5.53 (s, 2H), 4.78 (d, <i>J</i> = 5.1 Hz, 1H), 3.78–3.68 (m, 1H), 3.46–3.37 (m, 1H), 2.06–1.99 (m, 1H), 1.93–1.85 (m, 1H), 1.69–1.58 (m, 2H), 1.38–1.21 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.2, 144.0, 143.2, 137.5, 136.3, 129.8, 129.2, 128.3, 127.8, 119.7, 117.7, 110.7, 71.8, 53.9, 50.7, 34.4, 31.4, 24.4, 23.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub> calcd: 350.1869. Found: 350.1872. LC–MS <i>t</i><sub>R</sub> = 2.98.</div></div><div id="sec4_3_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)-1-(4-methoxybenzyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>29f</b>)</h3><div class="NLM_p last">Compound <b>9a</b> (28 mg, 0.11 mmol) and 4-methoxybenzyl chloride (<b>28f</b>) (12 μL, 0.11 mmol) were reacted according to general procedure B. The crude product was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>29f</b> as a white solid (32 mg, 80%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.75 (d, <i>J</i> = 7.6 Hz, 1H), 8.48 (dd, <i>J</i> = 4.7/1.3 Hz, 1H), 8.34 (s, 1H), 8.08 (dd, <i>J</i> = 8.4/1.3 Hz, 1H), 7.31–7.22 (m, 3H), 6,89 (d, <i>J</i> = 8.5 Hz, 2H), 5.43 (s, 2H), 4.79 (d, <i>J</i> = 5.1 Hz, 1H), 3.78–3.72 (m, 1H), 3.71 (s, 3H), 3.45–3.37 (m, 1H), 2.06–1.99 (m, 1H), 1.91–1.85 (m, 1H), 1.68–1.57 (m, 2H), 1.36–1.21 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.2, 159.3, 143.9, 143.2, 136.0, 129.6, 129.5, 129.3, 119.8, 117.6, 114.5, 110.6, 71.9, 55.5, 53.9, 49.7, 34.4, 31.4, 24.4, 23.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>22</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> calcd: 380.1974. Found: 380.1961. LC–MS <i>t</i><sub>R</sub> = 2.97.</div></div><div id="sec4_3_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Methyl 4-((3-(((1<i>S</i>,2<i>S</i>)-2-Gydroxycyclohexyl)carbamoyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-1-yl)methyl)benzoate (<b>29g</b>)</h3><div class="NLM_p last">Compound <b>9a</b> (28 mg, 0.11 mmol) and methyl 4-(chloromethyl)benzoate (<b>28g</b>) (25 mg, 0.11 mmol) were reacted according to general procedure B. The crude was purified by FCC (eluent CHCl<sub>3</sub>/MeOH 100:1) to afford <b>29g</b> as a white solid (22 mg, 50%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.78 (d, <i>J</i> = 7.6 Hz, 1H), 8.58 (dd, <i>J</i> = 4.6/1.2 Hz, 1H), 8.42 (s, 1H), 8.00 (dd, <i>J</i> = 8.4/1.2 Hz, 1H), 7,92 (d, <i>J</i> = 8.3 Hz, 2H), 7.38 (d, <i>J</i> = 8.3 Hz, 2H), 7.26 (dd, <i>J</i> = 8.4/4.6 Hz, 1H), 5.64 (s, 2H), 4.79 (d, <i>J</i> = 5.1 Hz, 1H), 3.81 (s, 3H), 3.78–3.71 (m, 1H), 3.47–3.39 (m, 1H), 2.06–1.99 (m, 1H), 1.93–1.86 (m, 1H), 1.70–1.59 (m, 2H), 1.37–1.24 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.2, 163.1, 144.1, 143.1, 142.9, 136.5, 130.1, 129.8, 129.5, 127.9, 119.7, 117.8, 110.9, 71.9, 53.9, 52.6, 49.9, 34.4, 31.4, 24.4, 23.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>23</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub> calcd: 408.1923. Found: 408.1926. LC–MS <i>t</i><sub>R</sub> = 3.04.</div></div><div id="sec4_3_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 4-((3-(((1<i>S</i>,2<i>S</i>)-2-Hydroxycyclohexyl)carbamoyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-1-yl)methyl)benzoic Acid (<b>29h</b>)</h3><div class="NLM_p last">A mixture of methyl ester <b>29g</b> (33 mg, 0.08 mmol), EtOH/H<sub>2</sub>O (1:1) (2 mL), and 1 M NaOH aqueous solution (1 mL) was stirred overnight under reflux. The reaction medium was diluted with 1 M HCl solution until pH 3.0, concentrated under reduced pressure, and filtered. The crude product was dried and purified by FCC (eluent CHCl<sub>3</sub>/MeOH 2:1) to afford <b>29h</b> as a white solid (14 mg, 45%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.77 (d, <i>J</i> = 7.6 Hz, 1H), 8.50 (dd, <i>J</i> = 4.7/1.2 Hz, 1H), 8.40 (s, 1H), 8.02 (dd, <i>J</i> = 8.4/1.2 Hz, 1H), 7,88 (d, <i>J</i> = 8.0 Hz, 2H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 7.25 (dd, <i>J</i> = 8.4/4.7 Hz, 1H), 5.62 (s, 2H), 4.80 (br s, 1H), 3.77–3.69 (m, 1H), 3.45–3.38 (m, 1H), 2.06–1.99 (m, 1H), 1.93–1.85 (m, 1H), 1.69–1.59 (m, 2H), 1.36–1.22 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 187.9, 163.1, 144.1, 143.1, 141.9, 136.4, 130.2, 130.1, 129.7, 127.6, 119.7, 117.8, 110.9, 71.9, 53.9, 49.9, 34.4, 31.4, 24.4, 23.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> calcd: 394.1767. Found: 394.1766. LC–MS <i>t</i><sub>R</sub> = 2.88.</div></div><div id="sec4_3_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 1-(4-Carbamoylbenzyl)-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-3-carboxamide (<b>29i</b>)</h3><div class="NLM_p last">Methyl ester <b>29g</b> (94 mg, 0.23 mmol), methanol (3 mL), and NH<sub>4</sub>OH (28% solution, 3 mL) were stirred under reflux for 3 d. The reaction medium was concentrated under reduced pressure, diluted with 1 M Na<sub>2</sub>CO<sub>3</sub> (80 mL), and extracted with EtOAc (3 × 80 mL). The combined organic layers were dried under reduced pressure. The crude product was purified by FCC (CHCl<sub>3</sub>/MeOH 20:1) to afford <b>29i</b> as a white solid (29 mg, 32%). <sup>1</sup>Η NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.77 (d, <i>J</i> = 7.7 Hz, 1H), 8.50 (dd, <i>J</i> = 4.6/1.2 Hz, 1H), 8.41 (s, 1H), 8.03 (dd, <i>J</i> = 8.3/1.2 Hz, 1H), 7.92 (br s, 1H), 7,83 (d, <i>J</i> = 8.2 Hz, 2H), 7.35–7.31 (m, 3H), 7.27 (dd, <i>J</i> = 8.3/4.6 Hz, 1H), 5.29 (s, 2H), 4.80 (d, <i>J</i> = 5.2 Hz, 1H), 3.78–3.68 (m, 1H), 3.46–3.39 (m, 1H), 2.06–1.99 (m, 1H), 1.92–1.85 (m, 1H), 1.68–1.58 (m, 2H), 1.37–1.19 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 168.0, 163.1, 144.1, 143.1, 140.6, 136.4, 134.3, 129.7, 128.4, 127.6, 119.7, 117.8, 110.8, 71.9, 53.9, 49.9, 34.4, 31.4, 24.4, 23.8. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (Q-TOF/ESI) C<sub>22</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> calcd: 393.1927. Found: 393.1921. LC–MS <i>t</i><sub>R</sub> = 2.79.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Whole Cell Radioligand Binding Assays</h3><div class="NLM_p last">FlpIn Chinese hamster ovary (CHO) cells stably expressing the human M<sub>1</sub> mAChR were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 5% fetal bovine serum (FBS) (ThermoTrace, Melbourne, Australia) and 300 μg/mL G418 (Invitrogen, Carlsbad, CA). The cells were plated at 50 000 cells per well in 96-well Isoplates (PerkinElmer) and incubated overnight. The following day, cells were washed twice with phosphate buffered saline (PBS) and incubated with varying concentrations of ACh (Sigma, St. Loius, MI) or PAMs or PAMs in the presence of EC<sub>20</sub> concentration of ACh and 0.2 nM [<sup>3</sup>H]NMS in binding buffer (20 mM HEPES, 100 mM NaCl, 10 mM MgCl<sub>2</sub>, pH 7.4) for 5 h at room temperature. Nonspecific binding was determined using atropine at the final concentration of 100 μM. The assays were terminated by rapid removal of radioligand followed by two 100 μL washes with ice-cold 0.9% NaCl buffer. Radioactivity was determined by addition of 100 μL of Microscint scintillation liquid (PerkinElmer Life Sciences) to each well and counting in a MicroBeta plate reader (PerkinElmer Life Sciences).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> IP<sub>1</sub> Accumulation Assays</h3><div class="NLM_p last">The IP<sub>1</sub> assay kit (Cisbio) was used for the direct quantitative measurement of myo-inositol 1 phosphate (IP<sub>1</sub>). FlpIn CHO cells stably expressing the hM<sub>1</sub> mAChR were seeded at 25 000 per well in 96-well transparent cell culture plates and incubated overnight. The following day, cells were preincubated with IP<sub>1</sub> stimulation buffer (1 mM CaCl<sub>2</sub>, 0.5 mM MgCl<sub>2</sub>, 4.2 mM KCl, 146 mM NaCl, 5.5 mM <span class="smallcaps smallerCapital">d</span>-glucose, 10 mM HEPES, and 50 mM LiCl, pH 7.4) for 1 h at 37 °C, 5% CO<sub>2</sub>. Cells were then incubated with varying concentration of ACh and the PAMs for 1 h at 37 °C, 5% CO<sub>2</sub>. The reactions were terminated by removal of the stimulation buffer and addition of 50 μL of lysis buffer (50 mM HEPES, pH 7.0, 15 mM KF, 1.5% v/v Triton-X-100, 3% v/v FBS, 0.2% W/V BSA). An amount of 7 μL of cell lysates was transferred to wells of 384-well Proxy-plates (PerkinElmer), and IP<sub>1</sub> levels were measured by incubating the lysates with 1.5 μL of the anti-IP<sub>1</sub> Tb cryptate conjugate and 1.5 μL of the IP<sub>1</sub>-D2 conjugate for 1 h at 37 °C. The emission signals were measured at 620 and 665 nm after excitation at 340 nm using an Envision multilabel plate reader (PerkinElmer). The signal was expressed as the HTRF ratio: [(fluorescence 665 nm/fluorescence 620 nm) × 10<sup>4</sup>], interpolated from the standard curve and normalized to the maximum response to ACh.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Data Analysis</h3><div class="NLM_p">All data were analyzed using Prism 7 (GraphPad Software, San Diego, CA). Binding interaction studies with allosteric ligands were fitted to the following allosteric ternary complex model (<a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_m001.gif" alt="" id="_i99" /></img><span class="labelSpan">(1)</span></span>where <i>B</i><sub>max</sub> is the total number of receptors, [A], [B], and [I] denote the concentrations of radioligand, allosteric modulator, and orthosteric ligand, respectively; <i>K</i><sub>A</sub>, <i>K</i><sub>B</sub>, and <i>K</i><sub>I</sub> are their respective equilibrium dissociation constants. α′ and α are the cooperativities between the allosteric ligand and radioligand or the allosteric modulator and orthosteric ligand, respectively. Values of α or α′ of >1 denote positive cooperativit, values of <1 but >0 denote negative cooperativity, and a value of 1 indicates neutral cooperativity. α′ values were determined from interaction studies between radioligand and allosetric modulator in the absence of the orthosteric agonist (i.e., [I] = 0).</div><div class="NLM_p">Functional interaction studies between orthosteric agonists and allosteric modulators in IP<sub>1</sub> assays were analyzed according to a three-parameter logistic equation or the following operational model of allosterism and agonism (<a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>):<a onclick="showRef(event, 'ref27 ref38'); return false;" href="javascript:void(0);" class="ref ref27 ref38">(27,38)</a><span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_m002.gif" alt="" id="_i100" /></img><span class="labelSpan">(2)</span></span>where E<sub>m</sub> is the maximal possible system response, and Basal is the response in the absence of agonist. [A] and [B] are concentrations of orthosteric and allosteric ligands, respectively. <i>K</i><sub>B</sub> is the equilibrium dissociation constant of allosteric ligand, and EC<sub>50</sub> is the concentration of orthosteric agonist required to achieve half maximal response. α and β represent the magnitude of the allosteric effects on orthosteric ligand affinity and efficacy, respectively; τ<sub>B</sub> is the efficacy of allosteric ligand, and <i>n</i> is the slope factor of the transducer function that links occupancy to response. The application of this simplified equation is only valid if the orthosteric agonist is a full agonist in both the absence and presence of all concentrations of modulator,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> which was the case in all studies conducted herein.</div><div class="NLM_p last">All potency, affinity, efficacy, and cooperativity values were estimated as logarithms,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and unpaired <i>t</i> test or one-way analysis of variance with a Dunnett’s multiple comparison post test was used to determine statistical differences, where appropriate. A value of <i>p</i> < 0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01812" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01812" class="ext-link">10.1021/acs.jmedchem.7b01812</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Table with shift values of ACh potency (ΔpEC<sub>50</sub>) and baseline (Δbaseline) of the graphs in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> at 1 and 10 μM; binding and functional response curves for compounds <b>1</b>, <b>2</b>, <b>3</b>, <b>6a</b>, <b>6o</b>, <b>15b</b>, <b>15d</b>, <b>24e</b>, <b>29h</b>; spectral data for all tested derivatives (<sup>1</sup>Η and <sup>13</sup>C NMR, HRMS, and LCMS retention times) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf">jm7b01812_si_001.pdf (417.82 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_002.csv">jm7b01812_si_002.csv (2.39 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01812" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur Christopoulos</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Biology, Monash Institute of Pharmaceutical Sciences &
Department of Pharmacology, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9d8cbcdd1cccb97dad1cbd0cacdd6c9d6ccd5d6caf9d4d6d7d8cad197dcddcc"><span class="__cf_email__" data-cfemail="335241475b46411d505b415a40475c435c465f5c40735e5c5d52405b1d565746">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Scammells</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2930-895X" title="Orcid link">http://orcid.org/0000-0003-2930-895X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e39386978691cd9080828e8e868f8f90a38e8c8d82908bcd868796"><span class="__cf_email__" data-cfemail="7505100110075b06161418181019190635181a1b14061d5b101100">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juliana
C. C. Dallagnol</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Federal University of Parana, Avenida Prefeito Lothario Meissner
632, Jardim Botanico, Curitiba, Parana, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elham Khajehali</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Biology, Monash Institute of Pharmaceutical Sciences &
Department of Pharmacology, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emma T. van der Westhuizen</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Biology, Monash Institute of Pharmaceutical Sciences &
Department of Pharmacology, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela Jörg</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celine Valant</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Biology, Monash Institute of Pharmaceutical Sciences &
Department of Pharmacology, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan G. Gonçalves</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Federal University of Parana, Avenida Prefeito Lothario Meissner
632, Jardim Botanico, Curitiba, Parana, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Capuano</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.C.C.D. and E.K. contributed equally to this manuscript. The manuscript was written through contributions of all authors and all authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by Discovery Grant DP110100687 of the Australian Research Council as well as Program Grant APP1055134 of the National Health and Medicinal Research Council (NHMRC) of Australia. A.C. is a Senior Principal Research Fellow of the NHMRC. J.C.C.D. thanks the CNPq (National Council for Scientific and Technological Development of Brazil) for a scholarship.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylchloline</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">equiv</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FCC</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr><tr><td class="NLM_term">IMHB</td><td class="NLM_def"><p class="first last">intramolecular hydrogen bond</p></td></tr><tr><td class="NLM_term">M<sub>1</sub> mAChR</td><td class="NLM_def"><p class="first last">M<sub>1</sub> muscarinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span>; <span class="NLM_string-name">Wimo, A.</span>; <span class="NLM_string-name">Guerchet, M.</span>; <span class="NLM_string-name">Ali, G.</span>; <span class="NLM_string-name">WU, Y.</span>; <span class="NLM_string-name">Prina, M.</span></span> <i>World Alzheimer Report 2015</i>; <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Prince&author=A.+Wimo&author=M.+Guerchet&author=G.+Ali&author=Y.+WU&author=M.+Prina&title=World+Alzheimer+Report+2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26btitle%3DWorld%2520Alzheimer%2520Report%25202015%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lah, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levey, A. I.</span></span> <span> </span><span class="NLM_article-title">Deletion of M<sub>1</sub> muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4190</span>– <span class="NLM_lpage">4196</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.6393-09.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1523%2FJNEUROSCI.6393-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=20335454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVagtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=4190-4196&issue=12&author=A.+A.+Davisauthor=J.+J.+Fritzauthor=J.+Wessauthor=J.+J.+Lahauthor=A.+I.+Levey&title=Deletion+of+M1+muscarinic+acetylcholine+receptors+increases+amyloid+pathology+in+vitro+and+in+vivo&doi=10.1523%2FJNEUROSCI.6393-09.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo</span></div><div class="casAuthors">Davis, Albert A.; Fritz, Jason J.; Wess, Jurgen; Lah, James J.; Levey, Allan I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4190-4196</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurol. disorder that causes dementia and poses a major public health crisis as the population ages.  Aberrant processing of the amyloid precursor protein (APP) is strongly implicated as a proximal event in AD pathophysiol., but the neurochem. signals that regulate APP processing in the brain are not completely understood.  Activation of muscarinic acetylcholine receptors (mAChRs) has been shown to affect APP processing and AD pathol., but less is known about the roles of specific mAChR subtypes.  In this study, the authors used M1 mAChR knock-out mice (M1KO) to isolate the effects of the M1 mAChR on APP processing in primary neurons and on the development of amyloid pathol. in a transgenic mouse model of AD.  The authors demonstrate that the loss of M1 mAChRs increases amyloidogenic APP processing in neurons, as evidenced by decreased agonist-regulated shedding of the neuroprotective APP ectodomain APPsα and increased prodn. of toxic Aβ peptides.  Expression of M1 mAChRs on the M1KO background rescued this phenotype, indicating that M1 mAChRs are sufficient to modulate nonamyloidogenic APP processing.  In APPSwe/Ind transgenic mice, the loss of M1 mAChRs resulted in increased levels of brain Aβ and greater accumulation of amyloid plaque pathol.  Anal. of APP metabolites in APPSwe/Ind brain tissue indicates that the loss of M1 mAChRs increases amyloidogenic APP processing.  These results indicate that the M1 mAChR is an important regulator of amyloidogenesis in the brain and provide strong support for targeting the M1 mAChR as a therapeutic candidate in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAo3J0xlgL0rVg90H21EOLACvtfcHk0lho0fQQn2jbfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVagtbg%253D&md5=40a6d71c0f01229f4134f0952dc73af7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.6393-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.6393-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DFritz%26aufirst%3DJ.%2BJ.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26atitle%3DDeletion%2520of%2520M1%2520muscarinic%2520acetylcholine%2520receptors%2520increases%2520amyloid%2520pathology%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26issue%3D12%26spage%3D4190%26epage%3D4196%26doi%3D10.1523%2FJNEUROSCI.6393-09.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baglietto-Vargas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada-Hernandez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cribbs, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laferla, F. M.</span></span> <span> </span><span class="NLM_article-title">Loss of muscarinic M<sub>1</sub> receptor exacerbates Alzheimer’s disease-like pathology and cognitive decline</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>179</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">980</span>– <span class="NLM_lpage">991</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2011.04.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2Fj.ajpath.2011.04.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=21704011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGjsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=980-991&issue=2&author=R.+Medeirosauthor=M.+Kitazawaauthor=A.+Caccamoauthor=D.+Baglietto-Vargasauthor=T.+Estrada-Hernandezauthor=D.+H.+Cribbsauthor=A.+Fisherauthor=F.+M.+Laferla&title=Loss+of+muscarinic+M1+receptor+exacerbates+Alzheimer%E2%80%99s+disease-like+pathology+and+cognitive+decline&doi=10.1016%2Fj.ajpath.2011.04.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline</span></div><div class="casAuthors">Medeiros, Rodrigo; Kitazawa, Masashi; Caccamo, Antonella; Baglietto-Vargas, David; Estrada-Hernandez, Tatiana; Cribbs, David H.; Fisher, Avraham; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">980-991</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is pathol. characterized by tau-laden neurofibrillary tangles and β-amyloid deposits.  Dysregulation of cholinergic neurotransmission has been implicated in AD pathogenesis, contributing to the assocd. memory impairments; yet, the exact mechanisms remain to be defined.  Activating the muscarinic acetylcholine M1 receptors (M1Rs) reduces AD-like pathol. features and enhances cognition in AD transgenic models.  To elucidate the mol. mechanisms by which M1Rs affect AD pathophysiol. features, we crossed the 3xTgAD and transgenic mice expressing human Swedish, Dutch, and Iowa triple-mutant amyloid precursor protein (Tg-SwDI), two widely used animal models, with the M1R-/- mice.  Our data show that M1R deletion in the 3xTgAD and Tg-SwDI mice exacerbates the cognitive impairment through mechanisms dependent on the transcriptional dysregulation of genes required for memory and through acceleration of AD-related synaptotoxicity.  Ablating the M1R increased plaque and tangle levels in the brains of 3xTgAD mice and elevated cerebrovascular deposition of fibrillar Aβ in Tg-SwDI mice.  Notably, tau hyperphosphorylation and potentiation of amyloidogenic processing in the mice with AD lacking M1R were attributed to changes in the glycogen synthase kinase 3β and protein kinase C activities.  Finally, deleting the M1R increased the astrocytic and microglial response assocd. with Aβ plaques.  Our data highlight the significant role that disrupting the M1R plays in exacerbating AD-related cognitive decline and pathol. features and provide crit. preclin. evidence to justify further development and evaluation of selective M1R agonists for treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmn8fzxarBbVg90H21EOLACvtfcHk0ljuBdNrtY_WSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGjsLzP&md5=f20cdd368aa5c1f8953ca565fd25cd5c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.04.041%26sid%3Dliteratum%253Aachs%26aulast%3DMedeiros%26aufirst%3DR.%26aulast%3DKitazawa%26aufirst%3DM.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DBaglietto-Vargas%26aufirst%3DD.%26aulast%3DEstrada-Hernandez%26aufirst%3DT.%26aulast%3DCribbs%26aufirst%3DD.%2BH.%26aulast%3DFisher%26aufirst%3DA.%26aulast%3DLaferla%26aufirst%3DF.%2BM.%26atitle%3DLoss%2520of%2520muscarinic%2520M1%2520receptor%2520exacerbates%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%2520and%2520cognitive%2520decline%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26issue%3D2%26spage%3D980%26epage%3D991%26doi%3D10.1016%2Fj.ajpath.2011.04.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mufson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Counts, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, S. D.</span></span> <span> </span><span class="NLM_article-title">Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1703</span>– <span class="NLM_lpage">1718</span>, <span class="refDoi"> DOI: 10.1586/14737175.8.11.1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1586%2F14737175.8.11.1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=18986241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlentLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1703-1718&issue=11&author=E.+J.+Mufsonauthor=S.+E.+Countsauthor=S.+E.+Perezauthor=S.+D.+Ginsberg&title=Cholinergic+system+during+the+progression+of+Alzheimer%E2%80%99s+disease%3A+therapeutic+implications&doi=10.1586%2F14737175.8.11.1703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinergic system during the progression of Alzheimer's disease: therapeutic implications</span></div><div class="casAuthors">Mufson, Elliott J.; Counts, Scott E.; Perez, Sylvia E.; Ginsberg, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1703-1718</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced cortical choline acetyltransferase activity assocd. with cognitive decline.  Delaying CBF neurodegeneration or minimizing its consequences is the mechanism of action for most currently available drug treatments for cognitive dysfunction in AD.  Growing evidence suggests that imbalances in the expression of NGF, its precursor proNGF and the high (TrkA) and low (p75NTR) affinity NGF receptors are crucial factors underlying CBF dysfunction in AD.  Drugs that maintain a homeostatic balance between TrkA and p75NTR may slow the onset of AD.  A NGF gene therapy trial reduced cognitive decline and stimulated cholinergic fiber growth in humans with mild AD.  Drugs treating the multiple pathologies and clin. symptoms in AD (e.g., M1 cholinoceptor and/or galaninergic drugs) should be considered for a more comprehensive treatment approach for cholinergic dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg6lsOaeDJ1rVg90H21EOLACvtfcHk0ljuBdNrtY_WSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlentLvP&md5=11a469f57aa07a70d57d7ee5bf0faf08</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1586%2F14737175.8.11.1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.8.11.1703%26sid%3Dliteratum%253Aachs%26aulast%3DMufson%26aufirst%3DE.%2BJ.%26aulast%3DCounts%26aufirst%3DS.%2BE.%26aulast%3DPerez%26aufirst%3DS.%2BE.%26aulast%3DGinsberg%26aufirst%3DS.%2BD.%26atitle%3DCholinergic%2520system%2520during%2520the%2520progression%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520therapeutic%2520implications%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2008%26volume%3D8%26issue%3D11%26spage%3D1703%26epage%3D1718%26doi%3D10.1586%2F14737175.8.11.1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span> <span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors: novel opportunities for drug development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1038/nrd4295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnrd4295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=24903776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlOitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=549-560&issue=7&author=A.+C.+Kruseauthor=B.+K.+Kobilkaauthor=D.+Gautamauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=J.+Wess&title=Muscarinic+acetylcholine+receptors%3A+novel+opportunities+for+drug+development&doi=10.1038%2Fnrd4295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors: novel opportunities for drug development</span></div><div class="casAuthors">Kruse, Andrew C.; Kobilka, Brian K.; Gautam, Dinesh; Sexton, Patrick M.; Christopoulos, Arthur; Wess, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The muscarinic acetylcholine receptors are a subfamily of G protein-coupled receptors that regulate numerous fundamental functions of the central and peripheral nervous system.  The past few years have witnessed unprecedented new insights into muscarinic receptor physiol., pharmacol. and structure.  These advances include the first structural views of muscarinic receptors in both inactive and active conformations, as well as a better understanding of the mol. underpinnings of muscarinic receptor regulation by allosteric modulators.  These recent findings should facilitate the development of new muscarinic receptor subtype-selective ligands that could prove to be useful for the treatment of many severe pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnDtWGoryjILVg90H21EOLACvtfcHk0lggpa7ldFaK2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlOitbc%253D&md5=cc31a22098b5c613afac26df629d2a47</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4295%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGautam%26aufirst%3DD.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%253A%2520novel%2520opportunities%2520for%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D7%26spage%3D549%26epage%3D560%26doi%3D10.1038%2Fnrd4295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Muscarinic receptor agonists and antagonists in the treatment of Alzheimer’s disease</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3353</span>– <span class="NLM_lpage">3361</span>, <span class="refDoi"> DOI: 10.2174/138161205774370762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.2174%2F138161205774370762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=16250841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWrs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3353-3361&author=J.+W.+Claderauthor=Y.+Wang&title=Muscarinic+receptor+agonists+and+antagonists+in+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F138161205774370762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease</span></div><div class="casAuthors">Clader, John W.; Wang, Yuguang</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3353-3361</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the consistent findings in the brains of Alzheimer's Disease (AD) patients is loss of cholinergic function.  The cholinergic approach to treatment of AD involves counteracting this loss in cholinergic activity by pharmacol. intervention to increase cholinergic transmission.  The cognitive effects of acetylcholine are mediated via the muscarinic M1 receptor.  Direct stimulation of this receptor using muscarinic M1 agonists improves cognition in animal models and improves performance in cognitive tests in Alzheimer's patients.  Alternatively, antagonists of central presynaptic M2 receptors improves cognition by increasing the central release of acetylcholine.  Both approaches require high selectivity for one muscarinic receptor sub-type both for efficacy and to avoid cholinergic side effects.  In this review summarizes recent progress in the identification and characterization of selective muscarinic receptor ligands for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2_wdSDisNRLVg90H21EOLACvtfcHk0lggpa7ldFaK2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWrs7vP&md5=d0d18c0299921abfbf6b815b223e743a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161205774370762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161205774370762%26sid%3Dliteratum%253Aachs%26aulast%3DClader%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DMuscarinic%2520receptor%2520agonists%2520and%2520antagonists%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26spage%3D3353%26epage%3D3361%26doi%3D10.2174%2F138161205774370762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potter, P. E.</span></span> <span> </span><span class="NLM_article-title">Investigational medications for treatment of patients with Alzheimer’s disease</span>. <i>J. Am. Osteopath. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">9, Suppl. 8</span>),  <span class="NLM_fpage">S27</span>– <span class="NLM_lpage">S36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=20926740" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=S27-S36&issue=9%2C+Suppl.+8&author=P.+E.+Potter&title=Investigational+medications+for+treatment+of+patients+with+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DP.%2BE.%26atitle%3DInvestigational%2520medications%2520for%2520treatment%2520of%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Osteopath.%2520Assoc.%26date%3D2010%26volume%3D110%26issue%3D9%252C%2520Suppl.%25208%26spage%3DS27%26epage%3DS36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, C.</span></span> <span> </span><span class="NLM_article-title">Use of cholinesterase inhibitors in dementia</span>. <i>Adv. Psychiatr. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1192/apt.8.2.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1192%2Fapt.8.2.89" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=89-96&issue=2&author=M.+Holdenauthor=C.+Kelly&title=Use+of+cholinesterase+inhibitors+in+dementia&doi=10.1192%2Fapt.8.2.89"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1192%2Fapt.8.2.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fapt.8.2.89%26sid%3Dliteratum%253Aachs%26aulast%3DHolden%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DC.%26atitle%3DUse%2520of%2520cholinesterase%2520inhibitors%2520in%2520dementia%26jtitle%3DAdv.%2520Psychiatr.%2520Treat.%26date%3D2002%26volume%3D8%26issue%3D2%26spage%3D89%26epage%3D96%26doi%3D10.1192%2Fapt.8.2.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. W.</span></span> <span> </span><span class="NLM_article-title">M<sub>1</sub> Muscarinic acetylcholine receptor in Alzheimer’s disease</span>. <i>Neurosci. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1007/s12264-013-1406-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1007%2Fs12264-013-1406-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=24590577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFCnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=295-307&author=S.+Jiangauthor=Y.+Liauthor=C.+Zhangauthor=Y.+Zhaoauthor=G.+Buauthor=H.+Xuauthor=Y.+W.+Zhang&title=M1+Muscarinic+acetylcholine+receptor+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs12264-013-1406-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">M1 muscarinic acetylcholine receptor in Alzheimer's disease</span></div><div class="casAuthors">Jiang, Shangtong; Li, Yanfang; Zhang, Cuilin; Zhao, Yingjun; Bu, Guojun; Xu, Huaxi; Zhang, Yun-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Bulletin</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-307</span>CODEN:
                <span class="NLM_cas:coden">NBEUAS</span>;
        ISSN:<span class="NLM_cas:issn">1995-8218</span>.
    
            (<span class="NLM_cas:orgname">Shanghai Institutes for Biological Sciences</span>)
        </div><div class="casAbstract">A review.  The degeneration of cholinergic neurons and cholinergic hypofunction are pathologies assocd. with Alzheimer's disease (AD).  Muscarinic acetylcholine receptors (mAChRs) mediate acetylcholine-induced neurotransmission and five mAChR subtypes (M1-M5) have been identified.  Among them, M1 mAChR is widely expressed in the central nervous system and has been implicated in many physiol. and pathol. brain functions.  In addn., M1 mAChR is postulated to be an important therapeutic target for AD and several other neurodegenerative diseases.  In this article, we review recent progress in understanding the functional involvement of M1 mAChR in AD pathol. and in developing M1 mAChR agonists for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyZ2OW85XkBLVg90H21EOLACvtfcHk0lgS7bcm_Axvqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFCnsLs%253D&md5=49d567fbadcd979d8da458bc6a384caa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs12264-013-1406-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12264-013-1406-z%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BW.%26atitle%3DM1%2520Muscarinic%2520acetylcholine%2520receptor%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurosci.%2520Bull.%26date%3D2014%26volume%3D30%26spage%3D295%26epage%3D307%26doi%3D10.1007%2Fs12264-013-1406-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yurugi-Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiroishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span> <span> </span><span class="NLM_article-title">Structure of the human M<sub>2</sub> muscarinic acetylcholine receptor bound to an antagonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>482</i></span> (<span class="NLM_issue">7386</span>),  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/nature10753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnature10753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=22278061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ejsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=547-551&issue=7386&author=K.+Hagaauthor=A.+C.+Kruseauthor=H.+Asadaauthor=T.+Yurugi-Kobayashiauthor=M.+Shiroishiauthor=C.+Zhangauthor=W.+I.+Weisauthor=T.+Okadaauthor=B.+K.+Kobilkaauthor=T.+Hagaauthor=T.+Kobayashi&title=Structure+of+the+human+M2+muscarinic+acetylcholine+receptor+bound+to+an+antagonist&doi=10.1038%2Fnature10753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist</span></div><div class="casAuthors">Haga, Kazuko; Kruse, Andrew C.; Asada, Hidetsugu; Yurugi-Kobayashi, Takami; Shiroishi, Mitsunori; Zhang, Cheng; Weis, William I.; Okada, Tetsuji; Kobilka, Brian K.; Haga, Tatsuya; Kobayashi, Takuya</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7386</span>),
    <span class="NLM_cas:pages">547-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The X-ray crystal structure of the M2 muscarinic acetylcholine receptor, which is essential for the physiol. control of cardiovascular function, is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosewFev-FNErVg90H21EOLACvtfcHk0lgS7bcm_Axvqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ejsro%253D&md5=c33b8d9303d58db7dfdd4c18ec4f597b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature10753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10753%26sid%3Dliteratum%253Aachs%26aulast%3DHaga%26aufirst%3DK.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DAsada%26aufirst%3DH.%26aulast%3DYurugi-Kobayashi%26aufirst%3DT.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DHaga%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26atitle%3DStructure%2520of%2520the%2520human%2520M2%2520muscarinic%2520acetylcholine%2520receptor%2520bound%2520to%2520an%2520antagonist%26jtitle%3DNature%26date%3D2012%26volume%3D482%26issue%3D7386%26spage%3D547%26epage%3D551%26doi%3D10.1038%2Fnature10753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlow, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosemond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chae, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure and dynamics of the M<sub>3</sub> muscarinic acetylcholine receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>482</i></span>,  <span class="NLM_fpage">552</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1038/nature10867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnature10867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=22358844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1eqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=552-556&author=A.+C.+Kruseauthor=J.+Huauthor=A.+C.+Panauthor=D.+H.+Arlowauthor=D.+M.+Rosenbaumauthor=E.+Rosemondauthor=H.+F.+Greenauthor=T.+Liuauthor=P.+S.+Chaeauthor=R.+O.+Drorauthor=D.+E.+Shawauthor=W.+I.+Weisauthor=J.+Wessauthor=B.+K.+Kobilka&title=Structure+and+dynamics+of+the+M3+muscarinic+acetylcholine+receptor&doi=10.1038%2Fnature10867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and dynamics of the M3 muscarinic acetylcholine receptor</span></div><div class="casAuthors">Kruse, Andrew C.; Hu, Jianxin; Pan, Albert C.; Arlow, Daniel H.; Rosenbaum, Daniel M.; Rosemond, Erica; Green, Hillary F.; Liu, Tong; Chae, Pil Seok; Dror, Ron O.; Shaw, David E.; Weis, William I.; Wess, Jurgen; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7386</span>),
    <span class="NLM_cas:pages">552-556</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acetylcholine, the first neurotransmitter to be identified, exerts many of its physiol. actions via activation of a family of G-protein-coupled receptors (GPCRs) known as muscarinic acetylcholine receptors (mAChRs).  Although the five mAChR subtypes (M1-M5) share a high degree of sequence homol., they show pronounced differences in G-protein coupling preference and the physiol. responses they mediate.  Unfortunately, despite decades of effort, no therapeutic agents endowed with clear mAChR subtype selectivity have been developed to exploit these differences.  We describe here the structure of the Gq/11-coupled M3 mAChR ('M3 receptor', from rat) bound to the bronchodilator drug tiotropium and identify the binding mode for this clin. important drug.  This structure, together with that of the Gi/o-coupled M2 receptor, offers possibilities for the design of mAChR subtype-selective ligands.  Importantly, the M3 receptor structure allows a structural comparison between two members of a mammalian GPCR subfamily displaying different G-protein coupling selectivities.  Furthermore, mol. dynamics simulations suggest that tiotropium binds transiently to an allosteric site en route to the binding pocket of both receptors.  These simulations offer a structural view of an allosteric binding mode for an orthosteric GPCR ligand and provide addnl. opportunities for the design of ligands with different affinities or binding kinetics for different mAChR subtypes.  Our findings not only offer insights into the structure and function of one of the most important GPCR families, but may also facilitate the design of improved therapeutics targeting these crit. receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozveVSiaQvz7Vg90H21EOLACvtfcHk0lgyqyCYf-X-kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1eqs7k%253D&md5=31bb89b1d14cf122353fced8f905e996</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature10867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10867%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DA.%2BC.%26aulast%3DArlow%26aufirst%3DD.%2BH.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DRosemond%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DH.%2BF.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DChae%26aufirst%3DP.%2BS.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520and%2520dynamics%2520of%2520the%2520M3%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D552%26epage%3D556%26doi%3D10.1038%2Fnature10867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawaratne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bures, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachhawat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the M<sub>1</sub> and M<sub>4</sub> muscarinic acetylcholine receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>531</i></span> (<span class="NLM_issue">7594</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1038/nature17188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnature17188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=26958838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlGjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2016&pages=335-340&issue=7594&author=D.+M.+Thalauthor=B.+Sunauthor=D.+Fengauthor=V.+Nawaratneauthor=K.+Leachauthor=C.+C.+Felderauthor=M.+G.+Buresauthor=D.+A.+Evansauthor=W.+I.+Weisauthor=P.+Bachhawatauthor=T.+S.+Kobilkaauthor=P.+M.+Sextonauthor=B.+K.+Kobilkaauthor=A.+Christopoulos&title=Crystal+structures+of+the+M1+and+M4+muscarinic+acetylcholine+receptors&doi=10.1038%2Fnature17188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the M1 and M4 muscarinic acetylcholine receptors</span></div><div class="casAuthors">Thal, David M.; Sun, Bingfa; Feng, Dan; Nawaratne, Vindhya; Leach, Katie; Felder, Christian C.; Bures, Mark G.; Evans, David A.; Weis, William I.; Bachhawat, Priti; Kobilka, Tong Sun; Sexton, Patrick M.; Kobilka, Brian K.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">7594</span>),
    <span class="NLM_cas:pages">335-340</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Muscarinic M1-M5 acetylcholine receptors are G protein-coupled receptors (GPCRs) that regulate many vital functions of the central and peripheral nervous systems.  In particular, the M1 and M4 receptor subtypes have emerged as attractive drug targets for treatments of neurol. disorders, such as Alzheimer's disease and schizophrenia, but the high conservation of the acetylcholine-binding pocket has spurred current research into targeting allosteric sites on these receptors.  Here we report the crystal structures of the M1 and M4 muscarinic receptors bound to the inverse agonist, tiotropium.  Comparison of these structures with each other, as well as with the previously reported M2 and M3 receptor structures, reveals differences in the orthosteric and allosteric binding sites that contribute to a role in drug selectivity at this important receptor family.  We also report identification of a cluster of residues that form a network linking the orthosteric and allosteric sites of the M4 receptor, which provides new insight into how allosteric modulation may be transmitted between the two spatially distinct domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3oy2Ml852CrVg90H21EOLACvtfcHk0lgyqyCYf-X-kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlGjurg%253D&md5=8ed3f453737ad0291cf5b2c088f528da</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature17188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17188%26sid%3Dliteratum%253Aachs%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DNawaratne%26aufirst%3DV.%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DBures%26aufirst%3DM.%2BG.%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DBachhawat%26aufirst%3DP.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DCrystal%2520structures%2520of%2520the%2520M1%2520and%2520M4%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DNature%26date%3D2016%26volume%3D531%26issue%3D7594%26spage%3D335%26epage%3D340%26doi%3D10.1038%2Fnature17188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seager, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graufelds, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCampbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shughrue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danziger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascarella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreatsoulas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabrook, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, W. J.</span></span> <span> </span><span class="NLM_article-title">Selective activation of the M<sub>1</sub> muscarinic acetylcholine receptor achieved by allosteric potentiation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">15950</span>– <span class="NLM_lpage">15955</span>, <span class="refDoi"> DOI: 10.1073/pnas.0900903106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=19717450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&issue=37&author=L.+Maauthor=M.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=K.+V.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=S.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M1+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation&doi=10.1073%2Fpnas.0900903106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span></div><div class="casAuthors">Ma, Lei; Seager, Matthew; Wittmann, Marion; Jacobson, Marlene; Bickel, Denise; Burno, Maryann; Jones, Keith; Graufelds, Valerie Kuzmick; Xu, Guangping; Pearson, Michelle; McCampbell, Alexander; Gaspar, Renee; Shughrue, Paul; Danziger, Andrew; Regan, Christopher; Flick, Rose; Pascarella, Danette; Garson, Susan; Doran, Scott; Kreatsoulas, Constantine; Veng, Lone; Lindsley, Craig W.; Shipe, William; Kuduk, Scott; Sur, Cyrille; Kinney, Gene; Seabrook, Guy R.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">15950-15955, S15950/1-S15950/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The forebrain cholinergic system promotes higher brain function in part by signaling through the M, muscarinic acetylcholine receptor (mAChR).  During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses assocd. with non-selective muscarinic agonists.  We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M1 mAChR.  BQCA reduces the concn. of ACh required to activate M1 up to 129-fold with an inflection point value of 845 nM.  No potentiation, agonism, or antagonism activity on other mAChRs is obsd. up to 100 ArM.  Furthermore studies in M1-/- mice demonstrates that BQCA requires M1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain.  Radioligand-binding assays, mol. modeling, and site-directed mutagenesis expts. indicate that BQCA acts at an allosteric site involving residues Y179 and W400.  BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep.  In contrast to M1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces 13-arrestin recruitment to M1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory.  In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M1 receptor and represents a promising therapeutic strategy for cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0SGRL-coGErVg90H21EOLACvtfcHk0lgIz2z35nyPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL&md5=4470732fd762f761a18d2bc96220dcb1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DK.%2BV.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DS.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D37%26spage%3D15950%26epage%3D15955%26doi%3D10.1073%2Fpnas.0900903106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Activation and allosteric modulation of a muscarinic acetylcholine receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1038/nature12735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnature12735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=24256733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyisLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2013&pages=101-106&author=A.+C.+Kruseauthor=A.+M.+Ringauthor=A.+Manglikauthor=J.+Huauthor=K.+Huauthor=K.+Eitelauthor=H.+Hubnerauthor=E.+Pardonauthor=C.+Valantauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=C.+C.+Felderauthor=P.+Gmeinerauthor=J.+Steyaertauthor=W.+I.+Weisauthor=C.+K.+Garciaauthor=J.+Wessauthor=B.+K.+Kobilka&title=Activation+and+allosteric+modulation+of+a+muscarinic+acetylcholine+receptor&doi=10.1038%2Fnature12735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and allosteric modulation of a muscarinic acetylcholine receptor</span></div><div class="casAuthors">Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish; Hu, Jianxin; Hu, Kelly; Eitel, Katrin; Huebner, Harald; Pardon, Els; Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur; Felder, Christian C.; Gmeiner, Peter; Steyaert, Jan; Weis, William I.; Garcia, K. Christopher; Wess, Juergen; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">7478</span>),
    <span class="NLM_cas:pages">101-106</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite recent advances in crystallog. and the availability of G-protein-coupled receptor (GPCR) structures, little is known about the mechanism of their activation process, as only the β2 adrenergic receptor (β2AR) and rhodopsin have been crystd. in fully active conformations.  Here we report the structure of an agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-protein mimetic camelid antibody fragment isolated by conformational selection using yeast surface display.  In addn. to the expected changes in the intracellular surface, the structure reveals larger conformational changes in the extracellular region and orthosteric binding site than obsd. in the active states of the β2AR and rhodopsin.  We also report the structure of the M2 receptor simultaneously bound to the orthosteric agonist iperoxo and the pos. allosteric modulator LY2119620.  This structure reveals that LY2119620 recognizes a largely pre-formed binding site in the extracellular vestibule of the iperoxo-bound receptor, inducing a slight contraction of this outer binding pocket.  These structures offer important insights into the activation mechanism and allosteric modulation of muscarinic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOuUgQSB7Dd7Vg90H21EOLACvtfcHk0liwh0RwqU993w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyisLjP&md5=ecddab0ab467321ac243b86bb82b71f8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature12735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12735%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DRing%26aufirst%3DA.%2BM.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DEitel%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DGarcia%26aufirst%3DC.%2BK.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DActivation%2520and%2520allosteric%2520modulation%2520of%2520a%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DNature%26date%3D2013%26volume%3D504%26spage%3D101%26epage%3D106%26doi%3D10.1038%2Fnature12735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Ridha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span> <span> </span><span class="NLM_article-title">Mechanistic insights into allosteric structure-function relationships at the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">33701</span>– <span class="NLM_lpage">33711</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.604967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1074%2Fjbc.M114.604967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=25326383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2rsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=33701-33711&issue=48&author=A.+Abdul-Ridhaauthor=J.+R.+Laneauthor=S.+N.+Mistryauthor=L.+Lopezauthor=P.+M.+Sextonauthor=P.+J.+Scammellsauthor=A.+Christopoulosauthor=M.+Canals&title=Mechanistic+insights+into+allosteric+structure-function+relationships+at+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M114.604967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Insights into Allosteric Structure-Function Relationships at the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Abdul-Ridha, Alaa; Lane, J. Robert; Mistry, Shailesh N.; Lopez, Laura; Sexton, Patrick M.; Scammells, Peter J.; Christopoulos, Arthur; Canals, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">33701-33711</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Benzylquinolone carboxylic acid (BQCA) is the first highly selective pos. allosteric modulator (PAM) for the M1 muscarinic acetylcholine receptor (mAChR), but it possesses low affinity for the allosteric site on the receptor.  More recent drug discovery efforts identified 3-((1S,2S)-2-hydroxycyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one (referred to herein as benzoquinazolinone 12) as a more potent M1 mAChR PAM with a structural ancestry originating from BQCA and related compds.  In the current study, we optimized the synthesis of and fully characterized the pharmacol. of benzoquinazolinone 12, finding that its improved potency derived from a 50-fold increase in allosteric site affinity as compared with BQCA, while retaining a similar level of pos. cooperativity with acetylcholine.  We then utilized site-directed mutagenesis and mol. modeling to validate the allosteric binding pocket we previously described for BQCA as a shared site for benzoquinazolinone 12 and provide a mol. basis for its improved activity at the M1 mAChR.  This includes a key role for hydrophobic and polar interactions with residues Tyr-179, in the second extracellular loop (ECL2) and Trp-4007.35 in transmembrane domain (TM) 7.  Collectively, this study highlights how the properties of affinity and cooperativity can be differentially modified on a common structural scaffold and identifies mol. features that can be exploited to tailor the development of M1 mAChR-targeting PAMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknjxCgLZYXLVg90H21EOLACvtfcHk0liwh0RwqU993w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2rsbjI&md5=c85ea5d192d466a495ebd58545dd4dc4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.604967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.604967%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DMechanistic%2520insights%2520into%2520allosteric%2520structure-function%2520relationships%2520at%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D48%26spage%3D33701%26epage%3D33711%26doi%3D10.1074%2Fjbc.M114.604967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Ridha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of allosteric modulation at the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">6067</span>– <span class="NLM_lpage">6079</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.539080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1074%2Fjbc.M113.539080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=6067-6079&issue=9&author=A.+Abdul-Ridhaauthor=L.+L%C3%B3pezauthor=P.+Keovauthor=D.+M.+Thalauthor=S.+N.+Mistryauthor=P.+M.+Sextonauthor=J.+R.+Laneauthor=M.+Canalsauthor=A.+Christopoulos&title=Molecular+determinants+of+allosteric+modulation+at+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M113.539080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.539080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.539080%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DKeov%26aufirst%3DP.%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DMolecular%2520determinants%2520of%2520allosteric%2520modulation%2520at%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D9%26spage%3D6067%26epage%3D6079%26doi%3D10.1074%2Fjbc.M113.539080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">A novel mechanism of G protein-coupled receptor functional selectivity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">29312</span>– <span class="NLM_lpage">29321</span>, <span class="refDoi"> DOI: 10.1074/jbc.M803801200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1074%2Fjbc.M803801200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=29312-29321&issue=43&author=C.+Valantauthor=K.+J.+Gregoryauthor=N.+E.+Hallauthor=P.+J.+Scammellsauthor=M.+J.+Lewauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=A+novel+mechanism+of+G+protein-coupled+receptor+functional+selectivity&doi=10.1074%2Fjbc.M803801200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803801200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803801200%26sid%3Dliteratum%253Aachs%26aulast%3DValant%26aufirst%3DC.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DHall%26aufirst%3DN.%2BE.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DLew%26aufirst%3DM.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520novel%2520mechanism%2520of%2520G%2520protein-coupled%2520receptor%2520functional%2520selectivity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26issue%3D43%26spage%3D29312%26epage%3D29321%26doi%3D10.1074%2Fjbc.M803801200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M<sub>1</sub> muscarinic receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5151</span>– <span class="NLM_lpage">5172</span>, <span class="refDoi"> DOI: 10.1021/jm400540b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400540b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5151-5172&author=S.+N.+Mistryauthor=C.+Valantauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Synthesis+and+pharmacological+profiling+of+analogues+of+benzyl+quinolone+carboxylic+acid+%28BQCA%29+as+allosteric+modulators+of+the+M1+muscarinic+receptor&doi=10.1021%2Fjm400540b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Profiling of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) as Allosteric Modulators of the M1 Muscarinic Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Valant, Celine; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5151-5172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Established therapy in Alzheimer's disease involves potentiation of the endogenous orthosteric ligand, acetylcholine, at the M1 muscarinic receptors found in higher concns. in the cortex and hippocampus.  Adverse effects, due to indiscriminate activation of other muscarinic receptor subtypes, are common.  M1 muscarinic pos. allosteric modulators/allosteric agonists such as BQCA [1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, I] offer an attractive soln., being exquisitely M1-selective over other muscarinic subtypes.  A common difficulty with allosteric ligands is interpreting SAR, based on composite potency values derived in the presence of fixed concn. of agonist.  In reality these values encompass multiple pharmacol. parameters, each potentially and differentially sensitive to structural modification of the ligand.  We report novel BQCA analogs which appear to augment ligand affinity for the receptor (pKB), intrinsic efficacy (τB), and both binding (α) and functional (β) cooperativity with acetylcholine.  Ultimately, development of such enriched SAR surrounding allosteric modulators will provide insight into their mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoigST7OJR7vbVg90H21EOLACvtfcHk0lgdlA95sRxB2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D&md5=ab134e0b5400aa825916695eaf1203b1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm400540b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400540b%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520profiling%2520of%2520analogues%2520of%2520benzyl%2520quinolone%2520carboxylic%2520acid%2520%2528BQCA%2529%2520as%2520allosteric%2520modulators%2520of%2520the%2520M1%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5151%26epage%3D5172%26doi%3D10.1021%2Fjm400540b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.
N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jörg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinh, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">4-Phenylpyridin-2-one derivatives: a novel class of positive allosteric modulator of the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01562</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01562" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFegu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=388-409&author=S.%0AN.+Mistryauthor=M.+J%C3%B6rgauthor=H.+Limauthor=N.+B.+Vinhauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=P.+J.+Scammells&title=4-Phenylpyridin-2-one+derivatives%3A+a+novel+class+of+positive+allosteric+modulator+of+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Facs.jmedchem.5b01562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Jorg, Manuela; Lim, Herman; Vinh, Natalie B.; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Lane, J. Robert; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">388-409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pos. allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promising strategy for the treatment of the cognitive deficits assocd. with diseases including Alzheimer's and schizophrenia.  Herein, we report the design, synthesis, and characterization of a novel family of M1 mAChR PAMs.  The most active compds. of the 4-phenylpyridin-2-one series exhibited comparable binding affinity to the ref. compd., 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA), but markedly improved pos. cooperativity with acetylcholine, and retained exquisite selectivity for the M1 mAChR.  Furthermore, the pharmacol. characterization revealed ligands with a diverse range of activities, including modulators that displayed both high intrinsic efficacy and PAM activity, those that showed no detectable agonism but robust PAM activity and ligands that displayed robust allosteric agonism but little modulatory activity.  Compd. I was found to have the best pharmacol. profile.  Thus, the 4-phenylpyridin-2-one scaffold offers an attractive starting point for further lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMlFmtgndXrbVg90H21EOLACvtfcHk0ljC3EHzWpC-_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFegu7zP&md5=315362c43e2b6c204f038f30c6ade642</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01562%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DJ%25C3%25B6rg%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%26aulast%3DVinh%26aufirst%3DN.%2BB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3D4-Phenylpyridin-2-one%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520positive%2520allosteric%2520modulator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D388%26epage%3D409%26doi%3D10.1021%2Facs.jmedchem.5b01562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jörg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">Novel fused arylpyrimidinone based allosteric modulators of the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=647-661&author=S.+N.+Mistryauthor=H.+Limauthor=M.+J%C3%B6rgauthor=B.+Capuanoauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=P.+J.+Scammells&title=Novel+fused+arylpyrimidinone+based+allosteric+modulators+of+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Facschemneuro.6b00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Lim, Herman; Jorg, Manuela; Capuano, Ben; Christopoulos, Arthur; Lane, J. Robert; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">647-661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzoquinazolinone 1 is a pos. allosteric modulator (PAM) of the M1 muscarinic acetylcholine receptor (mAChR), which is significantly more potent than the prototypical PAM, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA).  In this study, we explored the structural determinants that underlie the activity of 1 as a PAM of the M1 mAChR.  We paid particular attention to the importance of the tricyclic scaffold of compd. 1, for the activity of the mol.  Complete deletion of the peripheral fused benzene ring caused a significant decrease in affinity and binding cooperativity with acetylcholine (ACh).  This loss of affinity was rescued with the addn. of either one or two Me groups in the 7- and/or 8-position of the quinazolin-4(3H)-one core.  These results demonstrate that the tricyclic benzo[h]quinazolin-4(3H)-one core could be replaced with a quinazolin-4(3H)-one core and maintain functional affinity.  As such, the quinazolin-4(3H)-one core represents a novel scaffold to further explore M1 mAChR PAMs with improved physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpah7jlrVCf2rVg90H21EOLACvtfcHk0ljC3EHzWpC-_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaitL4%253D&md5=6e2271cd08c284eac5cdb0a553dd7839</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00018%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DLim%26aufirst%3DH.%26aulast%3DJ%25C3%25B6rg%26aufirst%3DM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520fused%2520arylpyrimidinone%2520based%2520allosteric%2520modulators%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D647%26epage%3D661%26doi%3D10.1021%2Facschemneuro.6b00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugolenski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgerton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotarski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon-Ferrer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Design and optimization of selective azaindole amide M<sub>1</sub> positive allosteric modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2Fj.bmcl.2015.11.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=26631313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=650-655&issue=2&author=J.+E.+Davorenauthor=S.+V.+O%E2%80%99Neilauthor=D.+P.+Andersonauthor=M.+a.+Brodneyauthor=L.+Chenardauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=M.+Greenauthor=M.+Garnseyauthor=S.+Grimwoodauthor=A.+R.+Harrisauthor=G.+W.+Kauffmanauthor=E.+Lachapelleauthor=J.+T.+Lazzaroauthor=C.+W.+Leeauthor=S.+M.+Lotarskiauthor=D.+M.+Nasonauthor=R.+S.+Obachauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=J.+Yanauthor=L.+Zhang&title=Design+and+optimization+of+selective+azaindole+amide+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2015.11.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span></div><div class="casAuthors">Davoren, Jennifer E.; O'Neil, Steven V.; Anderson, Dennis P.; Brodney, Michael A.; Chenard, Lois; Dlugolenski, Keith; Edgerton, Jeremy R.; Green, Michael; Garnsey, Michelle; Grimwood, Sarah; Harris, Anthony R.; Kauffman, Gregory W.; LaChapelle, Erik; Lazzaro, John T.; Lee, Che-Wah; Lotarski, Susan M.; Nason, Deane M.; Obach, R. Scott; Reinhart, Veronica; Salomon-Ferrer, Romelia; Steyn, Stefanus J.; Webb, Damien; Yan, Jiangli; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-655</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selective activation of the M1 receptor via a pos. allosteric modulator (PAM) is a new approach for the treatment of the cognitive impairments assocd. with schizophrenia and Alzheimer's disease.  A novel series of azaindole amides and their key pharmacophore elements are described.  The nitrogen of the azaindole core is a key design element as it forms an intramol. hydrogen bond with the amide N-H thus reinforcing the bioactive conformation predicted by published SAR and the authors' homol. model.  Representative compd. 25 is a potent and selective M1 PAM that has well aligned physicochem. properties, adequate brain penetration and pharmacokinetic (PK) properties, and is active in vivo.  These favorable properties indicate that this series possesses suitable qualities for further development and studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEhH8MxkKIrVg90H21EOLACvtfcHk0lidJ7C-CjqXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L&md5=5c227d1371fe4f0cc3348af8314dd370</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DBrodney%26aufirst%3DM.%2Ba.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLachapelle%26aufirst%3DE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDesign%2520and%2520optimization%2520of%2520selective%2520azaindole%2520amide%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D650%26epage%3D655%26doi%3D10.1016%2Fj.bmcl.2015.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugolenski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgerton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotarski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northcott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottebaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon-Ferrer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of the potent and selective M<sub>1</sub> PAM-agonist N-[(3R,4S)-3-hydroxytetrahydro-2h-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): evaluation of efficacy and cholinergic side effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6313</span>– <span class="NLM_lpage">6328</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsVCltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6313-6328&author=J.+E.+Davorenauthor=C.+W.+Leeauthor=M.+Garnseyauthor=M.+A.+Brodneyauthor=J.+Cordesauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=A.+R.+Harrisauthor=C.+J.+Helalauthor=S.+Jenkinsonauthor=G.+W.+Kauffmanauthor=T.+P.+Kenakinauthor=J.+T.+Lazzaroauthor=S.+M.+Lotarskiauthor=Y.+Maoauthor=D.+M.+Nasonauthor=C.+Northcottauthor=L.+Nottebaumauthor=S.+V.+O%E2%80%99Neilauthor=B.+Pettersenauthor=M.+Popiolekauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=L.+Zhangauthor=S.+Grimwood&title=Discovery+of+the+potent+and+selective+M1+PAM-agonist+N-%5B%283R%2C4S%29-3-hydroxytetrahydro-2h-pyran-4-yl%5D-5-methyl-4-%5B4-%281%2C3-thiazol-4-yl%29benzyl%5Dpyridine-2-carboxamide+%28PF-06767832%29%3A+evaluation+of+efficacy+and+cholinergic+side+effects&doi=10.1021%2Facs.jmedchem.6b00544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects</span></div><div class="casAuthors">Davoren, Jennifer E.; Lee, Che-Wah; Garnsey, Michelle; Brodney, Michael A.; Cordes, Jason; Dlugolenski, Keith; Edgerton, Jeremy R.; Harris, Anthony R.; Helal, Christopher J.; Jenkinson, Stephen; Kauffman, Gregory W.; Kenakin, Terrence P.; Lazzaro, John T.; Lotarski, Susan M.; Mao, Yuxia; Nason, Deane M.; Northcott, Carrie; Nottebaum, Lisa; O'Neil, Steven V.; Pettersen, Betty; Popiolek, Michael; Reinhart, Veronica; Salomon-Ferrer, Romelia; Steyn, Stefanus J.; Webb, Damien; Zhang, Lei; Grimwood, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6313-6328</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is hypothesized that selective muscarinic M1 subtype activation could be a strategy to provide cognitive benefits to schizophrenia and Alzheimer's disease patients while minimizing the cholinergic side effects obsd. with nonselective muscarinic orthosteric agonists.  Selective activation of M1 with a pos. allosteric modulator (PAM) has emerged as a new approach to achieve selective M1 activation.  This manuscript describes the development of a series of M1-selective pyridone and pyridine amides and their key pharmacophores.  Compd. I (PF-06767832) is a high quality M1 selective PAM that has well-aligned physicochem. properties, good brain penetration and pharmacokinetic properties.  Extensive safety profiling suggested that despite being devoid of mAChR M2/M3 subtype activity, compd. I still carries gastrointestinal and cardiovascular side effects.  These data provide strong evidence that M1 activation contributes to the cholinergic liabilities that were previously attributed to activation of the M2 and M3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR9OBduAoGH7Vg90H21EOLACvtfcHk0li0hRKFnDXigA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsVCltr4%253D&md5=1f45fef3e689b276a70154785d7d21e6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00544%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCordes%26aufirst%3DJ.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DNorthcott%26aufirst%3DC.%26aulast%3DNottebaum%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DPettersen%26aufirst%3DB.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520the%2520potent%2520and%2520selective%2520M1%2520PAM-agonist%2520N-%255B%25283R%252C4S%2529-3-hydroxytetrahydro-2h-pyran-4-yl%255D-5-methyl-4-%255B4-%25281%252C3-thiazol-4-yl%2529benzyl%255Dpyridine-2-carboxamide%2520%2528PF-06767832%2529%253A%2520evaluation%2520of%2520efficacy%2520and%2520cholinergic%2520side%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6313%26epage%3D6328%26doi%3D10.1021%2Facs.jmedchem.6b00544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nance, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remke, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barrantes, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engers, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engers, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Diverse effects on M<sub>1</sub> signaling and adverse effect liability within a series of M<sub>1</sub> ago-PAMs</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00429</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFaiurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=866-883&author=J.+M.+Rookauthor=M.+Abeauthor=H.+P.+Choauthor=K.+D.+Nanceauthor=V.+B.+Luscombeauthor=J.+J.+Adamsauthor=J.+W.+Dickersonauthor=D.+H.+Remkeauthor=P.+M.+Garcia-Barrantesauthor=D.+W.+Engersauthor=J.+L.+Engersauthor=S.+Changauthor=J.+J.+Fosterauthor=A.+L.+Blobaumauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Diverse+effects+on+M1+signaling+and+adverse+effect+liability+within+a+series+of+M1+ago-PAMs&doi=10.1021%2Facschemneuro.6b00429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs</span></div><div class="casAuthors">Rook, Jerri M.; Abe, Masahito; Cho, Hyekyung P.; Nance, Kellie D.; Luscombe, Vincent B.; Adams, Jeffrey J.; Dickerson, Jonathan W.; Remke, Daniel H.; Garcia-Barrantes, Pedro M.; Engers, Darren W.; Engers, Julie L.; Chang, Sichen; Foster, Jarrett J.; Blobaum, Anna L.; Niswender, Colleen M.; Jones, Carrie K.; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">866-883</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Both historical clin. and recent preclin. data suggest that the M1 muscarinic acetylcholine receptor is an exciting target for the treatment of Alzheimer's disease and the cognitive and neg. symptom clusters in schizophrenia; however, early drug discovery efforts targeting the orthosteric binding site have failed to afford selective M1 activation.  Efforts then shifted to focus on selective activation of M1 via either allosteric agonists or pos. allosteric modulators (PAMs).  While M1 PAMs have robust efficacy in rodent models, some chemotypes can induce cholinergic adverse effects (AEs) that could limit their clin. utility.  Here, the authors report studies aimed at understanding the subtle structural and pharmacol. nuances that differentiate efficacy from adverse effect liability within an indole-based series of M1 ago-PAMs.  The authors' data demonstrate that closely related M1 PAMs can display striking differences in their in vivo activities, and esp. their propensities to induce adverse effects.  The authors report the discovery of a novel PAM in this series that is devoid of observable adverse effect liability.  Interestingly, the mol. pharmacol. profile of this novel PAM is similar to that of a representative M1 PAM that induces severe AEs.  For instance, both compds. are potent ago-PAMs that demonstrate significant interaction with the orthosteric site (either bi-topic or neg. cooperativity).  However, there are subtle differences in efficacies of the compds. at potentiating M1 responses, agonist potencies, and abilities to induce receptor internalization.  While these differences may contribute to the differential in vivo profiles of these compds., the in vitro differences are relatively subtle and highlight the complexities of allosteric modulators and the need to focus on in vivo phenotypic screening to identify safe and effective M1 PAMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTbiEiZmJq3bVg90H21EOLACvtfcHk0li0hRKFnDXigA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFaiurzK&md5=06d92ac4fccfaf7ea8ff3be807dacdc5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00429%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DNance%26aufirst%3DK.%2BD.%26aulast%3DLuscombe%26aufirst%3DV.%2BB.%26aulast%3DAdams%26aufirst%3DJ.%2BJ.%26aulast%3DDickerson%26aufirst%3DJ.%2BW.%26aulast%3DRemke%26aufirst%3DD.%2BH.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DEngers%26aufirst%3DJ.%2BL.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DJ.%2BJ.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiverse%2520effects%2520on%2520M1%2520signaling%2520and%2520adverse%2520effect%2520liability%2520within%2520a%2520series%2520of%2520M1%2520ago-PAMs%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D866%26epage%3D883%26doi%3D10.1021%2Facschemneuro.6b00429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgerton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotarski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottebaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of γ- and δ-lactam m1 positive allosteric modulators (PAMs): convulsion and cholinergic toxicity of an M<sub>1</sub>-selective PAM with weak agonist activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6649</span>– <span class="NLM_lpage">6663</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6649-6663&issue=15&author=J.+E.+Davorenauthor=M.+Garnseyauthor=B.+Pettersenauthor=M.+A.+Brodneyauthor=J.+R.+Edgertonauthor=J.+P.+Fortinauthor=S.+Grimwoodauthor=A.+R.+Harrisauthor=S.+Jenkinsonauthor=T.+Kenakinauthor=J.+T.+Lazzaroauthor=C.+W.+Leeauthor=S.+M.+Lotarskiauthor=L.+Nottebaumauthor=S.+V.+O%E2%80%99Neilauthor=M.+Popiolekauthor=S.+Ramseyauthor=S.+J.+Steynauthor=C.+A.+Thornauthor=L.+Zhangauthor=D.+Webb&title=Design+and+synthesis+of+%CE%B3-+and+%CE%B4-lactam+m1+positive+allosteric+modulators+%28PAMs%29%3A+convulsion+and+cholinergic+toxicity+of+an+M1-selective+PAM+with+weak+agonist+activity&doi=10.1021%2Facs.jmedchem.7b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity</span></div><div class="casAuthors">Davoren, Jennifer E.; Garnsey, Michelle; Pettersen, Betty; Brodney, Michael A.; Edgerton, Jeremy R.; Fortin, Jean-Philippe; Grimwood, Sarah; Harris, Anthony R.; Jenkinson, Stephen; Kenakin, Terry; Lazzaro, John T.; Lee, Che-Wah; Lotarski, Susan M.; Nottebaum, Lisa; O'Neil, Steven V.; Popiolek, Michael; Ramsey, Simeon; Steyn, Stefanus J.; Thorn, Catherine A.; Zhang, Lei; Webb, Damien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6649-6663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent data demonstrated that activation of the muscarinic M1 receptor by a subtype-selective pos. allosteric modulator (PAM) contributes to the gastrointestinal (GI) and cardiovascular (CV) cholinergic adverse events (AEs) previously attributed to M2 and M3 activation.  These studies were conducted using PAMs that also exhibited allosteric agonist activity, leaving open the possibility that direct activation by allosteric agonism, rather than allosteric modulation, could be responsible for the adverse effects.  This article describes the design and synthesis of lactam-derived M1 PAMs that address this hypothesis.  The lead mol. from this series, compd. I (PF-06827443), is a potent, low-clearance, orally bioavailable and CNS-penetrant M1-selective PAM with minimal agonist activity.  Compd. I was tested in dose escalation studies in rats and dogs and was found to induce cholinergic AEs and convulsion at therapeutic indexes similar to previous compds. with more agonist activity.  These findings provide preliminary evidence that pos. allosteric modulation of M1 is sufficient to elicit cholinergic AEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdLnKqXoZLrVg90H21EOLACvtfcHk0lg3J9SrpjFvmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSktbg%253D&md5=abd7e12d7dc959269a0bae608467f827</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00597%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DPettersen%26aufirst%3DB.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DFortin%26aufirst%3DJ.%2BP.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DNottebaum%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DRamsey%26aufirst%3DS.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DThorn%26aufirst%3DC.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWebb%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B3-%2520and%2520%25CE%25B4-lactam%2520m1%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%253A%2520convulsion%2520and%2520cholinergic%2520toxicity%2520of%2520an%2520M1-selective%2520PAM%2520with%2520weak%2520agonist%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D15%26spage%3D6649%26epage%3D6663%26doi%3D10.1021%2Facs.jmedchem.7b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catterall, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlert, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">947</span>, <span class="refDoi"> DOI: 10.1124/pr.114.008862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1124%2Fpr.114.008862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=25026896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKht73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=918-947&issue=4&author=A.+Christopoulosauthor=J.-P.+Changeuxauthor=W.+A.+Catterallauthor=D.+Fabbroauthor=T.+P.+Burrisauthor=J.+A.+Cidlowskiauthor=R.+W.+Olsenauthor=J.+A.+Petersauthor=R.+R.+Neubigauthor=J.-P.+Pinauthor=P.+M.+Sextonauthor=T.+P.+Kenakinauthor=F.+J.+Ehlertauthor=M.+Speddingauthor=C.+J.+Langmead&title=International+Union+of+Basic+and+Clinical+Pharmacology.+XC.+multisite+pharmacology%3A+recommendations+for+the+nomenclature+of+receptor+allosterism+and+allosteric+ligands&doi=10.1124%2Fpr.114.008862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands</span></div><div class="casAuthors">Christopoulos, Arthur; Changeux, Jean-Pierre; Catterall, William A.; Fabbro, Doriano; Burris, Thomas P.; Cidlowski, John A.; Olsen, Richard W.; Peters, John A.; Neubig, Richard R.; Pin, Jean-Philippe; Sexton, Patrick M.; Kenakin, Terry P.; Ehlert, Frederick J.; Spedding, Michael; Langmead, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">918-947</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Allosteric interactions play vital roles in metabolic processes and signal transduction and, more recently, have become the focus of numerous pharmacol. studies because of the potential for discovering more target-selective chem. probes and therapeutic agents.  In addn. to classic early studies on enzymes, there are now examples of small mol. allosteric modulators for all superfamilies of receptors encoded by the genome, including ligand- and voltage-gated ion channels, G protein-coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases.  As a consequence, a vast array of pharmacol. behaviors has been ascribed to allosteric ligands that can vary in a target-, ligand-, and cell-/tissue-dependent manner.  The current article presents an overview of allostery as applied to receptor families and approaches for detecting and validating allosteric interactions and gives recommendations for the nomenclature of allosteric ligands and their properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2h0E0L_c0J7Vg90H21EOLACvtfcHk0lg3J9SrpjFvmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKht73N&md5=cca779691cfc36cc3f06aaf495522c22</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.008862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.008862%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DChangeux%26aufirst%3DJ.-P.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26aulast%3DOlsen%26aufirst%3DR.%2BW.%26aulast%3DPeters%26aufirst%3DJ.%2BA.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DEhlert%26aufirst%3DF.%2BJ.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520XC.%2520multisite%2520pharmacology%253A%2520recommendations%2520for%2520the%2520nomenclature%2520of%2520receptor%2520allosterism%2520and%2520allosteric%2520ligands%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D66%26issue%3D4%26spage%3D918%26epage%3D947%26doi%3D10.1124%2Fpr.114.008862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertekap, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benitex, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nophsker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwell, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sum, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrante, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendricson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvijic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentles, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span> <span> </span><span class="NLM_article-title">Evidence for classical cholinergic toxicity associated with selective activation of M<sub>1</sub> muscarinic receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.226910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1124%2Fjpet.115.226910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=26582730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVelsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=293-304&author=A.+Altauthor=A.+Pendriauthor=R.+L.+Bertekapauthor=G.+Liauthor=Y.+Benitexauthor=M.+Nophskerauthor=K.+L.+Rockwellauthor=N.+T.+Burfordauthor=C.+S.+Sumauthor=J.+Chenauthor=J.+J.+Herbstauthor=M.+Ferranteauthor=A.+Hendricsonauthor=M.+E.+Cvijicauthor=R.+S.+Westphalauthor=J.+O%E2%80%99Connellauthor=M.+Banksauthor=L.+Zhangauthor=R.+G.+Gentlesauthor=S.+Jenkinsauthor=J.+Loyauthor=J.+E.+Macor&title=Evidence+for+classical+cholinergic+toxicity+associated+with+selective+activation+of+M1+muscarinic+receptors&doi=10.1124%2Fjpet.115.226910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for classical cholinergic toxicity associated with selective activation of M1 muscarinic receptors</span></div><div class="casAuthors">Alt, Andrew; Pendri, Annapurna; Bertekap, Robert L., Jr.; Li, Guo; Benitex, Yulia; Nophsker, Michelle; Rockwell, Kristin L.; Burford, Neil T.; Sum, Chi Shing; Chen, Jing; Herbst, John J.; Ferrante, Meredith; Hendricson, Adam; Cvijic, Mary Ellen; Westphal, Ryan S.; O'Connell, Jonathan; Banks, Martyn; Zhang, Litao; Gentles, Robert G.; Jenkins, Susan; Loy, James; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The muscarinic acetylcholine receptor subtype 1 (M1) receptors play an important role in cognition and memory, and are considered to be attractive targets for the development of novel medications to treat cognitive impairments seen in schizophrenia and Alzheimer's disease.  Indeed, the M1 agonist xanomeline has been shown to produce beneficial cognitive effects in both Alzheimer's disease and schizophrenia patients.  Unfortunately, the therapeutic utility of xanomeline was limited by cholinergic side effects (sweating, salivation, gastrointestinal distress), which are believed to result from nonselective activation of other muscarinic receptor subtypes such as M2 and M3.  Therefore, drug discovery efforts targeting the M1 receptor have focused on the discovery of compds. with improved selectivity profiles.  Recently, allosteric M1 receptor ligands have been described, which exhibit excellent selectivity for M1 over other muscarinic receptor subtypes.  In the current study, the following three compds. with mixed agonist/pos. allosteric modulator activities that are highly functionally selective for the M1 receptor were tested in rats, dogs, and cynomologous monkeys: (3-((1S,2S)-2-hydrocyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one; 1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid; and (R)-Et 3-(2-methylbenzamido)-[1,4'-bipiperidine]-1'-carboxylate).  Despite their selectivity for the M1 receptor, all three compds. elicited cholinergic side effects such as salivation, diarrhea, and emesis.  These effects could not be explained by activity at other muscarinic receptor subtypes, or by activity at other receptors tested.  Together, these results suggest that activation of M1 receptors alone is sufficient to produce unwanted cholinergic side effects such as those seen with xanomeline.  This has important implications for the development of M1 receptor-targeted therapeutics since it suggests that dose-limiting cholinergic side effects still reside in M1 receptor selective activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zRN2771-9bVg90H21EOLACvtfcHk0ljBCaQyZEcRVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVelsLo%253D&md5=6cf55475ab7da402a6e08099bfc0f030</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.226910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.226910%26sid%3Dliteratum%253Aachs%26aulast%3DAlt%26aufirst%3DA.%26aulast%3DPendri%26aufirst%3DA.%26aulast%3DBertekap%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBenitex%26aufirst%3DY.%26aulast%3DNophsker%26aufirst%3DM.%26aulast%3DRockwell%26aufirst%3DK.%2BL.%26aulast%3DBurford%26aufirst%3DN.%2BT.%26aulast%3DSum%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHerbst%26aufirst%3DJ.%2BJ.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DHendricson%26aufirst%3DA.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DWestphal%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DBanks%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGentles%26aufirst%3DR.%2BG.%26aulast%3DJenkins%26aufirst%3DS.%26aulast%3DLoy%26aufirst%3DJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DEvidence%2520for%2520classical%2520cholinergic%2520toxicity%2520associated%2520with%2520selective%2520activation%2520of%2520M1%2520muscarinic%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D293%26epage%3D304%26doi%3D10.1124%2Fjpet.115.226910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2007.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2Fj.tips.2007.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=17629965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=382-389&issue=8&author=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+GPCR+modulators%3A+taking+advantage+of+permissive+receptor+pharmacology&doi=10.1016%2Fj.tips.2007.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology</span></div><div class="casAuthors">Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">382-389</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a dramatic increase in the identification of allosteric modulators of G-protein-coupled receptor (GPCR) activity.  Concomitantly, several new perspectives and hypotheses regarding the way ligands regulate GPCR signaling have also emerged.  Here, we briefly discuss how the concepts of collateral efficacy and permissive agonism-antagonism intersect the field of allosteric GPCR modulation.  Despite the challenges assocd. with detecting and quantifying the myriad of possible allosteric effects on GPCR activity, it is proposed that allosteric ligands offer the exciting prospect of engendering stimulus-bias in orthosteric ligand signaling, thus paving the way for not only receptor-selective but also signaling-pathway-selective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpHb_QsIW3TbVg90H21EOLACvtfcHk0ljBCaQyZEcRVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltLs%253D&md5=943da2312e7b136cb594ba0346e00301</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520GPCR%2520modulators%253A%2520taking%2520advantage%2520of%2520permissive%2520receptor%2520pharmacology%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26issue%3D8%26spage%3D382%26epage%3D389%26doi%3D10.1016%2Fj.tips.2007.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">A Monod-Wyman-Changeux Mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.314278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1074%2Fjbc.M111.314278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=22086918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=650-659&issue=1&author=M.+Canalsauthor=J.+R.+Laneauthor=A.+Wenauthor=P.+J.+Scammellsauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=A+Monod-Wyman-Changeux+Mechanism+can+explain+G+protein-coupled+receptor+%28GPCR%29+allosteric+modulation&doi=10.1074%2Fjbc.M111.314278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation</span></div><div class="casAuthors">Canals, Meritxell; Lane, J. Robert; Wen, Adriel; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">650-659</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Monod-Wyman-Changeux (MWC) model was initially proposed to describe the allosteric properties of regulatory enzymes and subsequently extended to receptors.  Yet despite GPCRs representing the largest family of receptors and drug targets, no study has systematically evaluated the MWC mechanism as it applies to GPCR allosteric ligands.  We reveal how the recently described allosteric modulator, benzyl quinolone carboxylic acid (BQCA), behaves according to a strict, two-state MWC mechanism at the M1 muscarinic acetylcholine receptor (mAChR).  Despite having a low affinity for the M1 mAChR, BQCA demonstrated state dependence, exhibiting high pos. cooperativity with orthosteric agonists in a manner that correlated with efficacy but neg. cooperativity with inverse agonists.  The activity of BQCA was significantly increased at a constitutively active M1 mAChR but abolished at an inactive mutant.  Interestingly, BQCA possessed intrinsic signaling efficacy, ranging from near-quiescence to full agonism depending on the coupling efficiency of the chosen intracellular pathway.  This latter cellular property also detd. the difference in magnitude of pos. cooperativity between BQCA and the orthosteric agonist, carbachol, across pathways.  The lack of addnl., pathway-biased, allosteric modulation by BQCA was confirmed in genetically engineered yeast strains expressing different chimeras between the endogenous yeast Gpa1 protein and human Gα subunits.  These findings define a chem. biol. framework that can be applied to the study and classification of allosteric modulators across different GPCR families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrrH0vtUu5lbVg90H21EOLACvtfcHk0lglEdI1_EnlyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVGh&md5=45d079afd141a137baf24fe171180124</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.314278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.314278%26sid%3Dliteratum%253Aachs%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DWen%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520Monod-Wyman-Changeux%2520Mechanism%2520can%2520explain%2520G%2520protein-coupled%2520receptor%2520%2528GPCR%2529%2520allosteric%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D1%26spage%3D650%26epage%3D659%26doi%3D10.1074%2Fjbc.M111.314278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Advances in G protein-coupled receptor allostery: from function to structure</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1124/mol.114.094342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1124%2Fmol.114.094342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=463-478&issue=5&author=A.+Christopoulos&title=Advances+in+G+protein-coupled+receptor+allostery%3A+from+function+to+structure&doi=10.1124%2Fmol.114.094342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.094342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.094342%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520G%2520protein-coupled%2520receptor%2520allostery%253A%2520from%2520function%2520to%2520structure%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26issue%3D5%26spage%3D463%26epage%3D478%26doi%3D10.1124%2Fmol.114.094342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S. D.</span>; <span class="NLM_string-name">Beshore, D. C.</span>; <span class="NLM_string-name">Di Marco, C. N.</span>; <span class="NLM_string-name">Greshock, T. J.</span></span> <span> </span><span class="NLM_article-title">Benzoquinazolinone Derivatives as M<sub>1</sub> Receptor Positive Allosteric Modulators and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases</span>. <span class="NLM_patent">WO 2010/059773</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=C.+N.+Di+Marco&author=T.+J.+Greshock&title=Benzoquinazolinone+Derivatives+as+M1+Receptor+Positive+Allosteric+Modulators+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DBenzoquinazolinone%2520Derivatives%2520as%2520M1%2520Receptor%2520Positive%2520Allosteric%2520Modulators%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadam, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A. L.</span></span> <span> </span><span class="NLM_article-title">A Series of 2,4,5-trisubstituted oxazole: synthesis, characterization and DFT modelling</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1114</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2016.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2Fj.molstruc.2016.02.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1114&publication_year=2016&pages=181-188&author=V.+S.+Kadamauthor=S.+G.+Shaikhauthor=A.+L.+Patel&title=A+Series+of+2%2C4%2C5-trisubstituted+oxazole%3A+synthesis%2C+characterization+and+DFT+modelling&doi=10.1016%2Fj.molstruc.2016.02.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2016.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2016.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DKadam%26aufirst%3DV.%2BS.%26aulast%3DShaikh%26aufirst%3DS.%2BG.%26aulast%3DPatel%26aufirst%3DA.%2BL.%26atitle%3DA%2520Series%2520of%25202%252C4%252C5-trisubstituted%2520oxazole%253A%2520synthesis%252C%2520characterization%2520and%2520DFT%2520modelling%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2016%26volume%3D1114%26spage%3D181%26epage%3D188%26doi%3D10.1016%2Fj.molstruc.2016.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed sequential C-N/C-O bond formations: synthesis of oxazole derivatives from amides and ketones</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">5906</span>– <span class="NLM_lpage">5909</span>, <span class="refDoi"> DOI: 10.1021/ol502916a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol502916a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5906-5909&issue=22&author=M.+Zhengauthor=L.+Huangauthor=H.+Huangauthor=X.+Liauthor=W.+Wuauthor=H.+Jiang&title=Palladium-catalyzed+sequential+C-N%2FC-O+bond+formations%3A+synthesis+of+oxazole+derivatives+from+amides+and+ketones&doi=10.1021%2Fol502916a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fol502916a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol502916a%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DPalladium-catalyzed%2520sequential%2520C-N%252FC-O%2520bond%2520formations%253A%2520synthesis%2520of%2520oxazole%2520derivatives%2520from%2520amides%2520and%2520ketones%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26issue%3D22%26spage%3D5906%26epage%3D5909%26doi%3D10.1021%2Fol502916a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desiraju, G. R.</span></span> <span> </span><span class="NLM_article-title">Strong and weak hydrogen bonds in the protein–ligand interface</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1002/prot.21253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1002%2Fprot.21253" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=128-141&author=S.+K.+Panigrahiauthor=G.+R.+Desiraju&title=Strong+and+weak+hydrogen+bonds+in+the+protein%E2%80%93ligand+interface&doi=10.1002%2Fprot.21253"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fprot.21253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21253%26sid%3Dliteratum%253Aachs%26aulast%3DPanigrahi%26aufirst%3DS.%2BK.%26aulast%3DDesiraju%26aufirst%3DG.%2BR.%26atitle%3DStrong%2520and%2520weak%2520hydrogen%2520bonds%2520in%2520the%2520protein%25E2%2580%2593ligand%2520interface%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2007%26volume%3D67%26spage%3D128%26epage%3D141%26doi%3D10.1002%2Fprot.21253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">Calculated using ChemDraw Ultra 12.0 Tools.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pajouhesh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G. R.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span>. <i>NeuroRx</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&issue=4&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eY7NMx2aOYNH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26issue%3D4%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulation of G protein-coupled receptors</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.47.120505.105159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=17009927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=1-51&author=L.+T.+Mayauthor=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+modulation+of+G+protein-coupled+receptors&doi=10.1146%2Fannurev.pharmtox.47.120505.105159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of G protein-coupled receptors</span></div><div class="casAuthors">May, Lauren T.; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-51</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a significant growth in the identification of allosteric modulators of G protein-coupled receptors (GPCRs), i.e., ligands that interact with binding sites that are topog. distinct from the orthosteric site recognized by the receptor's endogenous agonist.  Because of their ability to modulate receptor conformations in the presence of orthosteric ligand, allosteric modulators can "fine-tune" classical pharmacol. responses.  This is advantageous in terms of a potential for engendering greater GPCR subtype-selectivity, but represents a significant challenge for detecting and validating allosteric behaviors.  Although allosteric sites need not have evolved to accommodate endogenous ligands, there are a no. of examples of where such modulators have been shown to contribute to physiol. or pathophysiol. processes.  Studies are also beginning to unravel the structural basis of allosteric modulation of GPCRs.  It remains to be detd. whether such modulation represents interactions within monomers vs. across dimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6rgFXhej3ibVg90H21EOLACvtfcHk0lhrFtw6NVy33Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D&md5=848fa85abdfb3b40834887416479edec</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105159%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520modulation%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D1%26epage%3D51%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dallagnol, J. C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducatti, D. R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noseda, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, M. E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, A. G.</span></span> <span> </span><span class="NLM_article-title">Aqueous semisynthesis of C-glycoside glycamines from agarose</span>. <i>Beilstein J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1222</span>– <span class="NLM_lpage">1229</span>, <span class="refDoi"> DOI: 10.3762/bjoc.13.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.3762%2Fbjoc.13.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=28694868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKku7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1222-1229&author=J.+C.+C.+Dallagnolauthor=A.+Orsatoauthor=D.+R.+B.+Ducattiauthor=M.+D.+Nosedaauthor=M.+E.+R.+Duarteauthor=A.+G.+Gon%C3%A7alves&title=Aqueous+semisynthesis+of+C-glycoside+glycamines+from+agarose&doi=10.3762%2Fbjoc.13.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Aqueous semisynthesis of C-glycoside glycamines from agarose</span></div><div class="casAuthors">Dallagnol, Juliana C. Cunico; Orsato, Alexandre; Ducatti, Diogo R. B.; Noseda, Miguel D.; Duarte, Maria Eugenia R.; Goncalves, Alan G.</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1222-1229</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">Agarose was herein employed as starting material to produce primary, secondary and tertiary C-glycoside glycamines, including mono- and disaccharide structures.  The semisynthetic approach utilized was generally based on polysaccharide-controlled hydrolysis followed by reductive amination.  All reactions were conducted in aq. media and without the need of hydroxyl group protection.  We were able to identify optimal conditions for the reductive amination of agar hydrolysis products and to overcome the major difficulties related to this kind of reaction, also extending it to reducing anhydrosugars.  The excess of ammonium acetate, methyl- or dimethylamine, and the use of a dild. basic (pH 11) reaction media were identified as important aspects to achieve improved yields, as well as to decrease the amt. of byproducts commonly related to reductive amination of carbohydrates.  This strategy allowed the transposition of the 3,6-anhydro-α-L-galactopyranose unit (naturally present in the agarose structure) to all glycamines synthesized, constituting an amino-substituted C-threofuranoside moiety, which is closely related to (+)-muscarine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRHRRWDV_sw7Vg90H21EOLACvtfcHk0lhrFtw6NVy33Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKku7rP&md5=c6fd6d9e0b8c9f0f9b949d0ba8a015fa</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.13.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.13.121%26sid%3Dliteratum%253Aachs%26aulast%3DDallagnol%26aufirst%3DJ.%2BC.%2BC.%26aulast%3DOrsato%26aufirst%3DA.%26aulast%3DDucatti%26aufirst%3DD.%2BR.%2BB.%26aulast%3DNoseda%26aufirst%3DM.%2BD.%26aulast%3DDuarte%26aufirst%3DM.%2BE.%2BR.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DA.%2BG.%26atitle%3DAqueous%2520semisynthesis%2520of%2520C-glycoside%2520glycamines%2520from%2520agarose%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2017%26volume%3D13%26spage%3D1222%26epage%3D1229%26doi%3D10.3762%2Fbjoc.13.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulators of the adenosine A<sub>1</sub> receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4543</span>– <span class="NLM_lpage">4547</span>, <span class="refDoi"> DOI: 10.1021/jm9002582</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9002582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVyntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4543-4547&author=L.+Aurelioauthor=C.+Valantauthor=B.+L.+Flynnauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Allosteric+modulators+of+the+adenosine+A1+receptor%3A+synthesis+and+pharmacological+evaluation+of+4-substituted+2-amino-3-benzoylthiophenes&doi=10.1021%2Fjm9002582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Modulators of the Adenosine A1 Receptor: Synthesis and Pharmacological Evaluation of 4-Substituted 2-Amino-3-benzoylthiophenes</span></div><div class="casAuthors">Aurelio, Luigi; Valant, Celine; Flynn, Bernard L.; Sexton, Patrick M.; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4543-4547</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aminobenzoylthiophenes I [R = H, Cl; R1 = Ph, 3-F3CC6H4, 2-FC6H4, 3-FC6H4, 4-FC6H4, 3-ClC6H4, 4-ClC6H4, 3-BrC6H4, 4-BrC6H4, 4-IC6H4, 3-O2NC6H4, 4-O2NC6H4, 3-MeOC6H4, 4-MeOC6H4, 3,5-(F3C)2C6H3, 2-naphthyl] are prepd. either by titanium tetrachloride-mediated condensation of benzoylacetonitriles 4-RC6H4COCH2CN with acetophenones R1COMe followed by Ewart reactions with diethylamine and elemental sulfur in 3-40% yields or (in one case) by alkylation of benzoylacetonitrile with phenacyl bromide followed by cyclocondensation with sodium hydrosulfide in 60% yield.  I are tested for their ability to potentiate the modulation of the adenosine A1 receptor by the nonracemic phenylisopropyladenosine (R)-PIA; I [R = H; R1 = 3-F3CC6H4, 3,5-(F3C)2C6H3] are also tested for their abilities to potentiate the ability of (R)-PIA to activate adenosine A1 receptors for phosphorylation of ERK1/2 and for binding of an ATP analog to G protein α subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcV7jIOeR9RLVg90H21EOLACvtfcHk0lhrFtw6NVy33Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVyntb4%253D&md5=e91b1e7e8623c110a795c4a42d694af2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm9002582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9002582%26sid%3Dliteratum%253Aachs%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DFlynn%26aufirst%3DB.%2BL.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DAllosteric%2520modulators%2520of%2520the%2520adenosine%2520A1%2520receptor%253A%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%25204-substituted%25202-amino-3-benzoylthiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4543%26epage%3D4547%26doi%3D10.1021%2Fjm9002582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Assessing the distribution of parameters in models of ligand–receptor interaction: to log or not to log</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/S0165-6147(98)01240-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2FS0165-6147%2898%2901240-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=9786022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVegsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=351-357&issue=9&author=A.+Christopoulos&title=Assessing+the+distribution+of+parameters+in+models+of+ligand%E2%80%93receptor+interaction%3A+to+log+or+not+to+log&doi=10.1016%2FS0165-6147%2898%2901240-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log</span></div><div class="casAuthors">Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">351-357</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">It is quite common to see exptl. data analyzed according to a variety of models of ligand-receptor interaction.  Often, parameters derived from such models are compared statistically.  The most commonly employed statistical analyses contain explicit assumptions about the underlying distributions of the model parameters being compared, yet the validity of these assumptions is not often ascertained.  In this article, the author describes a general approach to Monte Carlo simulation of data, and outlines how the anal. of such simulated data may be used to address the question of the distribution of model parameters.  The results of such an exercise can guide the researcher to the appropriate choice of statistical test or data transform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGOgQrRExRnLVg90H21EOLACvtfcHk0liMw8Diron5hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVegsbg%253D&md5=c3f511b88eb38830ec5049e085e02306</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2898%2901240-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252898%252901240-1%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAssessing%2520the%2520distribution%2520of%2520parameters%2520in%2520models%2520of%2520ligand%25E2%2580%2593receptor%2520interaction%253A%2520to%2520log%2520or%2520not%2520to%2520log%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26issue%3D9%26spage%3D351%26epage%3D357%26doi%3D10.1016%2FS0165-6147%2898%2901240-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':[],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Karen J. Gregory, Thomas M. Bridges, Rocco G. Gogliotti, Shaun R. Stauffer, Meredith J. Noetzel, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, <span class="NLM_string-name hlFld-ContribAuthor">Colleen M. Niswender</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro to in Vivo Translation of Allosteric Modulator Concentration-Effect Relationships: Implications for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2019,</strong> <em>2 </em>
                                    (6)
                                     , 442-452. <a href="https://doi.org/10.1021/acsptsci.9b00062" title="DOI URL">https://doi.org/10.1021/acsptsci.9b00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.9b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.9b00062%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DIn%252BVitro%252Bto%252Bin%252BVivo%252BTranslation%252Bof%252BAllosteric%252BModulator%252BConcentration-Effect%252BRelationships%25253A%252BImplications%252Bfor%252BDrug%252BDiscovery%26aulast%3DGregory%26aufirst%3DKaren%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07082019%26date%3D27112019%26date%3D15112019%26volume%3D2%26issue%3D6%26spage%3D442%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manuela Jörg, Emma T. van der Westhuizen, Elham Khajehali, Wessel A. C. Burger, Jonathan M. White, Kwok H. C. Choy, Andrew B. Tobin, Patrick M. Sexton, Celine Valant, Ben Capuano, Arthur Christopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M1 mAChR: The Determinants of Allosteric Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 1099-1114. <a href="https://doi.org/10.1021/acschemneuro.8b00613" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00613%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D6-Phenylpyrimidin-4-ones%252Bas%252BPositive%252BAllosteric%252BModulators%252Bat%252Bthe%252BM1%252BmAChR%25253A%252BThe%252BDeterminants%252Bof%252BAllosteric%252BActivity%26aulast%3DJ%25C3%25B6rg%26aufirst%3DManuela%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06112018%26date%3D14122018%26date%3D28122018%26date%3D14122018%26volume%3D10%26issue%3D3%26spage%3D1099%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul K.  Spearing</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Vincent B.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Olivier  Boutaud</span>, <span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">P.  Jeffrey Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>47 </em>, 128193. <a href="https://doi.org/10.1016/j.bmcl.2021.128193" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128193%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bheteroaryl-pyrrolidinones%252Bas%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Bmuscarinic%252Bacetylcholine%252Breceptor%252BM1%26aulast%3DSpearing%26aufirst%3DPaul%2BK.%26date%3D2021%26volume%3D47%26spage%3D128193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liqiang  Hao</span>, <span class="hlFld-ContribAuthor ">Hongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Wen</span>, <span class="hlFld-ContribAuthor ">Chengcai  Xia</span>, <span class="hlFld-ContribAuthor ">Zengfen  Pang</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade reaction to 1H-pyrazoles from hydrazones via sodium Ni-trite promoted dual C–C/C–N formation, annulation and aromatization with 1,2-dichloroethane. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>32 </em>
                                    (7)
                                     , 2309-2312. <a href="https://doi.org/10.1016/j.cclet.2021.02.025" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.02.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.02.025%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DCascade%252Breaction%252Bto%252B1H-pyrazoles%252Bfrom%252Bhydrazones%252Bvia%252Bsodium%252BNi-trite%252Bpromoted%252Bdual%252BC%2525E2%252580%252593C%25252FC%2525E2%252580%252593N%252Bformation%25252C%252Bannulation%252Band%252Baromatization%252Bwith%252B1%25252C2-dichloroethane%26aulast%3DHao%26aufirst%3DLiqiang%26date%3D2021%26volume%3D32%26issue%3D7%26spage%3D2309%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma T.  van der Westhuizen</span>, <span class="hlFld-ContribAuthor ">K. H. Christopher  Choy</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Simon  McKenzie-Nickson</span>, <span class="hlFld-ContribAuthor ">Sophie J.  Bradley</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.606656" title="DOI URL">https://doi.org/10.3389/fphar.2020.606656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.606656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.606656%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DFine%252BTuning%252BMuscarinic%252BAcetylcholine%252BReceptor%252BSignaling%252BThrough%252BAllostery%252Band%252BBias%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DEmma%2BT.%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Elham  Khajehali</span>, <span class="hlFld-ContribAuthor ">Emma T.  Westhuizen</span>, <span class="hlFld-ContribAuthor ">K. H.  C. Choy</span>, <span class="hlFld-ContribAuthor ">David M.  Shackleford</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Novel 4‐Arylpyridin‐2‐one and 6‐Arylpyrimidin‐4‐one Positive Allosteric Modulators of the M
              1
              Muscarinic Acetylcholine Receptor. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 216-233. <a href="https://doi.org/10.1002/cmdc.202000540" title="DOI URL">https://doi.org/10.1002/cmdc.202000540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000540%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDevelopment%252Bof%252BNovel%252B4%2525E2%252580%252590Arylpyridin%2525E2%252580%2525902%2525E2%252580%252590one%252Band%252B6%2525E2%252580%252590Arylpyrimidin%2525E2%252580%2525904%2525E2%252580%252590one%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BM%252B1%252BMuscarinic%252BAcetylcholine%252BReceptor%26aulast%3DJ%25C3%25B6rg%26aufirst%3DManuela%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D216%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damoder Reddy  Motati</span>, <span class="hlFld-ContribAuthor ">Radhika  Amaradhi</span>, <span class="hlFld-ContribAuthor ">Thota  Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Azaindole therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115830. <a href="https://doi.org/10.1016/j.bmc.2020.115830" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115830%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAzaindole%252Btherapeutic%252Bagents%26aulast%3DMotati%26aufirst%3DDamoder%2BReddy%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroaki  Tanaka</span>, <span class="hlFld-ContribAuthor ">Kenji  Negoro</span>, <span class="hlFld-ContribAuthor ">Takanori  Koike</span>, <span class="hlFld-ContribAuthor ">Issei  Tsukamoto</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Yokoyama</span>, <span class="hlFld-ContribAuthor ">Jun  Maeda</span>, <span class="hlFld-ContribAuthor ">Yusuke  Inagaki</span>, <span class="hlFld-ContribAuthor ">Yukinori  Shimoshige</span>, <span class="hlFld-ContribAuthor ">Katsutoshi  Ino</span>, <span class="hlFld-ContribAuthor ">Kenichiro  Ishizu</span>, <span class="hlFld-ContribAuthor ">Taisuke  Takahashi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (13)
                                     , 115531. <a href="https://doi.org/10.1016/j.bmc.2020.115531" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115531%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bstructure-activity%252Brelationships%252Bstudy%252Bof%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bthe%252BM3%252Bmuscarinic%252Bacetylcholine%252Breceptor%26aulast%3DTanaka%26aufirst%3DHiroaki%26date%3D2020%26volume%3D28%26issue%3D13%26spage%3D115531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Jakubik</span>, <span class="hlFld-ContribAuthor ">Esam E.  El-Fakahany</span>. </span><span class="cited-content_cbyCitation_article-title">Current Advances in Allosteric Modulation of Muscarinic Receptors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 325. <a href="https://doi.org/10.3390/biom10020325" title="DOI URL">https://doi.org/10.3390/biom10020325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10020325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10020325%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DCurrent%252BAdvances%252Bin%252BAllosteric%252BModulation%252Bof%252BMuscarinic%252BReceptors%26aulast%3DJakubik%26aufirst%3DJan%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of M<sub>1</sub> mAChR PAM-agonists from Merck <b>1</b>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Pfizer <b>2</b>, <b>3</b>, <b>4</b>,<a onclick="showRef(event, 'ref21 ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref24">(21,22,24)</a> and Vanderbilt <b>5</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with the relevant pharmacological data. PAM EC<sub>50</sub> concentrations were obtained using calcium mobilization assays in the presence of a fixed EC<sub>20</sub> concentration of ACh (methodologies may differ slightly). Allosteric agonist EC<sub>50</sub> concentrations (Ago EC<sub>50</sub>) were obtained from concentration–response curves for the modulators in the absence of ACh. τ<sub>B</sub> values represent a measure of the efficacy of the modulators derived from operational model-fitting and were estimated in the present work from IP<sub>1</sub> accumulation assays. NA, not available.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of the representative M<sub>1</sub> mAChR PAM-agonist <b>6a</b>, labeling top, core, and pendant components of the molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route To Obtain a Diverse Range of Top Motifs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCTU, DIPEA, DMF; 21–46% yield; (b) <b>10</b>, K<sub>2</sub>CO<sub>3</sub>, DMF; 58–94% yield; (c) NH<sub>4</sub>OH<sub>(aq)</sub>, MeOH; 38% and 33% yield for <b>7b</b> and <b>7c</b>, respectively; (d) Boc<sub>2</sub>O, DCM/dioxane, 0 °C to rt; 15% yield; (e) TFA, DCM, 0 °C to rt; 67% and 86% yield for <b>6q</b> and <b>6r</b>, respectively; (f) CrO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, H<sub>2</sub>O, acetone, 0 °C to rt; 13% yield. All reactions were conducted overnight at rt unless otherwise stated.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of N,N-Disubstituted Amides and Oxazole Top Motifs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCTU, DIPEA, DMF; 17–25% for <b>14a</b>–<b>d</b> and 30–51% yield for <b>17a</b>–<b>e</b>; (b) <b>10</b>, K<sub>2</sub>CO<sub>3</sub>, DMF; 46–55% for <b>15a</b>–<b>d</b>, 58–98% for <b>18a</b>–<b>e</b>, and 19% yield for <b>21</b>; (c) TFA, DCM, 0 °C to rt; 56% yield; (d) 2-hydroxy-3-butanone, EDC·HCl, DMAP, DMF; <b>19</b> was not isolated; (e) NH<sub>4</sub>OAc, AcOH, 120 °C; 2% yield. All reactions were conducted overnight at rt unless otherwise stated.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route To Obtain a Diverse Range of Core Motifs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCTU, <i>trans</i>-2-aminocyclohexanol <b>7a</b>, DIPEA, DMF; 34–66% yield; (b) <b>10</b>, K<sub>2</sub>CO<sub>3</sub>, DMF; 47–82% yield. All reactions were conducted overnight at rt.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route To Obtain Compounds with a Range of Pendant Motifs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, THF/1 M Na<sub>2</sub>CO<sub>3</sub>, reflux; 70–72% yield; (b) SOCl<sub>2</sub>, DCM, 0 °C to rt; 95% yield; (c) <b>9a</b>, K<sub>2</sub>CO<sub>3</sub>, DMF; 26–83% yield; (d) EtOH/NaOH<sub>(aq)</sub>, reflux; 45% yield; (e) MeOH/NH<sub>4</sub>OH<sub>(aq)</sub>, reflux, 3 d; 32% yield. All reactions were conducted overnight at rt unless otherwise stated.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of ΔpEC<sub>50</sub> vs Δbaseline for carboxamide variants. Parameters were estimated from ACh concentration–response curves in the presence or absence of 10 μM of each compound in IP<sub>1</sub> accumulation assays in FlpIn CHO cells stably expressing the hM<sub>1</sub> mAChR. Plotted values represent the mean ± SEM of at least three experiments performed in duplicate. ΔpEC<sub>50</sub> = pEC<sub>50</sub> of (ACh + 10 μM compound) – pEC<sub>50</sub> of ACh (basal). Δbaseline = maximal stimulation of (ACh basal +10 μM compound) – maximal stimulation of ACh (basal). ΔpEC<sub>50</sub> was used as a surrogate of functional cooperativity for 10 μM modulator and Δbaseline as a surrogate of its direct agonism at the same concentration. In all graphs <b>1</b>, <b>2</b>, <b>3</b> (in blue) and <b>6a</b> (green) were included as reference compounds. Graphs: (A) plot of N-substituted carboxamides <b>6b</b>–<b>s</b>, top variants; (B) plot of N,N-disubstituted carboxamides <b>15a</b>–<b>d</b>, <b>18a</b>–<b>f</b>, and <b>21</b>, top variants. The estimated ΔpEC<sub>50</sub> and Δbaseline values are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf" class="ext-link">Supporting Information Table S1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of ΔpEC<sub>50</sub> vs Δbaseline for core and pendant variants. Parameters were estimated from ACh concentration–response curves in the presence or absence of 10 μM of each compound in IP<sub>1</sub> accumulation assays in FlpIn CHO cells stably expressing the hM<sub>1</sub> mAChR. Plotted values represent the mean ± SEM of three experiments performed in duplicate. Plotted values represent the mean ± SEM of at least three experiments performed in duplicate. ΔpEC<sub>50</sub> = pEC<sub>50</sub> of (ACh + 10 μM compound) – pEC<sub>50</sub> of ACh (basal). Δbaseline = maximal stimulation of (ACh basal + 10 μM compound) – maximal stimulation of ACh (basal). ΔpEC<sub>50</sub> was used as a surrogate of functional cooperativity for 10 μM modulator and Δbaseline as a surrogate of its direct agonism at the same concentration. In all graphs <b>1</b>, <b>2</b>, <b>3</b> (in blue) and <b>6a</b> (green) were included as reference compounds. Graphs: (A) plot of compounds <b>24a</b>–<b>e</b>, core variants; (B) plot of compounds <b>29b</b>–<b>i</b>, pendant variants. The estimated ΔpEC<sub>50</sub> and Δbaseline values are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_002.csv" class="ext-link">Supporting Information Table S1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/medium/jm-2017-01812t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Correlation analysis of the binding and functional parameters for the selected PAMs at the M<sub>1</sub> mAChR: (A) no significant correlation between binding cooperativity (α) estimates from whole cell radioligand binding assays and functional cooperativity (αβ) estimates from IP<sub>1</sub> accumulation assays; (B) significant correlation between functional cooperativity and intrinsic efficacy (τ<sub>B</sub>) values estimated from IP<sub>1</sub> accumulation assays. The solid line is the line of best fit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01812/20180406/images/large/jm-2017-01812t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01812&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i105">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span>; <span class="NLM_string-name">Wimo, A.</span>; <span class="NLM_string-name">Guerchet, M.</span>; <span class="NLM_string-name">Ali, G.</span>; <span class="NLM_string-name">WU, Y.</span>; <span class="NLM_string-name">Prina, M.</span></span> <i>World Alzheimer Report 2015</i>; <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Prince&author=A.+Wimo&author=M.+Guerchet&author=G.+Ali&author=Y.+WU&author=M.+Prina&title=World+Alzheimer+Report+2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26btitle%3DWorld%2520Alzheimer%2520Report%25202015%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lah, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levey, A. I.</span></span> <span> </span><span class="NLM_article-title">Deletion of M<sub>1</sub> muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4190</span>– <span class="NLM_lpage">4196</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.6393-09.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1523%2FJNEUROSCI.6393-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=20335454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVagtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=4190-4196&issue=12&author=A.+A.+Davisauthor=J.+J.+Fritzauthor=J.+Wessauthor=J.+J.+Lahauthor=A.+I.+Levey&title=Deletion+of+M1+muscarinic+acetylcholine+receptors+increases+amyloid+pathology+in+vitro+and+in+vivo&doi=10.1523%2FJNEUROSCI.6393-09.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo</span></div><div class="casAuthors">Davis, Albert A.; Fritz, Jason J.; Wess, Jurgen; Lah, James J.; Levey, Allan I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4190-4196</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurol. disorder that causes dementia and poses a major public health crisis as the population ages.  Aberrant processing of the amyloid precursor protein (APP) is strongly implicated as a proximal event in AD pathophysiol., but the neurochem. signals that regulate APP processing in the brain are not completely understood.  Activation of muscarinic acetylcholine receptors (mAChRs) has been shown to affect APP processing and AD pathol., but less is known about the roles of specific mAChR subtypes.  In this study, the authors used M1 mAChR knock-out mice (M1KO) to isolate the effects of the M1 mAChR on APP processing in primary neurons and on the development of amyloid pathol. in a transgenic mouse model of AD.  The authors demonstrate that the loss of M1 mAChRs increases amyloidogenic APP processing in neurons, as evidenced by decreased agonist-regulated shedding of the neuroprotective APP ectodomain APPsα and increased prodn. of toxic Aβ peptides.  Expression of M1 mAChRs on the M1KO background rescued this phenotype, indicating that M1 mAChRs are sufficient to modulate nonamyloidogenic APP processing.  In APPSwe/Ind transgenic mice, the loss of M1 mAChRs resulted in increased levels of brain Aβ and greater accumulation of amyloid plaque pathol.  Anal. of APP metabolites in APPSwe/Ind brain tissue indicates that the loss of M1 mAChRs increases amyloidogenic APP processing.  These results indicate that the M1 mAChR is an important regulator of amyloidogenesis in the brain and provide strong support for targeting the M1 mAChR as a therapeutic candidate in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAo3J0xlgL0rVg90H21EOLACvtfcHk0li1b-VpPQ9JRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVagtbg%253D&md5=40a6d71c0f01229f4134f0952dc73af7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.6393-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.6393-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DFritz%26aufirst%3DJ.%2BJ.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26atitle%3DDeletion%2520of%2520M1%2520muscarinic%2520acetylcholine%2520receptors%2520increases%2520amyloid%2520pathology%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26issue%3D12%26spage%3D4190%26epage%3D4196%26doi%3D10.1523%2FJNEUROSCI.6393-09.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baglietto-Vargas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada-Hernandez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cribbs, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laferla, F. M.</span></span> <span> </span><span class="NLM_article-title">Loss of muscarinic M<sub>1</sub> receptor exacerbates Alzheimer’s disease-like pathology and cognitive decline</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>179</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">980</span>– <span class="NLM_lpage">991</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2011.04.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2Fj.ajpath.2011.04.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=21704011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGjsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=980-991&issue=2&author=R.+Medeirosauthor=M.+Kitazawaauthor=A.+Caccamoauthor=D.+Baglietto-Vargasauthor=T.+Estrada-Hernandezauthor=D.+H.+Cribbsauthor=A.+Fisherauthor=F.+M.+Laferla&title=Loss+of+muscarinic+M1+receptor+exacerbates+Alzheimer%E2%80%99s+disease-like+pathology+and+cognitive+decline&doi=10.1016%2Fj.ajpath.2011.04.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline</span></div><div class="casAuthors">Medeiros, Rodrigo; Kitazawa, Masashi; Caccamo, Antonella; Baglietto-Vargas, David; Estrada-Hernandez, Tatiana; Cribbs, David H.; Fisher, Avraham; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">980-991</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is pathol. characterized by tau-laden neurofibrillary tangles and β-amyloid deposits.  Dysregulation of cholinergic neurotransmission has been implicated in AD pathogenesis, contributing to the assocd. memory impairments; yet, the exact mechanisms remain to be defined.  Activating the muscarinic acetylcholine M1 receptors (M1Rs) reduces AD-like pathol. features and enhances cognition in AD transgenic models.  To elucidate the mol. mechanisms by which M1Rs affect AD pathophysiol. features, we crossed the 3xTgAD and transgenic mice expressing human Swedish, Dutch, and Iowa triple-mutant amyloid precursor protein (Tg-SwDI), two widely used animal models, with the M1R-/- mice.  Our data show that M1R deletion in the 3xTgAD and Tg-SwDI mice exacerbates the cognitive impairment through mechanisms dependent on the transcriptional dysregulation of genes required for memory and through acceleration of AD-related synaptotoxicity.  Ablating the M1R increased plaque and tangle levels in the brains of 3xTgAD mice and elevated cerebrovascular deposition of fibrillar Aβ in Tg-SwDI mice.  Notably, tau hyperphosphorylation and potentiation of amyloidogenic processing in the mice with AD lacking M1R were attributed to changes in the glycogen synthase kinase 3β and protein kinase C activities.  Finally, deleting the M1R increased the astrocytic and microglial response assocd. with Aβ plaques.  Our data highlight the significant role that disrupting the M1R plays in exacerbating AD-related cognitive decline and pathol. features and provide crit. preclin. evidence to justify further development and evaluation of selective M1R agonists for treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmn8fzxarBbVg90H21EOLACvtfcHk0ljqTYv2ib4sLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGjsLzP&md5=f20cdd368aa5c1f8953ca565fd25cd5c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.04.041%26sid%3Dliteratum%253Aachs%26aulast%3DMedeiros%26aufirst%3DR.%26aulast%3DKitazawa%26aufirst%3DM.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DBaglietto-Vargas%26aufirst%3DD.%26aulast%3DEstrada-Hernandez%26aufirst%3DT.%26aulast%3DCribbs%26aufirst%3DD.%2BH.%26aulast%3DFisher%26aufirst%3DA.%26aulast%3DLaferla%26aufirst%3DF.%2BM.%26atitle%3DLoss%2520of%2520muscarinic%2520M1%2520receptor%2520exacerbates%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%2520and%2520cognitive%2520decline%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26issue%3D2%26spage%3D980%26epage%3D991%26doi%3D10.1016%2Fj.ajpath.2011.04.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mufson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Counts, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, S. D.</span></span> <span> </span><span class="NLM_article-title">Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1703</span>– <span class="NLM_lpage">1718</span>, <span class="refDoi"> DOI: 10.1586/14737175.8.11.1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1586%2F14737175.8.11.1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=18986241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlentLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1703-1718&issue=11&author=E.+J.+Mufsonauthor=S.+E.+Countsauthor=S.+E.+Perezauthor=S.+D.+Ginsberg&title=Cholinergic+system+during+the+progression+of+Alzheimer%E2%80%99s+disease%3A+therapeutic+implications&doi=10.1586%2F14737175.8.11.1703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinergic system during the progression of Alzheimer's disease: therapeutic implications</span></div><div class="casAuthors">Mufson, Elliott J.; Counts, Scott E.; Perez, Sylvia E.; Ginsberg, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1703-1718</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced cortical choline acetyltransferase activity assocd. with cognitive decline.  Delaying CBF neurodegeneration or minimizing its consequences is the mechanism of action for most currently available drug treatments for cognitive dysfunction in AD.  Growing evidence suggests that imbalances in the expression of NGF, its precursor proNGF and the high (TrkA) and low (p75NTR) affinity NGF receptors are crucial factors underlying CBF dysfunction in AD.  Drugs that maintain a homeostatic balance between TrkA and p75NTR may slow the onset of AD.  A NGF gene therapy trial reduced cognitive decline and stimulated cholinergic fiber growth in humans with mild AD.  Drugs treating the multiple pathologies and clin. symptoms in AD (e.g., M1 cholinoceptor and/or galaninergic drugs) should be considered for a more comprehensive treatment approach for cholinergic dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg6lsOaeDJ1rVg90H21EOLACvtfcHk0ljqTYv2ib4sLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlentLvP&md5=11a469f57aa07a70d57d7ee5bf0faf08</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1586%2F14737175.8.11.1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.8.11.1703%26sid%3Dliteratum%253Aachs%26aulast%3DMufson%26aufirst%3DE.%2BJ.%26aulast%3DCounts%26aufirst%3DS.%2BE.%26aulast%3DPerez%26aufirst%3DS.%2BE.%26aulast%3DGinsberg%26aufirst%3DS.%2BD.%26atitle%3DCholinergic%2520system%2520during%2520the%2520progression%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520therapeutic%2520implications%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2008%26volume%3D8%26issue%3D11%26spage%3D1703%26epage%3D1718%26doi%3D10.1586%2F14737175.8.11.1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span> <span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors: novel opportunities for drug development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1038/nrd4295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnrd4295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=24903776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlOitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=549-560&issue=7&author=A.+C.+Kruseauthor=B.+K.+Kobilkaauthor=D.+Gautamauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=J.+Wess&title=Muscarinic+acetylcholine+receptors%3A+novel+opportunities+for+drug+development&doi=10.1038%2Fnrd4295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors: novel opportunities for drug development</span></div><div class="casAuthors">Kruse, Andrew C.; Kobilka, Brian K.; Gautam, Dinesh; Sexton, Patrick M.; Christopoulos, Arthur; Wess, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The muscarinic acetylcholine receptors are a subfamily of G protein-coupled receptors that regulate numerous fundamental functions of the central and peripheral nervous system.  The past few years have witnessed unprecedented new insights into muscarinic receptor physiol., pharmacol. and structure.  These advances include the first structural views of muscarinic receptors in both inactive and active conformations, as well as a better understanding of the mol. underpinnings of muscarinic receptor regulation by allosteric modulators.  These recent findings should facilitate the development of new muscarinic receptor subtype-selective ligands that could prove to be useful for the treatment of many severe pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnDtWGoryjILVg90H21EOLACvtfcHk0ljYjbyhFoxDMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlOitbc%253D&md5=cc31a22098b5c613afac26df629d2a47</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4295%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGautam%26aufirst%3DD.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%253A%2520novel%2520opportunities%2520for%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D7%26spage%3D549%26epage%3D560%26doi%3D10.1038%2Fnrd4295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Muscarinic receptor agonists and antagonists in the treatment of Alzheimer’s disease</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3353</span>– <span class="NLM_lpage">3361</span>, <span class="refDoi"> DOI: 10.2174/138161205774370762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.2174%2F138161205774370762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=16250841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWrs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3353-3361&author=J.+W.+Claderauthor=Y.+Wang&title=Muscarinic+receptor+agonists+and+antagonists+in+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F138161205774370762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease</span></div><div class="casAuthors">Clader, John W.; Wang, Yuguang</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3353-3361</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the consistent findings in the brains of Alzheimer's Disease (AD) patients is loss of cholinergic function.  The cholinergic approach to treatment of AD involves counteracting this loss in cholinergic activity by pharmacol. intervention to increase cholinergic transmission.  The cognitive effects of acetylcholine are mediated via the muscarinic M1 receptor.  Direct stimulation of this receptor using muscarinic M1 agonists improves cognition in animal models and improves performance in cognitive tests in Alzheimer's patients.  Alternatively, antagonists of central presynaptic M2 receptors improves cognition by increasing the central release of acetylcholine.  Both approaches require high selectivity for one muscarinic receptor sub-type both for efficacy and to avoid cholinergic side effects.  In this review summarizes recent progress in the identification and characterization of selective muscarinic receptor ligands for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2_wdSDisNRLVg90H21EOLACvtfcHk0ljYjbyhFoxDMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWrs7vP&md5=d0d18c0299921abfbf6b815b223e743a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161205774370762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161205774370762%26sid%3Dliteratum%253Aachs%26aulast%3DClader%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DMuscarinic%2520receptor%2520agonists%2520and%2520antagonists%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26spage%3D3353%26epage%3D3361%26doi%3D10.2174%2F138161205774370762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potter, P. E.</span></span> <span> </span><span class="NLM_article-title">Investigational medications for treatment of patients with Alzheimer’s disease</span>. <i>J. Am. Osteopath. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">9, Suppl. 8</span>),  <span class="NLM_fpage">S27</span>– <span class="NLM_lpage">S36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=20926740" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=S27-S36&issue=9%2C+Suppl.+8&author=P.+E.+Potter&title=Investigational+medications+for+treatment+of+patients+with+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DP.%2BE.%26atitle%3DInvestigational%2520medications%2520for%2520treatment%2520of%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Osteopath.%2520Assoc.%26date%3D2010%26volume%3D110%26issue%3D9%252C%2520Suppl.%25208%26spage%3DS27%26epage%3DS36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, C.</span></span> <span> </span><span class="NLM_article-title">Use of cholinesterase inhibitors in dementia</span>. <i>Adv. Psychiatr. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1192/apt.8.2.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1192%2Fapt.8.2.89" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=89-96&issue=2&author=M.+Holdenauthor=C.+Kelly&title=Use+of+cholinesterase+inhibitors+in+dementia&doi=10.1192%2Fapt.8.2.89"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1192%2Fapt.8.2.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fapt.8.2.89%26sid%3Dliteratum%253Aachs%26aulast%3DHolden%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DC.%26atitle%3DUse%2520of%2520cholinesterase%2520inhibitors%2520in%2520dementia%26jtitle%3DAdv.%2520Psychiatr.%2520Treat.%26date%3D2002%26volume%3D8%26issue%3D2%26spage%3D89%26epage%3D96%26doi%3D10.1192%2Fapt.8.2.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. W.</span></span> <span> </span><span class="NLM_article-title">M<sub>1</sub> Muscarinic acetylcholine receptor in Alzheimer’s disease</span>. <i>Neurosci. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1007/s12264-013-1406-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1007%2Fs12264-013-1406-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=24590577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFCnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=295-307&author=S.+Jiangauthor=Y.+Liauthor=C.+Zhangauthor=Y.+Zhaoauthor=G.+Buauthor=H.+Xuauthor=Y.+W.+Zhang&title=M1+Muscarinic+acetylcholine+receptor+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs12264-013-1406-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">M1 muscarinic acetylcholine receptor in Alzheimer's disease</span></div><div class="casAuthors">Jiang, Shangtong; Li, Yanfang; Zhang, Cuilin; Zhao, Yingjun; Bu, Guojun; Xu, Huaxi; Zhang, Yun-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Bulletin</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-307</span>CODEN:
                <span class="NLM_cas:coden">NBEUAS</span>;
        ISSN:<span class="NLM_cas:issn">1995-8218</span>.
    
            (<span class="NLM_cas:orgname">Shanghai Institutes for Biological Sciences</span>)
        </div><div class="casAbstract">A review.  The degeneration of cholinergic neurons and cholinergic hypofunction are pathologies assocd. with Alzheimer's disease (AD).  Muscarinic acetylcholine receptors (mAChRs) mediate acetylcholine-induced neurotransmission and five mAChR subtypes (M1-M5) have been identified.  Among them, M1 mAChR is widely expressed in the central nervous system and has been implicated in many physiol. and pathol. brain functions.  In addn., M1 mAChR is postulated to be an important therapeutic target for AD and several other neurodegenerative diseases.  In this article, we review recent progress in understanding the functional involvement of M1 mAChR in AD pathol. and in developing M1 mAChR agonists for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyZ2OW85XkBLVg90H21EOLACvtfcHk0lg-8Cpe-sdVvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFCnsLs%253D&md5=49d567fbadcd979d8da458bc6a384caa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs12264-013-1406-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12264-013-1406-z%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BW.%26atitle%3DM1%2520Muscarinic%2520acetylcholine%2520receptor%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurosci.%2520Bull.%26date%3D2014%26volume%3D30%26spage%3D295%26epage%3D307%26doi%3D10.1007%2Fs12264-013-1406-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yurugi-Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiroishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span> <span> </span><span class="NLM_article-title">Structure of the human M<sub>2</sub> muscarinic acetylcholine receptor bound to an antagonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>482</i></span> (<span class="NLM_issue">7386</span>),  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/nature10753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnature10753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=22278061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ejsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=547-551&issue=7386&author=K.+Hagaauthor=A.+C.+Kruseauthor=H.+Asadaauthor=T.+Yurugi-Kobayashiauthor=M.+Shiroishiauthor=C.+Zhangauthor=W.+I.+Weisauthor=T.+Okadaauthor=B.+K.+Kobilkaauthor=T.+Hagaauthor=T.+Kobayashi&title=Structure+of+the+human+M2+muscarinic+acetylcholine+receptor+bound+to+an+antagonist&doi=10.1038%2Fnature10753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist</span></div><div class="casAuthors">Haga, Kazuko; Kruse, Andrew C.; Asada, Hidetsugu; Yurugi-Kobayashi, Takami; Shiroishi, Mitsunori; Zhang, Cheng; Weis, William I.; Okada, Tetsuji; Kobilka, Brian K.; Haga, Tatsuya; Kobayashi, Takuya</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7386</span>),
    <span class="NLM_cas:pages">547-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The X-ray crystal structure of the M2 muscarinic acetylcholine receptor, which is essential for the physiol. control of cardiovascular function, is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosewFev-FNErVg90H21EOLACvtfcHk0lg-8Cpe-sdVvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ejsro%253D&md5=c33b8d9303d58db7dfdd4c18ec4f597b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature10753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10753%26sid%3Dliteratum%253Aachs%26aulast%3DHaga%26aufirst%3DK.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DAsada%26aufirst%3DH.%26aulast%3DYurugi-Kobayashi%26aufirst%3DT.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DHaga%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26atitle%3DStructure%2520of%2520the%2520human%2520M2%2520muscarinic%2520acetylcholine%2520receptor%2520bound%2520to%2520an%2520antagonist%26jtitle%3DNature%26date%3D2012%26volume%3D482%26issue%3D7386%26spage%3D547%26epage%3D551%26doi%3D10.1038%2Fnature10753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlow, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosemond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chae, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure and dynamics of the M<sub>3</sub> muscarinic acetylcholine receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>482</i></span>,  <span class="NLM_fpage">552</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1038/nature10867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnature10867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=22358844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1eqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=552-556&author=A.+C.+Kruseauthor=J.+Huauthor=A.+C.+Panauthor=D.+H.+Arlowauthor=D.+M.+Rosenbaumauthor=E.+Rosemondauthor=H.+F.+Greenauthor=T.+Liuauthor=P.+S.+Chaeauthor=R.+O.+Drorauthor=D.+E.+Shawauthor=W.+I.+Weisauthor=J.+Wessauthor=B.+K.+Kobilka&title=Structure+and+dynamics+of+the+M3+muscarinic+acetylcholine+receptor&doi=10.1038%2Fnature10867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and dynamics of the M3 muscarinic acetylcholine receptor</span></div><div class="casAuthors">Kruse, Andrew C.; Hu, Jianxin; Pan, Albert C.; Arlow, Daniel H.; Rosenbaum, Daniel M.; Rosemond, Erica; Green, Hillary F.; Liu, Tong; Chae, Pil Seok; Dror, Ron O.; Shaw, David E.; Weis, William I.; Wess, Jurgen; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7386</span>),
    <span class="NLM_cas:pages">552-556</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acetylcholine, the first neurotransmitter to be identified, exerts many of its physiol. actions via activation of a family of G-protein-coupled receptors (GPCRs) known as muscarinic acetylcholine receptors (mAChRs).  Although the five mAChR subtypes (M1-M5) share a high degree of sequence homol., they show pronounced differences in G-protein coupling preference and the physiol. responses they mediate.  Unfortunately, despite decades of effort, no therapeutic agents endowed with clear mAChR subtype selectivity have been developed to exploit these differences.  We describe here the structure of the Gq/11-coupled M3 mAChR ('M3 receptor', from rat) bound to the bronchodilator drug tiotropium and identify the binding mode for this clin. important drug.  This structure, together with that of the Gi/o-coupled M2 receptor, offers possibilities for the design of mAChR subtype-selective ligands.  Importantly, the M3 receptor structure allows a structural comparison between two members of a mammalian GPCR subfamily displaying different G-protein coupling selectivities.  Furthermore, mol. dynamics simulations suggest that tiotropium binds transiently to an allosteric site en route to the binding pocket of both receptors.  These simulations offer a structural view of an allosteric binding mode for an orthosteric GPCR ligand and provide addnl. opportunities for the design of ligands with different affinities or binding kinetics for different mAChR subtypes.  Our findings not only offer insights into the structure and function of one of the most important GPCR families, but may also facilitate the design of improved therapeutics targeting these crit. receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozveVSiaQvz7Vg90H21EOLACvtfcHk0lji9yiF1rc1EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1eqs7k%253D&md5=31bb89b1d14cf122353fced8f905e996</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature10867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10867%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DA.%2BC.%26aulast%3DArlow%26aufirst%3DD.%2BH.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DRosemond%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DH.%2BF.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DChae%26aufirst%3DP.%2BS.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520and%2520dynamics%2520of%2520the%2520M3%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D552%26epage%3D556%26doi%3D10.1038%2Fnature10867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawaratne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bures, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachhawat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the M<sub>1</sub> and M<sub>4</sub> muscarinic acetylcholine receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>531</i></span> (<span class="NLM_issue">7594</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1038/nature17188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnature17188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=26958838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlGjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2016&pages=335-340&issue=7594&author=D.+M.+Thalauthor=B.+Sunauthor=D.+Fengauthor=V.+Nawaratneauthor=K.+Leachauthor=C.+C.+Felderauthor=M.+G.+Buresauthor=D.+A.+Evansauthor=W.+I.+Weisauthor=P.+Bachhawatauthor=T.+S.+Kobilkaauthor=P.+M.+Sextonauthor=B.+K.+Kobilkaauthor=A.+Christopoulos&title=Crystal+structures+of+the+M1+and+M4+muscarinic+acetylcholine+receptors&doi=10.1038%2Fnature17188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the M1 and M4 muscarinic acetylcholine receptors</span></div><div class="casAuthors">Thal, David M.; Sun, Bingfa; Feng, Dan; Nawaratne, Vindhya; Leach, Katie; Felder, Christian C.; Bures, Mark G.; Evans, David A.; Weis, William I.; Bachhawat, Priti; Kobilka, Tong Sun; Sexton, Patrick M.; Kobilka, Brian K.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">7594</span>),
    <span class="NLM_cas:pages">335-340</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Muscarinic M1-M5 acetylcholine receptors are G protein-coupled receptors (GPCRs) that regulate many vital functions of the central and peripheral nervous systems.  In particular, the M1 and M4 receptor subtypes have emerged as attractive drug targets for treatments of neurol. disorders, such as Alzheimer's disease and schizophrenia, but the high conservation of the acetylcholine-binding pocket has spurred current research into targeting allosteric sites on these receptors.  Here we report the crystal structures of the M1 and M4 muscarinic receptors bound to the inverse agonist, tiotropium.  Comparison of these structures with each other, as well as with the previously reported M2 and M3 receptor structures, reveals differences in the orthosteric and allosteric binding sites that contribute to a role in drug selectivity at this important receptor family.  We also report identification of a cluster of residues that form a network linking the orthosteric and allosteric sites of the M4 receptor, which provides new insight into how allosteric modulation may be transmitted between the two spatially distinct domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3oy2Ml852CrVg90H21EOLACvtfcHk0lji9yiF1rc1EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlGjurg%253D&md5=8ed3f453737ad0291cf5b2c088f528da</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature17188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17188%26sid%3Dliteratum%253Aachs%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DNawaratne%26aufirst%3DV.%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DBures%26aufirst%3DM.%2BG.%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DBachhawat%26aufirst%3DP.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DCrystal%2520structures%2520of%2520the%2520M1%2520and%2520M4%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DNature%26date%3D2016%26volume%3D531%26issue%3D7594%26spage%3D335%26epage%3D340%26doi%3D10.1038%2Fnature17188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seager, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graufelds, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCampbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shughrue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danziger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascarella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreatsoulas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabrook, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, W. J.</span></span> <span> </span><span class="NLM_article-title">Selective activation of the M<sub>1</sub> muscarinic acetylcholine receptor achieved by allosteric potentiation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">15950</span>– <span class="NLM_lpage">15955</span>, <span class="refDoi"> DOI: 10.1073/pnas.0900903106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=19717450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&issue=37&author=L.+Maauthor=M.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=K.+V.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=S.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M1+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation&doi=10.1073%2Fpnas.0900903106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span></div><div class="casAuthors">Ma, Lei; Seager, Matthew; Wittmann, Marion; Jacobson, Marlene; Bickel, Denise; Burno, Maryann; Jones, Keith; Graufelds, Valerie Kuzmick; Xu, Guangping; Pearson, Michelle; McCampbell, Alexander; Gaspar, Renee; Shughrue, Paul; Danziger, Andrew; Regan, Christopher; Flick, Rose; Pascarella, Danette; Garson, Susan; Doran, Scott; Kreatsoulas, Constantine; Veng, Lone; Lindsley, Craig W.; Shipe, William; Kuduk, Scott; Sur, Cyrille; Kinney, Gene; Seabrook, Guy R.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">15950-15955, S15950/1-S15950/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The forebrain cholinergic system promotes higher brain function in part by signaling through the M, muscarinic acetylcholine receptor (mAChR).  During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses assocd. with non-selective muscarinic agonists.  We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M1 mAChR.  BQCA reduces the concn. of ACh required to activate M1 up to 129-fold with an inflection point value of 845 nM.  No potentiation, agonism, or antagonism activity on other mAChRs is obsd. up to 100 ArM.  Furthermore studies in M1-/- mice demonstrates that BQCA requires M1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain.  Radioligand-binding assays, mol. modeling, and site-directed mutagenesis expts. indicate that BQCA acts at an allosteric site involving residues Y179 and W400.  BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep.  In contrast to M1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces 13-arrestin recruitment to M1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory.  In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M1 receptor and represents a promising therapeutic strategy for cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0SGRL-coGErVg90H21EOLACvtfcHk0ljEo3yyOI6ywg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL&md5=4470732fd762f761a18d2bc96220dcb1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DK.%2BV.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DS.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D37%26spage%3D15950%26epage%3D15955%26doi%3D10.1073%2Fpnas.0900903106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Activation and allosteric modulation of a muscarinic acetylcholine receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1038/nature12735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1038%2Fnature12735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=24256733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyisLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2013&pages=101-106&author=A.+C.+Kruseauthor=A.+M.+Ringauthor=A.+Manglikauthor=J.+Huauthor=K.+Huauthor=K.+Eitelauthor=H.+Hubnerauthor=E.+Pardonauthor=C.+Valantauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=C.+C.+Felderauthor=P.+Gmeinerauthor=J.+Steyaertauthor=W.+I.+Weisauthor=C.+K.+Garciaauthor=J.+Wessauthor=B.+K.+Kobilka&title=Activation+and+allosteric+modulation+of+a+muscarinic+acetylcholine+receptor&doi=10.1038%2Fnature12735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and allosteric modulation of a muscarinic acetylcholine receptor</span></div><div class="casAuthors">Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish; Hu, Jianxin; Hu, Kelly; Eitel, Katrin; Huebner, Harald; Pardon, Els; Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur; Felder, Christian C.; Gmeiner, Peter; Steyaert, Jan; Weis, William I.; Garcia, K. Christopher; Wess, Juergen; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">7478</span>),
    <span class="NLM_cas:pages">101-106</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite recent advances in crystallog. and the availability of G-protein-coupled receptor (GPCR) structures, little is known about the mechanism of their activation process, as only the β2 adrenergic receptor (β2AR) and rhodopsin have been crystd. in fully active conformations.  Here we report the structure of an agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-protein mimetic camelid antibody fragment isolated by conformational selection using yeast surface display.  In addn. to the expected changes in the intracellular surface, the structure reveals larger conformational changes in the extracellular region and orthosteric binding site than obsd. in the active states of the β2AR and rhodopsin.  We also report the structure of the M2 receptor simultaneously bound to the orthosteric agonist iperoxo and the pos. allosteric modulator LY2119620.  This structure reveals that LY2119620 recognizes a largely pre-formed binding site in the extracellular vestibule of the iperoxo-bound receptor, inducing a slight contraction of this outer binding pocket.  These structures offer important insights into the activation mechanism and allosteric modulation of muscarinic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOuUgQSB7Dd7Vg90H21EOLACvtfcHk0ljEo3yyOI6ywg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyisLjP&md5=ecddab0ab467321ac243b86bb82b71f8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature12735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12735%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DRing%26aufirst%3DA.%2BM.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DEitel%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DGarcia%26aufirst%3DC.%2BK.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DActivation%2520and%2520allosteric%2520modulation%2520of%2520a%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DNature%26date%3D2013%26volume%3D504%26spage%3D101%26epage%3D106%26doi%3D10.1038%2Fnature12735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Ridha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span> <span> </span><span class="NLM_article-title">Mechanistic insights into allosteric structure-function relationships at the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">33701</span>– <span class="NLM_lpage">33711</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.604967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1074%2Fjbc.M114.604967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=25326383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2rsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=33701-33711&issue=48&author=A.+Abdul-Ridhaauthor=J.+R.+Laneauthor=S.+N.+Mistryauthor=L.+Lopezauthor=P.+M.+Sextonauthor=P.+J.+Scammellsauthor=A.+Christopoulosauthor=M.+Canals&title=Mechanistic+insights+into+allosteric+structure-function+relationships+at+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M114.604967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Insights into Allosteric Structure-Function Relationships at the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Abdul-Ridha, Alaa; Lane, J. Robert; Mistry, Shailesh N.; Lopez, Laura; Sexton, Patrick M.; Scammells, Peter J.; Christopoulos, Arthur; Canals, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">33701-33711</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Benzylquinolone carboxylic acid (BQCA) is the first highly selective pos. allosteric modulator (PAM) for the M1 muscarinic acetylcholine receptor (mAChR), but it possesses low affinity for the allosteric site on the receptor.  More recent drug discovery efforts identified 3-((1S,2S)-2-hydroxycyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one (referred to herein as benzoquinazolinone 12) as a more potent M1 mAChR PAM with a structural ancestry originating from BQCA and related compds.  In the current study, we optimized the synthesis of and fully characterized the pharmacol. of benzoquinazolinone 12, finding that its improved potency derived from a 50-fold increase in allosteric site affinity as compared with BQCA, while retaining a similar level of pos. cooperativity with acetylcholine.  We then utilized site-directed mutagenesis and mol. modeling to validate the allosteric binding pocket we previously described for BQCA as a shared site for benzoquinazolinone 12 and provide a mol. basis for its improved activity at the M1 mAChR.  This includes a key role for hydrophobic and polar interactions with residues Tyr-179, in the second extracellular loop (ECL2) and Trp-4007.35 in transmembrane domain (TM) 7.  Collectively, this study highlights how the properties of affinity and cooperativity can be differentially modified on a common structural scaffold and identifies mol. features that can be exploited to tailor the development of M1 mAChR-targeting PAMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknjxCgLZYXLVg90H21EOLACvtfcHk0lggWHhsW8pQSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2rsbjI&md5=c85ea5d192d466a495ebd58545dd4dc4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.604967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.604967%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DMechanistic%2520insights%2520into%2520allosteric%2520structure-function%2520relationships%2520at%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D48%26spage%3D33701%26epage%3D33711%26doi%3D10.1074%2Fjbc.M114.604967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Ridha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of allosteric modulation at the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">6067</span>– <span class="NLM_lpage">6079</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.539080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1074%2Fjbc.M113.539080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=6067-6079&issue=9&author=A.+Abdul-Ridhaauthor=L.+L%C3%B3pezauthor=P.+Keovauthor=D.+M.+Thalauthor=S.+N.+Mistryauthor=P.+M.+Sextonauthor=J.+R.+Laneauthor=M.+Canalsauthor=A.+Christopoulos&title=Molecular+determinants+of+allosteric+modulation+at+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M113.539080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.539080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.539080%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DKeov%26aufirst%3DP.%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DMolecular%2520determinants%2520of%2520allosteric%2520modulation%2520at%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D9%26spage%3D6067%26epage%3D6079%26doi%3D10.1074%2Fjbc.M113.539080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">A novel mechanism of G protein-coupled receptor functional selectivity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">29312</span>– <span class="NLM_lpage">29321</span>, <span class="refDoi"> DOI: 10.1074/jbc.M803801200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1074%2Fjbc.M803801200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=29312-29321&issue=43&author=C.+Valantauthor=K.+J.+Gregoryauthor=N.+E.+Hallauthor=P.+J.+Scammellsauthor=M.+J.+Lewauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=A+novel+mechanism+of+G+protein-coupled+receptor+functional+selectivity&doi=10.1074%2Fjbc.M803801200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803801200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803801200%26sid%3Dliteratum%253Aachs%26aulast%3DValant%26aufirst%3DC.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DHall%26aufirst%3DN.%2BE.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DLew%26aufirst%3DM.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520novel%2520mechanism%2520of%2520G%2520protein-coupled%2520receptor%2520functional%2520selectivity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26issue%3D43%26spage%3D29312%26epage%3D29321%26doi%3D10.1074%2Fjbc.M803801200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M<sub>1</sub> muscarinic receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5151</span>– <span class="NLM_lpage">5172</span>, <span class="refDoi"> DOI: 10.1021/jm400540b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400540b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5151-5172&author=S.+N.+Mistryauthor=C.+Valantauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Synthesis+and+pharmacological+profiling+of+analogues+of+benzyl+quinolone+carboxylic+acid+%28BQCA%29+as+allosteric+modulators+of+the+M1+muscarinic+receptor&doi=10.1021%2Fjm400540b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Profiling of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) as Allosteric Modulators of the M1 Muscarinic Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Valant, Celine; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5151-5172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Established therapy in Alzheimer's disease involves potentiation of the endogenous orthosteric ligand, acetylcholine, at the M1 muscarinic receptors found in higher concns. in the cortex and hippocampus.  Adverse effects, due to indiscriminate activation of other muscarinic receptor subtypes, are common.  M1 muscarinic pos. allosteric modulators/allosteric agonists such as BQCA [1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, I] offer an attractive soln., being exquisitely M1-selective over other muscarinic subtypes.  A common difficulty with allosteric ligands is interpreting SAR, based on composite potency values derived in the presence of fixed concn. of agonist.  In reality these values encompass multiple pharmacol. parameters, each potentially and differentially sensitive to structural modification of the ligand.  We report novel BQCA analogs which appear to augment ligand affinity for the receptor (pKB), intrinsic efficacy (τB), and both binding (α) and functional (β) cooperativity with acetylcholine.  Ultimately, development of such enriched SAR surrounding allosteric modulators will provide insight into their mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoigST7OJR7vbVg90H21EOLACvtfcHk0lggWHhsW8pQSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D&md5=ab134e0b5400aa825916695eaf1203b1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm400540b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400540b%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520profiling%2520of%2520analogues%2520of%2520benzyl%2520quinolone%2520carboxylic%2520acid%2520%2528BQCA%2529%2520as%2520allosteric%2520modulators%2520of%2520the%2520M1%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5151%26epage%3D5172%26doi%3D10.1021%2Fjm400540b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.
N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jörg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinh, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">4-Phenylpyridin-2-one derivatives: a novel class of positive allosteric modulator of the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01562</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01562" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFegu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=388-409&author=S.%0AN.+Mistryauthor=M.+J%C3%B6rgauthor=H.+Limauthor=N.+B.+Vinhauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=P.+J.+Scammells&title=4-Phenylpyridin-2-one+derivatives%3A+a+novel+class+of+positive+allosteric+modulator+of+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Facs.jmedchem.5b01562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Jorg, Manuela; Lim, Herman; Vinh, Natalie B.; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Lane, J. Robert; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">388-409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pos. allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promising strategy for the treatment of the cognitive deficits assocd. with diseases including Alzheimer's and schizophrenia.  Herein, we report the design, synthesis, and characterization of a novel family of M1 mAChR PAMs.  The most active compds. of the 4-phenylpyridin-2-one series exhibited comparable binding affinity to the ref. compd., 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA), but markedly improved pos. cooperativity with acetylcholine, and retained exquisite selectivity for the M1 mAChR.  Furthermore, the pharmacol. characterization revealed ligands with a diverse range of activities, including modulators that displayed both high intrinsic efficacy and PAM activity, those that showed no detectable agonism but robust PAM activity and ligands that displayed robust allosteric agonism but little modulatory activity.  Compd. I was found to have the best pharmacol. profile.  Thus, the 4-phenylpyridin-2-one scaffold offers an attractive starting point for further lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMlFmtgndXrbVg90H21EOLACvtfcHk0lg2e0fK8n44rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFegu7zP&md5=315362c43e2b6c204f038f30c6ade642</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01562%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DJ%25C3%25B6rg%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%26aulast%3DVinh%26aufirst%3DN.%2BB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3D4-Phenylpyridin-2-one%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520positive%2520allosteric%2520modulator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D388%26epage%3D409%26doi%3D10.1021%2Facs.jmedchem.5b01562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jörg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">Novel fused arylpyrimidinone based allosteric modulators of the M<sub>1</sub> muscarinic acetylcholine receptor</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=647-661&author=S.+N.+Mistryauthor=H.+Limauthor=M.+J%C3%B6rgauthor=B.+Capuanoauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=P.+J.+Scammells&title=Novel+fused+arylpyrimidinone+based+allosteric+modulators+of+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Facschemneuro.6b00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Lim, Herman; Jorg, Manuela; Capuano, Ben; Christopoulos, Arthur; Lane, J. Robert; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">647-661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzoquinazolinone 1 is a pos. allosteric modulator (PAM) of the M1 muscarinic acetylcholine receptor (mAChR), which is significantly more potent than the prototypical PAM, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA).  In this study, we explored the structural determinants that underlie the activity of 1 as a PAM of the M1 mAChR.  We paid particular attention to the importance of the tricyclic scaffold of compd. 1, for the activity of the mol.  Complete deletion of the peripheral fused benzene ring caused a significant decrease in affinity and binding cooperativity with acetylcholine (ACh).  This loss of affinity was rescued with the addn. of either one or two Me groups in the 7- and/or 8-position of the quinazolin-4(3H)-one core.  These results demonstrate that the tricyclic benzo[h]quinazolin-4(3H)-one core could be replaced with a quinazolin-4(3H)-one core and maintain functional affinity.  As such, the quinazolin-4(3H)-one core represents a novel scaffold to further explore M1 mAChR PAMs with improved physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpah7jlrVCf2rVg90H21EOLACvtfcHk0lg9WUngtpSMvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaitL4%253D&md5=6e2271cd08c284eac5cdb0a553dd7839</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00018%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DLim%26aufirst%3DH.%26aulast%3DJ%25C3%25B6rg%26aufirst%3DM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520fused%2520arylpyrimidinone%2520based%2520allosteric%2520modulators%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D647%26epage%3D661%26doi%3D10.1021%2Facschemneuro.6b00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugolenski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgerton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotarski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon-Ferrer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Design and optimization of selective azaindole amide M<sub>1</sub> positive allosteric modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2Fj.bmcl.2015.11.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=26631313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=650-655&issue=2&author=J.+E.+Davorenauthor=S.+V.+O%E2%80%99Neilauthor=D.+P.+Andersonauthor=M.+a.+Brodneyauthor=L.+Chenardauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=M.+Greenauthor=M.+Garnseyauthor=S.+Grimwoodauthor=A.+R.+Harrisauthor=G.+W.+Kauffmanauthor=E.+Lachapelleauthor=J.+T.+Lazzaroauthor=C.+W.+Leeauthor=S.+M.+Lotarskiauthor=D.+M.+Nasonauthor=R.+S.+Obachauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=J.+Yanauthor=L.+Zhang&title=Design+and+optimization+of+selective+azaindole+amide+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2015.11.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span></div><div class="casAuthors">Davoren, Jennifer E.; O'Neil, Steven V.; Anderson, Dennis P.; Brodney, Michael A.; Chenard, Lois; Dlugolenski, Keith; Edgerton, Jeremy R.; Green, Michael; Garnsey, Michelle; Grimwood, Sarah; Harris, Anthony R.; Kauffman, Gregory W.; LaChapelle, Erik; Lazzaro, John T.; Lee, Che-Wah; Lotarski, Susan M.; Nason, Deane M.; Obach, R. Scott; Reinhart, Veronica; Salomon-Ferrer, Romelia; Steyn, Stefanus J.; Webb, Damien; Yan, Jiangli; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-655</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selective activation of the M1 receptor via a pos. allosteric modulator (PAM) is a new approach for the treatment of the cognitive impairments assocd. with schizophrenia and Alzheimer's disease.  A novel series of azaindole amides and their key pharmacophore elements are described.  The nitrogen of the azaindole core is a key design element as it forms an intramol. hydrogen bond with the amide N-H thus reinforcing the bioactive conformation predicted by published SAR and the authors' homol. model.  Representative compd. 25 is a potent and selective M1 PAM that has well aligned physicochem. properties, adequate brain penetration and pharmacokinetic (PK) properties, and is active in vivo.  These favorable properties indicate that this series possesses suitable qualities for further development and studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEhH8MxkKIrVg90H21EOLACvtfcHk0lg9WUngtpSMvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L&md5=5c227d1371fe4f0cc3348af8314dd370</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DBrodney%26aufirst%3DM.%2Ba.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLachapelle%26aufirst%3DE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDesign%2520and%2520optimization%2520of%2520selective%2520azaindole%2520amide%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D650%26epage%3D655%26doi%3D10.1016%2Fj.bmcl.2015.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugolenski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgerton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotarski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northcott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottebaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon-Ferrer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of the potent and selective M<sub>1</sub> PAM-agonist N-[(3R,4S)-3-hydroxytetrahydro-2h-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): evaluation of efficacy and cholinergic side effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6313</span>– <span class="NLM_lpage">6328</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsVCltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6313-6328&author=J.+E.+Davorenauthor=C.+W.+Leeauthor=M.+Garnseyauthor=M.+A.+Brodneyauthor=J.+Cordesauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=A.+R.+Harrisauthor=C.+J.+Helalauthor=S.+Jenkinsonauthor=G.+W.+Kauffmanauthor=T.+P.+Kenakinauthor=J.+T.+Lazzaroauthor=S.+M.+Lotarskiauthor=Y.+Maoauthor=D.+M.+Nasonauthor=C.+Northcottauthor=L.+Nottebaumauthor=S.+V.+O%E2%80%99Neilauthor=B.+Pettersenauthor=M.+Popiolekauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=L.+Zhangauthor=S.+Grimwood&title=Discovery+of+the+potent+and+selective+M1+PAM-agonist+N-%5B%283R%2C4S%29-3-hydroxytetrahydro-2h-pyran-4-yl%5D-5-methyl-4-%5B4-%281%2C3-thiazol-4-yl%29benzyl%5Dpyridine-2-carboxamide+%28PF-06767832%29%3A+evaluation+of+efficacy+and+cholinergic+side+effects&doi=10.1021%2Facs.jmedchem.6b00544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects</span></div><div class="casAuthors">Davoren, Jennifer E.; Lee, Che-Wah; Garnsey, Michelle; Brodney, Michael A.; Cordes, Jason; Dlugolenski, Keith; Edgerton, Jeremy R.; Harris, Anthony R.; Helal, Christopher J.; Jenkinson, Stephen; Kauffman, Gregory W.; Kenakin, Terrence P.; Lazzaro, John T.; Lotarski, Susan M.; Mao, Yuxia; Nason, Deane M.; Northcott, Carrie; Nottebaum, Lisa; O'Neil, Steven V.; Pettersen, Betty; Popiolek, Michael; Reinhart, Veronica; Salomon-Ferrer, Romelia; Steyn, Stefanus J.; Webb, Damien; Zhang, Lei; Grimwood, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6313-6328</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is hypothesized that selective muscarinic M1 subtype activation could be a strategy to provide cognitive benefits to schizophrenia and Alzheimer's disease patients while minimizing the cholinergic side effects obsd. with nonselective muscarinic orthosteric agonists.  Selective activation of M1 with a pos. allosteric modulator (PAM) has emerged as a new approach to achieve selective M1 activation.  This manuscript describes the development of a series of M1-selective pyridone and pyridine amides and their key pharmacophores.  Compd. I (PF-06767832) is a high quality M1 selective PAM that has well-aligned physicochem. properties, good brain penetration and pharmacokinetic properties.  Extensive safety profiling suggested that despite being devoid of mAChR M2/M3 subtype activity, compd. I still carries gastrointestinal and cardiovascular side effects.  These data provide strong evidence that M1 activation contributes to the cholinergic liabilities that were previously attributed to activation of the M2 and M3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR9OBduAoGH7Vg90H21EOLACvtfcHk0lgomc3ubpSJRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsVCltr4%253D&md5=1f45fef3e689b276a70154785d7d21e6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00544%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCordes%26aufirst%3DJ.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DNorthcott%26aufirst%3DC.%26aulast%3DNottebaum%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DPettersen%26aufirst%3DB.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520the%2520potent%2520and%2520selective%2520M1%2520PAM-agonist%2520N-%255B%25283R%252C4S%2529-3-hydroxytetrahydro-2h-pyran-4-yl%255D-5-methyl-4-%255B4-%25281%252C3-thiazol-4-yl%2529benzyl%255Dpyridine-2-carboxamide%2520%2528PF-06767832%2529%253A%2520evaluation%2520of%2520efficacy%2520and%2520cholinergic%2520side%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6313%26epage%3D6328%26doi%3D10.1021%2Facs.jmedchem.6b00544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nance, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remke, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barrantes, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engers, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engers, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Diverse effects on M<sub>1</sub> signaling and adverse effect liability within a series of M<sub>1</sub> ago-PAMs</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00429</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFaiurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=866-883&author=J.+M.+Rookauthor=M.+Abeauthor=H.+P.+Choauthor=K.+D.+Nanceauthor=V.+B.+Luscombeauthor=J.+J.+Adamsauthor=J.+W.+Dickersonauthor=D.+H.+Remkeauthor=P.+M.+Garcia-Barrantesauthor=D.+W.+Engersauthor=J.+L.+Engersauthor=S.+Changauthor=J.+J.+Fosterauthor=A.+L.+Blobaumauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Diverse+effects+on+M1+signaling+and+adverse+effect+liability+within+a+series+of+M1+ago-PAMs&doi=10.1021%2Facschemneuro.6b00429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs</span></div><div class="casAuthors">Rook, Jerri M.; Abe, Masahito; Cho, Hyekyung P.; Nance, Kellie D.; Luscombe, Vincent B.; Adams, Jeffrey J.; Dickerson, Jonathan W.; Remke, Daniel H.; Garcia-Barrantes, Pedro M.; Engers, Darren W.; Engers, Julie L.; Chang, Sichen; Foster, Jarrett J.; Blobaum, Anna L.; Niswender, Colleen M.; Jones, Carrie K.; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">866-883</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Both historical clin. and recent preclin. data suggest that the M1 muscarinic acetylcholine receptor is an exciting target for the treatment of Alzheimer's disease and the cognitive and neg. symptom clusters in schizophrenia; however, early drug discovery efforts targeting the orthosteric binding site have failed to afford selective M1 activation.  Efforts then shifted to focus on selective activation of M1 via either allosteric agonists or pos. allosteric modulators (PAMs).  While M1 PAMs have robust efficacy in rodent models, some chemotypes can induce cholinergic adverse effects (AEs) that could limit their clin. utility.  Here, the authors report studies aimed at understanding the subtle structural and pharmacol. nuances that differentiate efficacy from adverse effect liability within an indole-based series of M1 ago-PAMs.  The authors' data demonstrate that closely related M1 PAMs can display striking differences in their in vivo activities, and esp. their propensities to induce adverse effects.  The authors report the discovery of a novel PAM in this series that is devoid of observable adverse effect liability.  Interestingly, the mol. pharmacol. profile of this novel PAM is similar to that of a representative M1 PAM that induces severe AEs.  For instance, both compds. are potent ago-PAMs that demonstrate significant interaction with the orthosteric site (either bi-topic or neg. cooperativity).  However, there are subtle differences in efficacies of the compds. at potentiating M1 responses, agonist potencies, and abilities to induce receptor internalization.  While these differences may contribute to the differential in vivo profiles of these compds., the in vitro differences are relatively subtle and highlight the complexities of allosteric modulators and the need to focus on in vivo phenotypic screening to identify safe and effective M1 PAMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTbiEiZmJq3bVg90H21EOLACvtfcHk0lgNQBinviz7RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFaiurzK&md5=06d92ac4fccfaf7ea8ff3be807dacdc5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00429%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DNance%26aufirst%3DK.%2BD.%26aulast%3DLuscombe%26aufirst%3DV.%2BB.%26aulast%3DAdams%26aufirst%3DJ.%2BJ.%26aulast%3DDickerson%26aufirst%3DJ.%2BW.%26aulast%3DRemke%26aufirst%3DD.%2BH.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DEngers%26aufirst%3DJ.%2BL.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DJ.%2BJ.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiverse%2520effects%2520on%2520M1%2520signaling%2520and%2520adverse%2520effect%2520liability%2520within%2520a%2520series%2520of%2520M1%2520ago-PAMs%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D866%26epage%3D883%26doi%3D10.1021%2Facschemneuro.6b00429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgerton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotarski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottebaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of γ- and δ-lactam m1 positive allosteric modulators (PAMs): convulsion and cholinergic toxicity of an M<sub>1</sub>-selective PAM with weak agonist activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6649</span>– <span class="NLM_lpage">6663</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6649-6663&issue=15&author=J.+E.+Davorenauthor=M.+Garnseyauthor=B.+Pettersenauthor=M.+A.+Brodneyauthor=J.+R.+Edgertonauthor=J.+P.+Fortinauthor=S.+Grimwoodauthor=A.+R.+Harrisauthor=S.+Jenkinsonauthor=T.+Kenakinauthor=J.+T.+Lazzaroauthor=C.+W.+Leeauthor=S.+M.+Lotarskiauthor=L.+Nottebaumauthor=S.+V.+O%E2%80%99Neilauthor=M.+Popiolekauthor=S.+Ramseyauthor=S.+J.+Steynauthor=C.+A.+Thornauthor=L.+Zhangauthor=D.+Webb&title=Design+and+synthesis+of+%CE%B3-+and+%CE%B4-lactam+m1+positive+allosteric+modulators+%28PAMs%29%3A+convulsion+and+cholinergic+toxicity+of+an+M1-selective+PAM+with+weak+agonist+activity&doi=10.1021%2Facs.jmedchem.7b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity</span></div><div class="casAuthors">Davoren, Jennifer E.; Garnsey, Michelle; Pettersen, Betty; Brodney, Michael A.; Edgerton, Jeremy R.; Fortin, Jean-Philippe; Grimwood, Sarah; Harris, Anthony R.; Jenkinson, Stephen; Kenakin, Terry; Lazzaro, John T.; Lee, Che-Wah; Lotarski, Susan M.; Nottebaum, Lisa; O'Neil, Steven V.; Popiolek, Michael; Ramsey, Simeon; Steyn, Stefanus J.; Thorn, Catherine A.; Zhang, Lei; Webb, Damien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6649-6663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent data demonstrated that activation of the muscarinic M1 receptor by a subtype-selective pos. allosteric modulator (PAM) contributes to the gastrointestinal (GI) and cardiovascular (CV) cholinergic adverse events (AEs) previously attributed to M2 and M3 activation.  These studies were conducted using PAMs that also exhibited allosteric agonist activity, leaving open the possibility that direct activation by allosteric agonism, rather than allosteric modulation, could be responsible for the adverse effects.  This article describes the design and synthesis of lactam-derived M1 PAMs that address this hypothesis.  The lead mol. from this series, compd. I (PF-06827443), is a potent, low-clearance, orally bioavailable and CNS-penetrant M1-selective PAM with minimal agonist activity.  Compd. I was tested in dose escalation studies in rats and dogs and was found to induce cholinergic AEs and convulsion at therapeutic indexes similar to previous compds. with more agonist activity.  These findings provide preliminary evidence that pos. allosteric modulation of M1 is sufficient to elicit cholinergic AEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdLnKqXoZLrVg90H21EOLACvtfcHk0lgNQBinviz7RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSktbg%253D&md5=abd7e12d7dc959269a0bae608467f827</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00597%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DPettersen%26aufirst%3DB.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DFortin%26aufirst%3DJ.%2BP.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DNottebaum%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DRamsey%26aufirst%3DS.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DThorn%26aufirst%3DC.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWebb%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B3-%2520and%2520%25CE%25B4-lactam%2520m1%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%253A%2520convulsion%2520and%2520cholinergic%2520toxicity%2520of%2520an%2520M1-selective%2520PAM%2520with%2520weak%2520agonist%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D15%26spage%3D6649%26epage%3D6663%26doi%3D10.1021%2Facs.jmedchem.7b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catterall, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlert, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">947</span>, <span class="refDoi"> DOI: 10.1124/pr.114.008862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1124%2Fpr.114.008862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=25026896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKht73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=918-947&issue=4&author=A.+Christopoulosauthor=J.-P.+Changeuxauthor=W.+A.+Catterallauthor=D.+Fabbroauthor=T.+P.+Burrisauthor=J.+A.+Cidlowskiauthor=R.+W.+Olsenauthor=J.+A.+Petersauthor=R.+R.+Neubigauthor=J.-P.+Pinauthor=P.+M.+Sextonauthor=T.+P.+Kenakinauthor=F.+J.+Ehlertauthor=M.+Speddingauthor=C.+J.+Langmead&title=International+Union+of+Basic+and+Clinical+Pharmacology.+XC.+multisite+pharmacology%3A+recommendations+for+the+nomenclature+of+receptor+allosterism+and+allosteric+ligands&doi=10.1124%2Fpr.114.008862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands</span></div><div class="casAuthors">Christopoulos, Arthur; Changeux, Jean-Pierre; Catterall, William A.; Fabbro, Doriano; Burris, Thomas P.; Cidlowski, John A.; Olsen, Richard W.; Peters, John A.; Neubig, Richard R.; Pin, Jean-Philippe; Sexton, Patrick M.; Kenakin, Terry P.; Ehlert, Frederick J.; Spedding, Michael; Langmead, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">918-947</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Allosteric interactions play vital roles in metabolic processes and signal transduction and, more recently, have become the focus of numerous pharmacol. studies because of the potential for discovering more target-selective chem. probes and therapeutic agents.  In addn. to classic early studies on enzymes, there are now examples of small mol. allosteric modulators for all superfamilies of receptors encoded by the genome, including ligand- and voltage-gated ion channels, G protein-coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases.  As a consequence, a vast array of pharmacol. behaviors has been ascribed to allosteric ligands that can vary in a target-, ligand-, and cell-/tissue-dependent manner.  The current article presents an overview of allostery as applied to receptor families and approaches for detecting and validating allosteric interactions and gives recommendations for the nomenclature of allosteric ligands and their properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2h0E0L_c0J7Vg90H21EOLACvtfcHk0lgjJs5nl3apmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKht73N&md5=cca779691cfc36cc3f06aaf495522c22</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.008862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.008862%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DChangeux%26aufirst%3DJ.-P.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26aulast%3DOlsen%26aufirst%3DR.%2BW.%26aulast%3DPeters%26aufirst%3DJ.%2BA.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DEhlert%26aufirst%3DF.%2BJ.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520XC.%2520multisite%2520pharmacology%253A%2520recommendations%2520for%2520the%2520nomenclature%2520of%2520receptor%2520allosterism%2520and%2520allosteric%2520ligands%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D66%26issue%3D4%26spage%3D918%26epage%3D947%26doi%3D10.1124%2Fpr.114.008862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertekap, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benitex, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nophsker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwell, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sum, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrante, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendricson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvijic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentles, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span> <span> </span><span class="NLM_article-title">Evidence for classical cholinergic toxicity associated with selective activation of M<sub>1</sub> muscarinic receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.226910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1124%2Fjpet.115.226910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=26582730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVelsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=293-304&author=A.+Altauthor=A.+Pendriauthor=R.+L.+Bertekapauthor=G.+Liauthor=Y.+Benitexauthor=M.+Nophskerauthor=K.+L.+Rockwellauthor=N.+T.+Burfordauthor=C.+S.+Sumauthor=J.+Chenauthor=J.+J.+Herbstauthor=M.+Ferranteauthor=A.+Hendricsonauthor=M.+E.+Cvijicauthor=R.+S.+Westphalauthor=J.+O%E2%80%99Connellauthor=M.+Banksauthor=L.+Zhangauthor=R.+G.+Gentlesauthor=S.+Jenkinsauthor=J.+Loyauthor=J.+E.+Macor&title=Evidence+for+classical+cholinergic+toxicity+associated+with+selective+activation+of+M1+muscarinic+receptors&doi=10.1124%2Fjpet.115.226910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for classical cholinergic toxicity associated with selective activation of M1 muscarinic receptors</span></div><div class="casAuthors">Alt, Andrew; Pendri, Annapurna; Bertekap, Robert L., Jr.; Li, Guo; Benitex, Yulia; Nophsker, Michelle; Rockwell, Kristin L.; Burford, Neil T.; Sum, Chi Shing; Chen, Jing; Herbst, John J.; Ferrante, Meredith; Hendricson, Adam; Cvijic, Mary Ellen; Westphal, Ryan S.; O'Connell, Jonathan; Banks, Martyn; Zhang, Litao; Gentles, Robert G.; Jenkins, Susan; Loy, James; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The muscarinic acetylcholine receptor subtype 1 (M1) receptors play an important role in cognition and memory, and are considered to be attractive targets for the development of novel medications to treat cognitive impairments seen in schizophrenia and Alzheimer's disease.  Indeed, the M1 agonist xanomeline has been shown to produce beneficial cognitive effects in both Alzheimer's disease and schizophrenia patients.  Unfortunately, the therapeutic utility of xanomeline was limited by cholinergic side effects (sweating, salivation, gastrointestinal distress), which are believed to result from nonselective activation of other muscarinic receptor subtypes such as M2 and M3.  Therefore, drug discovery efforts targeting the M1 receptor have focused on the discovery of compds. with improved selectivity profiles.  Recently, allosteric M1 receptor ligands have been described, which exhibit excellent selectivity for M1 over other muscarinic receptor subtypes.  In the current study, the following three compds. with mixed agonist/pos. allosteric modulator activities that are highly functionally selective for the M1 receptor were tested in rats, dogs, and cynomologous monkeys: (3-((1S,2S)-2-hydrocyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one; 1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid; and (R)-Et 3-(2-methylbenzamido)-[1,4'-bipiperidine]-1'-carboxylate).  Despite their selectivity for the M1 receptor, all three compds. elicited cholinergic side effects such as salivation, diarrhea, and emesis.  These effects could not be explained by activity at other muscarinic receptor subtypes, or by activity at other receptors tested.  Together, these results suggest that activation of M1 receptors alone is sufficient to produce unwanted cholinergic side effects such as those seen with xanomeline.  This has important implications for the development of M1 receptor-targeted therapeutics since it suggests that dose-limiting cholinergic side effects still reside in M1 receptor selective activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zRN2771-9bVg90H21EOLACvtfcHk0lgjJs5nl3apmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVelsLo%253D&md5=6cf55475ab7da402a6e08099bfc0f030</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.226910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.226910%26sid%3Dliteratum%253Aachs%26aulast%3DAlt%26aufirst%3DA.%26aulast%3DPendri%26aufirst%3DA.%26aulast%3DBertekap%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBenitex%26aufirst%3DY.%26aulast%3DNophsker%26aufirst%3DM.%26aulast%3DRockwell%26aufirst%3DK.%2BL.%26aulast%3DBurford%26aufirst%3DN.%2BT.%26aulast%3DSum%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHerbst%26aufirst%3DJ.%2BJ.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DHendricson%26aufirst%3DA.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DWestphal%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DBanks%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGentles%26aufirst%3DR.%2BG.%26aulast%3DJenkins%26aufirst%3DS.%26aulast%3DLoy%26aufirst%3DJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DEvidence%2520for%2520classical%2520cholinergic%2520toxicity%2520associated%2520with%2520selective%2520activation%2520of%2520M1%2520muscarinic%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D293%26epage%3D304%26doi%3D10.1124%2Fjpet.115.226910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2007.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2Fj.tips.2007.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=17629965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=382-389&issue=8&author=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+GPCR+modulators%3A+taking+advantage+of+permissive+receptor+pharmacology&doi=10.1016%2Fj.tips.2007.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology</span></div><div class="casAuthors">Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">382-389</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a dramatic increase in the identification of allosteric modulators of G-protein-coupled receptor (GPCR) activity.  Concomitantly, several new perspectives and hypotheses regarding the way ligands regulate GPCR signaling have also emerged.  Here, we briefly discuss how the concepts of collateral efficacy and permissive agonism-antagonism intersect the field of allosteric GPCR modulation.  Despite the challenges assocd. with detecting and quantifying the myriad of possible allosteric effects on GPCR activity, it is proposed that allosteric ligands offer the exciting prospect of engendering stimulus-bias in orthosteric ligand signaling, thus paving the way for not only receptor-selective but also signaling-pathway-selective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpHb_QsIW3TbVg90H21EOLACvtfcHk0ljngtqsbFDAjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltLs%253D&md5=943da2312e7b136cb594ba0346e00301</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520GPCR%2520modulators%253A%2520taking%2520advantage%2520of%2520permissive%2520receptor%2520pharmacology%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26issue%3D8%26spage%3D382%26epage%3D389%26doi%3D10.1016%2Fj.tips.2007.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">A Monod-Wyman-Changeux Mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.314278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1074%2Fjbc.M111.314278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=22086918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=650-659&issue=1&author=M.+Canalsauthor=J.+R.+Laneauthor=A.+Wenauthor=P.+J.+Scammellsauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=A+Monod-Wyman-Changeux+Mechanism+can+explain+G+protein-coupled+receptor+%28GPCR%29+allosteric+modulation&doi=10.1074%2Fjbc.M111.314278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation</span></div><div class="casAuthors">Canals, Meritxell; Lane, J. Robert; Wen, Adriel; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">650-659</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Monod-Wyman-Changeux (MWC) model was initially proposed to describe the allosteric properties of regulatory enzymes and subsequently extended to receptors.  Yet despite GPCRs representing the largest family of receptors and drug targets, no study has systematically evaluated the MWC mechanism as it applies to GPCR allosteric ligands.  We reveal how the recently described allosteric modulator, benzyl quinolone carboxylic acid (BQCA), behaves according to a strict, two-state MWC mechanism at the M1 muscarinic acetylcholine receptor (mAChR).  Despite having a low affinity for the M1 mAChR, BQCA demonstrated state dependence, exhibiting high pos. cooperativity with orthosteric agonists in a manner that correlated with efficacy but neg. cooperativity with inverse agonists.  The activity of BQCA was significantly increased at a constitutively active M1 mAChR but abolished at an inactive mutant.  Interestingly, BQCA possessed intrinsic signaling efficacy, ranging from near-quiescence to full agonism depending on the coupling efficiency of the chosen intracellular pathway.  This latter cellular property also detd. the difference in magnitude of pos. cooperativity between BQCA and the orthosteric agonist, carbachol, across pathways.  The lack of addnl., pathway-biased, allosteric modulation by BQCA was confirmed in genetically engineered yeast strains expressing different chimeras between the endogenous yeast Gpa1 protein and human Gα subunits.  These findings define a chem. biol. framework that can be applied to the study and classification of allosteric modulators across different GPCR families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrrH0vtUu5lbVg90H21EOLACvtfcHk0ljngtqsbFDAjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVGh&md5=45d079afd141a137baf24fe171180124</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.314278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.314278%26sid%3Dliteratum%253Aachs%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DWen%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520Monod-Wyman-Changeux%2520Mechanism%2520can%2520explain%2520G%2520protein-coupled%2520receptor%2520%2528GPCR%2529%2520allosteric%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D1%26spage%3D650%26epage%3D659%26doi%3D10.1074%2Fjbc.M111.314278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Advances in G protein-coupled receptor allostery: from function to structure</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1124/mol.114.094342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1124%2Fmol.114.094342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=463-478&issue=5&author=A.+Christopoulos&title=Advances+in+G+protein-coupled+receptor+allostery%3A+from+function+to+structure&doi=10.1124%2Fmol.114.094342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.094342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.094342%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520G%2520protein-coupled%2520receptor%2520allostery%253A%2520from%2520function%2520to%2520structure%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26issue%3D5%26spage%3D463%26epage%3D478%26doi%3D10.1124%2Fmol.114.094342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S. D.</span>; <span class="NLM_string-name">Beshore, D. C.</span>; <span class="NLM_string-name">Di Marco, C. N.</span>; <span class="NLM_string-name">Greshock, T. J.</span></span> <span> </span><span class="NLM_article-title">Benzoquinazolinone Derivatives as M<sub>1</sub> Receptor Positive Allosteric Modulators and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases</span>. <span class="NLM_patent">WO 2010/059773</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=C.+N.+Di+Marco&author=T.+J.+Greshock&title=Benzoquinazolinone+Derivatives+as+M1+Receptor+Positive+Allosteric+Modulators+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DBenzoquinazolinone%2520Derivatives%2520as%2520M1%2520Receptor%2520Positive%2520Allosteric%2520Modulators%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadam, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A. L.</span></span> <span> </span><span class="NLM_article-title">A Series of 2,4,5-trisubstituted oxazole: synthesis, characterization and DFT modelling</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1114</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2016.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2Fj.molstruc.2016.02.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1114&publication_year=2016&pages=181-188&author=V.+S.+Kadamauthor=S.+G.+Shaikhauthor=A.+L.+Patel&title=A+Series+of+2%2C4%2C5-trisubstituted+oxazole%3A+synthesis%2C+characterization+and+DFT+modelling&doi=10.1016%2Fj.molstruc.2016.02.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2016.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2016.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DKadam%26aufirst%3DV.%2BS.%26aulast%3DShaikh%26aufirst%3DS.%2BG.%26aulast%3DPatel%26aufirst%3DA.%2BL.%26atitle%3DA%2520Series%2520of%25202%252C4%252C5-trisubstituted%2520oxazole%253A%2520synthesis%252C%2520characterization%2520and%2520DFT%2520modelling%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2016%26volume%3D1114%26spage%3D181%26epage%3D188%26doi%3D10.1016%2Fj.molstruc.2016.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed sequential C-N/C-O bond formations: synthesis of oxazole derivatives from amides and ketones</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">5906</span>– <span class="NLM_lpage">5909</span>, <span class="refDoi"> DOI: 10.1021/ol502916a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol502916a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5906-5909&issue=22&author=M.+Zhengauthor=L.+Huangauthor=H.+Huangauthor=X.+Liauthor=W.+Wuauthor=H.+Jiang&title=Palladium-catalyzed+sequential+C-N%2FC-O+bond+formations%3A+synthesis+of+oxazole+derivatives+from+amides+and+ketones&doi=10.1021%2Fol502916a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fol502916a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol502916a%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DPalladium-catalyzed%2520sequential%2520C-N%252FC-O%2520bond%2520formations%253A%2520synthesis%2520of%2520oxazole%2520derivatives%2520from%2520amides%2520and%2520ketones%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26issue%3D22%26spage%3D5906%26epage%3D5909%26doi%3D10.1021%2Fol502916a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desiraju, G. R.</span></span> <span> </span><span class="NLM_article-title">Strong and weak hydrogen bonds in the protein–ligand interface</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1002/prot.21253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1002%2Fprot.21253" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=128-141&author=S.+K.+Panigrahiauthor=G.+R.+Desiraju&title=Strong+and+weak+hydrogen+bonds+in+the+protein%E2%80%93ligand+interface&doi=10.1002%2Fprot.21253"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fprot.21253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21253%26sid%3Dliteratum%253Aachs%26aulast%3DPanigrahi%26aufirst%3DS.%2BK.%26aulast%3DDesiraju%26aufirst%3DG.%2BR.%26atitle%3DStrong%2520and%2520weak%2520hydrogen%2520bonds%2520in%2520the%2520protein%25E2%2580%2593ligand%2520interface%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2007%26volume%3D67%26spage%3D128%26epage%3D141%26doi%3D10.1002%2Fprot.21253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">Calculated using ChemDraw Ultra 12.0 Tools.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pajouhesh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G. R.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span>. <i>NeuroRx</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&issue=4&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eb4utqOLbGNx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26issue%3D4%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulation of G protein-coupled receptors</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.47.120505.105159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=17009927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=1-51&author=L.+T.+Mayauthor=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+modulation+of+G+protein-coupled+receptors&doi=10.1146%2Fannurev.pharmtox.47.120505.105159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of G protein-coupled receptors</span></div><div class="casAuthors">May, Lauren T.; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-51</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a significant growth in the identification of allosteric modulators of G protein-coupled receptors (GPCRs), i.e., ligands that interact with binding sites that are topog. distinct from the orthosteric site recognized by the receptor's endogenous agonist.  Because of their ability to modulate receptor conformations in the presence of orthosteric ligand, allosteric modulators can "fine-tune" classical pharmacol. responses.  This is advantageous in terms of a potential for engendering greater GPCR subtype-selectivity, but represents a significant challenge for detecting and validating allosteric behaviors.  Although allosteric sites need not have evolved to accommodate endogenous ligands, there are a no. of examples of where such modulators have been shown to contribute to physiol. or pathophysiol. processes.  Studies are also beginning to unravel the structural basis of allosteric modulation of GPCRs.  It remains to be detd. whether such modulation represents interactions within monomers vs. across dimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6rgFXhej3ibVg90H21EOLACvtfcHk0lhqm6rri4audA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D&md5=848fa85abdfb3b40834887416479edec</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105159%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520modulation%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D1%26epage%3D51%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dallagnol, J. C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducatti, D. R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noseda, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, M. E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, A. G.</span></span> <span> </span><span class="NLM_article-title">Aqueous semisynthesis of C-glycoside glycamines from agarose</span>. <i>Beilstein J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1222</span>– <span class="NLM_lpage">1229</span>, <span class="refDoi"> DOI: 10.3762/bjoc.13.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.3762%2Fbjoc.13.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=28694868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKku7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1222-1229&author=J.+C.+C.+Dallagnolauthor=A.+Orsatoauthor=D.+R.+B.+Ducattiauthor=M.+D.+Nosedaauthor=M.+E.+R.+Duarteauthor=A.+G.+Gon%C3%A7alves&title=Aqueous+semisynthesis+of+C-glycoside+glycamines+from+agarose&doi=10.3762%2Fbjoc.13.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Aqueous semisynthesis of C-glycoside glycamines from agarose</span></div><div class="casAuthors">Dallagnol, Juliana C. Cunico; Orsato, Alexandre; Ducatti, Diogo R. B.; Noseda, Miguel D.; Duarte, Maria Eugenia R.; Goncalves, Alan G.</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1222-1229</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">Agarose was herein employed as starting material to produce primary, secondary and tertiary C-glycoside glycamines, including mono- and disaccharide structures.  The semisynthetic approach utilized was generally based on polysaccharide-controlled hydrolysis followed by reductive amination.  All reactions were conducted in aq. media and without the need of hydroxyl group protection.  We were able to identify optimal conditions for the reductive amination of agar hydrolysis products and to overcome the major difficulties related to this kind of reaction, also extending it to reducing anhydrosugars.  The excess of ammonium acetate, methyl- or dimethylamine, and the use of a dild. basic (pH 11) reaction media were identified as important aspects to achieve improved yields, as well as to decrease the amt. of byproducts commonly related to reductive amination of carbohydrates.  This strategy allowed the transposition of the 3,6-anhydro-α-L-galactopyranose unit (naturally present in the agarose structure) to all glycamines synthesized, constituting an amino-substituted C-threofuranoside moiety, which is closely related to (+)-muscarine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRHRRWDV_sw7Vg90H21EOLACvtfcHk0lhqm6rri4audA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKku7rP&md5=c6fd6d9e0b8c9f0f9b949d0ba8a015fa</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.13.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.13.121%26sid%3Dliteratum%253Aachs%26aulast%3DDallagnol%26aufirst%3DJ.%2BC.%2BC.%26aulast%3DOrsato%26aufirst%3DA.%26aulast%3DDucatti%26aufirst%3DD.%2BR.%2BB.%26aulast%3DNoseda%26aufirst%3DM.%2BD.%26aulast%3DDuarte%26aufirst%3DM.%2BE.%2BR.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DA.%2BG.%26atitle%3DAqueous%2520semisynthesis%2520of%2520C-glycoside%2520glycamines%2520from%2520agarose%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2017%26volume%3D13%26spage%3D1222%26epage%3D1229%26doi%3D10.3762%2Fbjoc.13.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulators of the adenosine A<sub>1</sub> receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4543</span>– <span class="NLM_lpage">4547</span>, <span class="refDoi"> DOI: 10.1021/jm9002582</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9002582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVyntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4543-4547&author=L.+Aurelioauthor=C.+Valantauthor=B.+L.+Flynnauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Allosteric+modulators+of+the+adenosine+A1+receptor%3A+synthesis+and+pharmacological+evaluation+of+4-substituted+2-amino-3-benzoylthiophenes&doi=10.1021%2Fjm9002582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Modulators of the Adenosine A1 Receptor: Synthesis and Pharmacological Evaluation of 4-Substituted 2-Amino-3-benzoylthiophenes</span></div><div class="casAuthors">Aurelio, Luigi; Valant, Celine; Flynn, Bernard L.; Sexton, Patrick M.; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4543-4547</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aminobenzoylthiophenes I [R = H, Cl; R1 = Ph, 3-F3CC6H4, 2-FC6H4, 3-FC6H4, 4-FC6H4, 3-ClC6H4, 4-ClC6H4, 3-BrC6H4, 4-BrC6H4, 4-IC6H4, 3-O2NC6H4, 4-O2NC6H4, 3-MeOC6H4, 4-MeOC6H4, 3,5-(F3C)2C6H3, 2-naphthyl] are prepd. either by titanium tetrachloride-mediated condensation of benzoylacetonitriles 4-RC6H4COCH2CN with acetophenones R1COMe followed by Ewart reactions with diethylamine and elemental sulfur in 3-40% yields or (in one case) by alkylation of benzoylacetonitrile with phenacyl bromide followed by cyclocondensation with sodium hydrosulfide in 60% yield.  I are tested for their ability to potentiate the modulation of the adenosine A1 receptor by the nonracemic phenylisopropyladenosine (R)-PIA; I [R = H; R1 = 3-F3CC6H4, 3,5-(F3C)2C6H3] are also tested for their abilities to potentiate the ability of (R)-PIA to activate adenosine A1 receptors for phosphorylation of ERK1/2 and for binding of an ATP analog to G protein α subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcV7jIOeR9RLVg90H21EOLACvtfcHk0lhqm6rri4audA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVyntb4%253D&md5=e91b1e7e8623c110a795c4a42d694af2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm9002582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9002582%26sid%3Dliteratum%253Aachs%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DFlynn%26aufirst%3DB.%2BL.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DAllosteric%2520modulators%2520of%2520the%2520adenosine%2520A1%2520receptor%253A%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%25204-substituted%25202-amino-3-benzoylthiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4543%26epage%3D4547%26doi%3D10.1021%2Fjm9002582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Assessing the distribution of parameters in models of ligand–receptor interaction: to log or not to log</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/S0165-6147(98)01240-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=10.1016%2FS0165-6147%2898%2901240-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=9786022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVegsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=351-357&issue=9&author=A.+Christopoulos&title=Assessing+the+distribution+of+parameters+in+models+of+ligand%E2%80%93receptor+interaction%3A+to+log+or+not+to+log&doi=10.1016%2FS0165-6147%2898%2901240-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log</span></div><div class="casAuthors">Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">351-357</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">It is quite common to see exptl. data analyzed according to a variety of models of ligand-receptor interaction.  Often, parameters derived from such models are compared statistically.  The most commonly employed statistical analyses contain explicit assumptions about the underlying distributions of the model parameters being compared, yet the validity of these assumptions is not often ascertained.  In this article, the author describes a general approach to Monte Carlo simulation of data, and outlines how the anal. of such simulated data may be used to address the question of the distribution of model parameters.  The results of such an exercise can guide the researcher to the appropriate choice of statistical test or data transform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGOgQrRExRnLVg90H21EOLACvtfcHk0lijYMbgsdS5sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVegsbg%253D&md5=c3f511b88eb38830ec5049e085e02306</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2898%2901240-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252898%252901240-1%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAssessing%2520the%2520distribution%2520of%2520parameters%2520in%2520models%2520of%2520ligand%25E2%2580%2593receptor%2520interaction%253A%2520to%2520log%2520or%2520not%2520to%2520log%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26issue%3D9%26spage%3D351%26epage%3D357%26doi%3D10.1016%2FS0165-6147%2898%2901240-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i101"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01812">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62575"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01812">10.1021/acs.jmedchem.7b01812</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Table with shift values of ACh potency (ΔpEC<sub>50</sub>) and baseline (Δbaseline) of the graphs in <a id="rightTab-" class=" internalNav" href="#fig3">Figures <a id="rightTab-" class=" internalNav" href="#fig3">3</a></a> and <a id="rightTab-" class=" internalNav" href="#fig4">4</a> at 1 and 10 μM; binding and functional response curves for compounds <b>1</b>, <b>2</b>, <b>3</b>, <b>6a</b>, <b>6o</b>, <b>15b</b>, <b>15d</b>, <b>24e</b>, <b>29h</b>; spectral data for all tested derivatives (<sup>1</sup>Η and <sup>13</sup>C NMR, HRMS, and LCMS retention times) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_001.pdf">jm7b01812_si_001.pdf (417.82 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01812/suppl_file/jm7b01812_si_002.csv">jm7b01812_si_002.csv (2.39 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01812&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01812" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01812" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a8055ac0a3cb2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
